Prof. Mayowa Ojo OWOLABI                                                 

OFFICE ADDRESS

Department of Medicine,

Faculty of Clinical Sciences,

University of Ibadan.

Email address: mayowaowolabi@yahoo.com

Telephone: +234 802 077 5595 and +234 807 8496 775

Postal Address: Department of Medicine, University College Hospital, Ibadan, 200001, Oyo State, Nigeria

ORCID

https://orcid.org/0000-0003-1146-3070

PERSONAL PROFILE

DATE OF BIRTH                               17 Novermber, 1973

GENDER                                            Male

COUNTRY OF CITIZEN                   Nigeria

CURRENT POSITION:                    Dean, Faculty of Clinical Sciences, University of Ibadan

Director, Center for Genomic and Precision Medicine, University of          Ibadan

EDUCATION  AND DEGREES    

1990 – 1997:  MBBS, University of Ibadan, Ibadan, Nigeria

2005 – 2006:  Doctor Medicinae, DrM, Charité University of Medicine, Berlin, Germany

2005 – 2006:  Doctor Medicinae, DrM, Humboldt University, Berlin, Germany

2005 – 2006:  Doctor Medicinae, DrM, Free University, Berlin, Berlin, Germany

2010:              Certificate in Epidemiology & Global Health, University of Dundee, Scotland, UK

2009 – 2011:  M.Sc. Biomedical Education with distinction, University of Ibadan, Ibadan, Nigeria

2021               Foundation Doctor of Medicine MD degree, National Postgraduate College of Nigeria

FELLOWSHIPS

Fellow, National Postgraduate Medical College of Nigeria in Neurology, FMCP, 2005.  

Fellow of the American Academy of Neurology, FAAN, 2017

Fellow of the Academy of Science (Nigeria) , FAS, 2018

Fellow of the American Neurological Association, FANA, 2018

Fellow, Royal College of Physicians (London), FRCP, 2019

Foundation Fellow of the Academy of Medical Specialties of Nigeria, FAcadMedS, 2021

PROFESSIONAL AND GRADUATE TRAINING

1997 – 1998      House Officer, University College Hospital (UCH), Ibadan, Nigeria.

1999 – 2002      Registrar, University College Hospital, Ibadan, Nigeria, National Postgraduate Medical College of Nigeria.

2002 – 2006      Senior Registrar and Chief Resident,Neurology Unit, Dept. of Medicine, UCH, Ibadan, Nigeria. National Postgraduate Medical College of Nigeria

2004 – 2006      DAAD Research Scholar and Clinical Fellow,Department of Neurology, Charité,  Germany.

ACADEMIC AND ADMINISTRATIVE POSITIONS HELD

1997 – 1998      House Officer, University College Hospital (UCH), Ibadan, Nigeria.

1998 – 1999      Medical Officer and Youth Corper, General Hospital, Kontagora, Nigeria

1999 – 2002      Registrar, University College Hospital, Ibadan, Nigeria

2002 – 2006      Senior Registrar and Chief Resident, Neurology Unit, Dept. of Medicine, UCH, Ibadan, Nigeria.

2002 – 2004      Physician/Investigator, Ibadan-Indianapolis Dementia Research Project

2005 – 2006      Consultant Neurologist, Federal Medical Center, Abeokuta, Nigeria.

2006 – now       Honorary Consultant Neurologist, University College Hospital, Ibadan, Nigeria

2006 – 2009:   Lecturer 1, Neurology Unit, Department of Medicine, University of Ibadan, Nigeria.

2011 – 2012:   Postgraduate Programs Coordinator, Department of Medicine, University of Ibadan, Nigeria

2010 – 2012:   Faculty Representative on Technical and Research Training Sub-committee, University of Ibadan.

2012 – 2014:   Sub- Dean (Postgraduate), Faculty of Clinical Sciences, University of Ibadan, Nigeria

2009 – 2014:   Senior Lecturer, Neurology Unit, Department of Medicine, University of Ibadan,  Nigeria.

2009 – 2014:   Congregation Representative in the Senate, University of Ibadan

2014 – now:    Professor, Department of Medicine, University of Ibadan

2016- 2017      Abstract reviewer for College Research Day, College of Medicine, University of Ibadan

2016 – 2017    Pioneer Chair, Clinical Skills laboratory, University of Ibadan

2016 – now:    Pioneer Director, Center for Genomic and Precision Medicine, University of Ibadan

2018  –             Dean, Faculty of Clinical Sciences, University of Ibadan.

AWARDS AND DISTINCTIONS

  1. UNIVERSITY AND NATIONAL

1990- 1991: Faculty prize/Undergraduate scholarship, Faculty of Basic Medical Sciences

1991/1992:  Departmental prize in Anatomy

1991/1992:  May and Baker prize for best student in Preclinical Medical School

1997:            Best student in Medicine (Part IV MBBS exam ).

1997:            Ekpo Eyo prize in Medicine and Radiology

2002 :           Best result in, (National Postgraduate Medical College of Nigeria) FMCP Part I Faculty of  Internal Medicine examination.

2005 :           Dr. A.E. Ohwovoriole Endowed Prize for the best candidate in Part II FMCP Exams,

2008:             Mac Arthur Foundation Research Grant for “Doppler Ultrasound Studies of the Carotid

2011              Arteries in Patients with Stroke and Transient Ischemic Attack (TIA)” $17,700

                      Award of Excellence for the Best Project in M.Sc. Biomedical Education (Pioneer set).

2002    Member, West African College of Physicians (MWACP)

2005    Fellow, National Postgraduate Medical College of Nigeria in Neurology (FMCP)

2017    Co-Founder, Nigerian Federation for Neurorehabilitation

2018    Fellow Academy of Science (Nigerian Academy of Science)

  • INTERNATIONAL RECOGNITION AND CONSULTANCY

2004 -2006     Awarded DAAD (German Academic Exchange Programme) research fellowship/scholarship for deepening of knowledge in neurology in Berlin

2008 –  now      Pioneer Regional Vice President (Sub-Sahara Africa) World Federation for NeuroRehabilitation

2008 –   now     Secretary, Specialist Interest Group, Clinical Pathways, World Federation for NeuroRehabilitation (WFNR)

2008                 American Academy of Neurology International Scholarship Award

2011                 AU-TWAS (African Union and The World Academy of Sciences ) Young Scientist National Award Winner (Earth and Life Sciences).

2011                 Winner of the 2011 Interacademy Medical Panel (IAMP) International Award for Young Physician Leaders. World Health Summit, Berlin, Germany.

2012                 American Academy of Neurology Palatucci Advocacy Leadership Award.

2012                 First Runner up for the WCNR Early Career Development Award for the Best Oral Presentation at the WCNR 2012 (Melbourne, Australia)

2012                 NIH grant for Tailored Hospital-based Risk Reduction to Impede Vascular Events after Stroke (THRIVES) THRIVES study (Co-PI)

2013                The NIH-funded Medical Education Partnership In Nigeria (MEPIN)-linked Neurologic oUtcome MEasurement in Research for Intervention and Care (NUMERIC) NIH grant. (Co-Investigator)

2013                NIH Center Grant for Stroke Investigative Research and Educational Network (SIREN) Project- Principal Investigator.

2011-2014        Reviewer for Grant Applications to the Grant Review Board, Health and Health Services Research Fund, Hong Kong.

2014                Pioneer chair of the H3Africa Cardiovascular Diseases Working Group. the  largest cohort (>55,000) for cardiovascular diseases in Africa.

  •            Chair, H3Africa Cardiovascular Workshop Organizing Committee, (Stellenbosch)

2011-2016        Reviewer for Grant Applications to the Grant Review Board, Health and Health Services Research Fund, Hong Kong, China.

2015- now        Co-chair Joint Publications Committee: Global Alliance for Chronic Diseases

2015- now        Foundation Chair,  Control Unique to CVDs In LMICs (COUNCIL) Initiative

2016 – now       Lead Co-Chair, WHO-Lancet Commission on stroke in LMIC

2016 – now       Collaborator, Member, stroke expert panel, Global Burden of Diseases

2016 – now      Reviewer for UK-Malaysia Newton Fund Non-Communicable Diseases

2016 – now      Reviewer for Grant Applications to UK-MRC;

2016-2018       Honorary member of Advisory Committee, 10th World Congress of Neurorehabilitation,

2017                Congress President, First Conference for Neurorehabilitation in East, West and Central Africa February 28 to March 2, 2017. Neurorehabilitation in Africa: Adaptions and Innovations.

2017                Vice President, Nigerian Federation of NeuroRehabilitation

2018                Vice-Chair: American Heart Association Scientific Statement Committee on “Stroke in people of African Ancestry”

2017                Reviewer, Grant applications to National Heath Service (NHS), National Institute for Health Research (NIHR), UK

2017-               Lead Guest Editor ‘Behavioural Neurology’ Special issue on ‘Behavioural and Cognitive Effects of Cerebrovascular Diseases

2017                Fellow American Academy of Neurology

2017                Council Member, World Hypertension League

2018                Consulting Editor, eNeurologicalSci

2018                Member of the Presidium, World Federation for NeuroRehabilitation (WFNR)

2018                Representative of the WFNR on Global Rehabilitation Alliance

2018                Director, Stroke Control Innovations Initiative Of Nigeria (SCIION)

2018                Member, Global Burden of Stroke Group, World Stroke Organization

2018                Member, Expert Review Group, Wellcome Trust, UK

2018                Fellow, American Neurological Association

2019                Fellow, Royal College of Physicians (London) 

2019                Member, Movement Disorders Society 

2019-2021       Regional Office Director ,World Hypertension League  Sub-Saharan Africa,

2020-               Nature Driving Global Impact Award Judging Panel member

2020-               Member, Board of Directors, World Stroke Organization

2020-               Member, Publications Committee, World Federation of Neurology

2020                 2020 Paul Dudley White Award for best abstract from Nigeria at the International Stroke Conference

2020                 WHO Rehabilitation Programme on the development of the Package of Interventions for Rehabilitation (PIR). member of the Development Group for Parkinson’s Disease.

2020-2022     STROKE Quality and Outcomes Committee of the Stroke Council for the term beginning 7/1/2020 and ending 6/30/2022.

2020               Scientific Advisory Board of the Non-Communicable Diseases – Genetic Heritage Study (NCD-GHS) Consortium

2020-2023    Member Board of Directors, the World Hypertension League

2020              Member, World Stroke Organization Guidelines committee

2020       Member, 2021 World Stroke Congress Scientific Program Committee

2020        MT Thrombectomy 2020, West African Regional Director and Board Member

2020          Member, National Institute of Health Research (NIHR), UK Global Health Research Groups Funding Committee.

2020           WHO Rehabilitation Programme on the development of the Package of Interventions for Rehabilitation (PIR). member of the Development Group for Dementia

2021        Member, College of Experts, International Society of Hypertension

2021         Member, Global Policy Committee, World Stroke Organization

  • INTERNATIONAL LINKAGES
  1. Kwame Nkruma University of Science and Technology, Kumasi, Ghana
  2. University of Ghana, Ghana
  3. Medical University of South Carolina, USA
  4. University of Alabama at Birmingham, USA
  5. University of Kentucky, USA
  6. New York University, USA
  7. Monash University, Australia
  8. University of Melbourne, Australia
  9. University of Cambridge, UK
  10. World Health Organization
  11. World Federation for Neurorehabilitation

MEMBERSHIP OF RESEARCH AND PROFESSIONAL SOCIETY

  • Member, Nigerian Medical Association
    • Fellow, National Postgraduate Medical College of Nigeria
    • Member, Nigerian Hypertension Society
    • Member, West African College of Physicians
    • Member, Society of Neuroscientists of Africa
    • Member, Society for Neuroscience
    • Member, Nigerian Society of Neurological Sciences,- Secretary, Strategic planning Committee
    • Member, International Brain Research Organisation
    • Member, Pan-African Association of Neurological Sciences
    • Member Neurology training for East Africa Working Group, school of medicine, Yale University, USA.
    • Member/leader AHA, AAN Core group; guidelines for the management of hypertension in developing countries.
    • Member, Medical Association, Berlin (Ärztekammer Berlin), 2005-2006.
    • Member, DAAD (German Academic Exchange) Alumni Association
    • European Federation of Neurological Societies (EFNS): Member of the Faculty and governing body, Regional Training Courses in Africa
    • American Academy of Neurology (Corresponding Active Member), 2008.
    • Member, International Prevention Research Institute (IPRI) Alumni Association
    • Member, Departmental Postgraduate Committee, 2010.
  • Secretary, Specialist Interest Group, Clinical Pathways, World Federation for NeuroRehabilitation (WFNR) 2006-   now      
  • Pioneer Regional Vice President (Sub-Sahara Africa) World Federation for  NeuroRehabilitation 2006-  now      
  • WFNR Special Grant for the Establishment of the first Center for Neurorehabilitation Services, Research and Training in East, West and Central Africa, 2010.
    • Member Medical and Dental Consultants Association of Nigeria (MDCAN) Research Committee, 2010-2012.
    • Foundation Member: World Federation of Neurology Outcomes Research Working Group, 2012.
    • Member, Global Alliance for Chronic Diseases (GACD), 2012.

PEER-REVIEWER AND EDITORIAL BOARD MEMBER FOR JOURNALS

Editorial Board Membership

2010 – date     West Indian Medical Journal

2012 – date     World Journal of Neurology

 2014 – date    Journal of the Neurological Sciences (Flagship Journal of the World Federation of Neurology),

2016- date      International Journal of Stroke

2017- date      Lead Guest Editor ‘Behavioural Neurology’ Special issue on ‘Behavioural and Cognitive Effects of Cerebrovascular Diseases

2017                Lead Guest Editor: eNS Special Issue on Neurological Rehabilitation

2018                Consulting Editor, eNeurologicalSci

2018                Journal of Stroke Medicine

2018                Associate Editor, BMC Neurology

2018- Lead Guest Editor, Special Issue of Frontiers in Neurology :Translating innovations in stroke rehabilitation to improve recovery and quality of life across the globe

2018- Guest Editor, Special Issue of Frontiers in Genetics : The Genetic and Environmental Basis for Diseases in Understudied Populations

2020       Neurorehabilitation

Peer Reviewer

2010– date    Reviewer for Stroke, NeuroRehabilitation, Disability and Rehabilitation, Neuropsychiatric Disesases and Treatment, Stroke Research and Treatment, Atherosclerosis, Neurology, European Journal of Neurology, Neuroepidemiology, Clinical Neurology and Neurosurgery, Journal of the Neurological Sciences, Biomedical Central Neurology, International Journal of Stroke, Perspectives on Medical Education, Nigerian Journal of Cardiology, Nigerian Journal of Clinical Practice, Health Economics Review, African Journal of Pharmacy and Pharmacological Research,  African Journal of Medicine and Medical Science, Nigerian Journal of Medicine, Biomedical Central, Ethnicity and Diseases and International Stroke Congress abstracts.

TEACHING EXPERIENCE

  1. UNDERGRADUATE TEACHING:

Teaching, examination and mentorship of undergraduate medical (300 level to 600 level), dental and pharmacy students including delivery of didactic lectures in neurology and internal medicine, as well as bedside teachings, seminars and tutorials since employment by the University including five years at Senior lecturer level. Conduction of clinical teaching during ward rounds and in specialist clinics. Presently coordinating Medicine 1 posting with the HOD. Convener, grand rounds in the Department of Medicine.

  1. Curriculum development, Postgraduate: Reactivation and rejuvenation of the Masters of Medicine Curriculum, approved by the Senate of the University of Ibadan (2014). Internal/External Examiner for PhD in Neurophysiotherapy, Department of Physiotherapy, University of Ibadan 2010, 2011, 2012
  1. Clinical Skills Laboratory: Member of the College of Medicine committee on the Clinical skills laboratory; developed the proposal for the clinical skills laboratory in collaboration with others. This is initially for undergraduate teaching but will be useful later on for postgraduate teaching.
  1. Subdean Postgraduate, Faculty of Clinical Sciences (2012 to 2014): During the period mentioned above, the Faculty had 6 postgraduate diploma students, 215 Master’s degree students, and 59 doctoral degree students.Several postgraduate curricular were also developed and approved at the Senate while many others from various departments are at various stages in the pipeline including eight already approved at the postgraduate school.  We also re-organized the Postgraduate student records in the Faculty.  The pro-forma for capturing biodata, contact information and progress of postgraduate students was re-designed. A folder was opened for each postgraduate student and kept in a secure cabinet. Data from each student’s file was compiled into a Masters’ degree or doctoral degree Excel database. This has made it easy to track the progress of Postgraduate students in the Faculty thereby facilitating timely completion of their studies.
  • POSTGRADUATE PROJECTS SUPERVISED AND COMPLETED
  1. Development and Psychometric Testing of Ibadan Stroke Specific pain scale. Oladunni Caroline Osundiya. PhD Thesis Neurophysiotherapy. Matric Number 125722 Defence date:30 th September, 2014 External examiner: Prof. Rufus Adedoyin, Obafemi Awolowo University, Ile Ife, Nigeria
  2. Efficacy of Cognitive rehabilitation therapy on post-stroke depression among first ever stroke survivors in Ibadan. Olugbemi OLUKOLADE. PhD Thesis Matric No: 136605 Defence date 14 October 2014: External examiner: Prof. B. Y. Oladimeji, Department of Mental Health, Obafemi Awolowo University Ile-Ife.
  3. A 12-month pattern and interrelationships of motor performance, functional activity, societal participation and health-related quality of life after stroke (PhD Thesis). Miss Grace PETERS (Matric Number: 86534) .2010. Defence date 31st August, 2012: External examiner: Professor Emmanuel Maximim -Agha
  4. Development and evaluation of a primary health care-based physiotherapy programme for patients with stroke (PhD Thesis) Mrs. Olubukola A. OLALEYE (Matric number: 69806). 2009. Defence date 30th December, 2011: External examiner. Prof Rufus Adebukola Adedoyin, Obafemi Awolowo University, Ile-Ife, Nigeria
  5. A Study of Stroke in Southern Ghana: Epidemiology, Quality of Life and Community Perceptions. (PhD Thesis) Eric SAMPANE-DONKOR, University of Iceland, Iceland. 2010. Published ISBN 978-9935-9138-5-2 Defence date 12 February, 2015: External examiner: Prof. Adesola Ogunniyi
  6. Health-related quality of life in adults with Parkinson’s Disease in Nigeria (Part II FWACP Fellowship Dissertation): Dr Olaitan OKUNOYE. 2010.
  7. Assessment of Neurocognitive function in patients with chronic kidney disease stages 3 to 5 at the UCH Ibadan (Part II FMCP Fellowship Dissertation): Dr Uduak E. WILLIAMS. 2009.
  8. Factors militating against clinic attendance in epileptic patients in Ibadan (Part II FWACP Fellowship Dissertation): Dr Emmanuel O. EZUNU. 2010.
  9. Health- related quality of life adults with epilepsy in Ibadan (Part II FMCP Fellowship Dissertation): Dr Michael B. FAWALE. 2008.
  10. The outcome of stroke in Jos University Teaching Hospital (Part II FMCP Fellowship Dissertation): Dr Bertha C. EKEH. 2007.
  11. Frequency and effect of dysphagia on 30-day outcome in acute stroke patients at the University College Hospital, Ibadan. Part II FMCP Fellowship Dissertation Dr. Bode OLAJIDE, 2013.
  12. Frequency, associated risk factors and pattern of cognitive dysfunction in stroke survivors at three months: a case – control study        Dr  Funmilola TAIWO Dissertation: FMCP            2014
  13. The Relationship between Sickle Cell Trait, Stroke Severity and 30- Day Stroke Outcome. Part II FWACP Dissertation , Dr Paul OLOWOYO: 2015
  14.   Post-stroke Infections (Urinary Tract Infection and Pneumonia) and their Association With Short-Term Stroke Outcomes Dr Tomiwa MAKANJUOLA Part II Dissertation: WACP April 2019
  15.  Calibration of Clinical History Concerning Seizure Semiology in a Neurology Clinic in Nigeria: National Postgraduate Medical College of Nigeria: Dr Joseph YARIA(Part II FMCP Dissertation) May 2019.
  16. Sleep disorders and their effects on quality of life in Parkinson’s disease patients in Ibadan. Part II WACP Dissertation Dr Richard  OGUNTOYE October 2020.
  17.  Post-stroke pain: the frequency, profile , determinants and association with quality of life in stroke survivors seen at UCH Ibadan. WACPFellowshipDr Ayotunde BISI Dissertation, October 2020
  18. POSTDOCTORAL FELLOW

Onoja Matthew Akpa. H3Africa Cardiovascular Diseases Working Group. Harmonization of tool s and phenotypes for the genetic epidemiology of cardiovascular diseases in Africa involving > 55,000 research subjects. (2016 to 2018)

  •  POSTGRADUATE PROJECTS BEING SUPERVISED/CO-SUPERVISED
  1. Abiodun Moshood  Adeoye
  2. Callistus Akinleye ASSESSMENT OF GENETIC POLYMORPHISM AND ASSOCIATION WITH TYPE 2 DIABETES AMONG STROKE PATIENTS IN THE SIREN PROJECT From 2019. Matric number 129629
  1. Godwin Ogbole: Predictors of Delayed Neuroimaging in Acute Stroke Matric Number 63003 (MD Thesis) From Year 2014
  2. Folorunsho E. Awoniyi. Post-stroke apahasia and neurorehabilitation in SubSaharan Africa (PhD Thesis) Matric Number 72367 From Year 2016
  3. Development and psychometric properties of a new tool for measuring neuropathic pain in HIV/AIDS patients Alagoma Murtala IYAGBA (MD Thesis, Department of Medicine) Matric Number : 194051. Year 2016 till date.
  4. Predictors of weight reduction among Nigerian patients with obesity. Dr. Adetola M. Ogunbode (MD Thesis, Department of Medicine) From 2011 till date. Matric Number 54486.
  5. Determinants of Morbidity and Mortality in elderly patients on admission in UCH. Dr. ADEBUSOYE Lawrence. Matric number 49028. (MD Thesis)  From 2011.
  • EXAMINATION OF THESES
  1. AJAYI, Babatunde F, Matric number 57731, MPhil/PhD conversion examination 20 May, 2010: Effect of a 12-week endurance exercise program on cognitive function, mobility and quality of life of patients with dementia
  2. AJAYI, Babatunde F, Matric number 57731, PhD examination 25 August 2011: Effect of a 12-week endurance exercise program on cognitive function, mobility and quality of life of patients with dementia
  3. DADA, Olumide Olasunkanmi, Matric number 80481, PhD examination   11 April, 2012: Influence of sociodemographic and clinical characteristics on outcomes of constraint-induced movement therapy for upper limb function in hemiparetic stroke survivors.
  4. OSUALA Eunice Ogonna, Matric number 30566. PhD Examination 25 November, 2014. Effects of a Community Health Nurse-led Intervention of Knowledge, Attitude, and Lifestyle Towards Hypertension among Isunjaba Dwellers in Imo State 
  5. OLAIYA Muideen Tunbosun, Benefits and barriers to the implementation of a chronic disease management program in survivors of stroke. PhD Examination. University of Monash, Australia, July 2017
  6. Up to 49 PhDs held under my supervision as Sub-Dean Postgraduate, Faculty of Clinical Sciences, University of Ibadan.

RESEARCH FUNDING/GRANT AWARDS

  1. PI – Stroke Inpatient Rehabilitation Reinforcement of ACTivity (SIRRACT) University if Ibadan Senate Research Grant Number SRG/FCS/2010/1B, 2010-2014.  – 2,000,000 naira
  2. PI – Carotid Doppler ultrasound study in stroke patients to determine the pattern and associations of carotid atherosclerosis in stroke patients supported by the 2008 Mac Arthur Foundation Research Grant. Grant Number 800/406/54/01/D2008/2, 2008- 2012 -$17,700.
  3. Co-Investigator -Pattern and correlates of the metabolic syndrome among adult Nigerians funded by the 2009 Mac Arthur Multidisciplinary Research Grant. 2009- 2015
  4. Co-PI, Tailored Hospital-based Risk reduction to Impede Vascular Events after Stroke (THRIVES) . National Institutes of Health, USA Grant .U01NS079179, 2012-2018,  $2,126,772
  5. PI, Stroke Investigative Research & Educational Network (SIREN) U54 U54HG007479, 2013- 2018  $ 4,236,930 Collaborative Center Research Grant from National Institutes of Health (NIH), USA Grant (NINDS and NHGRI), H3Africa.
  6. Co-Investigator. Improving neurologic outcome measurement for interventional research in Ibadan. Neurologic  oUtcome Measurement in Research for Intervention and Care (NUMERIC) MEPI-linked R25 grant from NIH (NINDS).. R25NS080949 . 2012-2014 .           $541,507 .
  7. Co-Investigator. Ibadan Brain Bank. Ibadan (Dementia, Ageing and Neurodegeneration) Brain Bank [IBADAN Brain Bank] (College Research and Innovationation Management Unit CRIM Grant CTR16A012) 2016-2018, 1,000,000 million naira.
  8. Co-Investigator. Enhancing Capacity for Stroke Recognition, Documentation, Care and Prevention in Nigeria. Grant World Federation for Neurology/ World Stroke Organisation. 2013- 2015, $40,000.
  9. Principal Investigator: Stroke information and Surveillance System Grant. Center for Global Health Pilot Grant, Medical University of South Carolina, USA. 2017 to 2019. $20,000.
  10. Principal Investigator,  Systematic Investigation of Blacks with Stroke using Genomics (SIBS Genomics) R01. NIH . 2018 to 2022. R01NS107900 . > $1, 704, 193.00
  11. PI Africa-UK Collaboration for the genetic Epidemiology of Stroke (ACES). Academy of Medical Sciences Global Challenges Research Fund Networking Grant Scheme. GCRFNGR2\10190,   £25,000. 2018 to 2019
  1. Co- Investigator,  African Neurobiobank for Precision Stroke Medicine – (ELSI) Project . NIH . 2018 to 2022. 1U01HG010273 . >$412,588.00
  1. Mentor Future Leaders – African Independent Research (FLAIR) Fellowship. : African Innovative Genetics of Vascular Cognitive Impairment Study. Fellow: Akinyemi RO. African Academy of Sciences, the Royal Society and Global Challenges Research Fund (GCRF)£391,000 over two years. Role : Mentor
  1.  SIBS Gen Gen (NIH/NINDS) – (3R01NS107900-02S1). Facilitating Implementation Science within the SIBS Genomics Study $111,434 : PI: Owolabi
  1. H3Africa CVD Supplement (3U24HG009780-03S5)  -green leafy vegetables and cardiovascular diseases. >$95,201. PI: Owolabi
  1. Rockefeller Foundation and Bellagio Center funding for the first face to face meeting of the steering committee (27 members) the WHO WSO Lancet Neurology Commission on Stroke. >$40,000. PI Owolabi
  1. GCRF – University of Glasgow, UK/University of Ibadan, Nigeria (Ref. #: 308082) Pilot grant on Stroke inflammatory protein biomarkers. £75,000
  1. GCRF – ACES: Cambridge University, UK/University of Ibadan, Nigeria GCRFNGR2\10190 . £25,000
  1. NIH/NINDS – CaNVAS (1R01NS114045-01)… To discover Stroke copy number variations CNVs . Owolabi /Co-investigator
  • African Rigorous Innovative Stroke Epidemiological Surveillance (ARISES) R01NS115944-01 $2,160,000 (Role: PI)
  • Sub-Saharan Africa Conference on Stroke (SSACS) Conference 1R13NS115395-01A1– $50, 395 (Co-Chair)
  • ARUA-UKRI 600,000 Pounds Sterling. University of Ibadan Center of Excellence for NCDs (Role : Director)
  1. African Neurobiobank for Stroke Precision Medicine (ELSI) – (1U01HG010273)
  2. AAS/Royal Society & GCRF – Future Leaders African Independent Research (FLAIR) Fellowship : VCI
  3. NIH/NINDS – CaNVAS (1R01NS114045-01)… To discover Stroke copy number variations CNV
  4. $40,000. PI Owolabi

Pilot Collaborative Grants

  1. £75,000
  2. £25,000

1. Awarding Body: National Institute of Health, USA

Grant Holder: Prof Mayowa Owolabi

Title of Project: Systematic Investigation of Blacks with Stroke using Genomics (SIBS Genomics) – R01NS107900

Amount awarded: $ 1,704,193.00

Role on the project: Principal Investigator

Start date: 15/09/2018

End date: 31/08/2022

# of hours spent on grant – 11/week

2. Awarding Body: National Institutes of Health, USA

Grant Holder: Dr Rufus Akinyemi/Prof Oyedunni Arulogun (MPI)

Title of Project: African Neurobiobank for Precision Stroke Medicine (ELSI) – 1U01HG010273

Amount Awarded: >$412,588.00

Role on the project: Co-investigator

Start date: 21/09/2018

End date: 30/06/2022

# of hours spent on grant – 1/week

3.  Awarding Body: U54 Collaborative Center Research Grant from NIH (NINDS and NHGRI), H3 Africa. U54HG007479

Consortium (NIH and Wellcome Trust)

Grant Holder: Prof Owolabi, M.O

Title of Project: Stroke Investigative Research & Educational Network (SIREN)

Amount awarded: $ 4,236,930

Role on the project: Overall Principal Investigator

Start date: 20/09/2013

End date:31/07/2019

# of hours spent on grant – 4hrs/wk

4. Awarding Body: Academy of Medical Sciences Global Challenges Research Fund Networking Grant

Scheme. GCRFNGR2\10190

Grant Holder: Prof Mayowa Owolabi/Prof Hugh Markus

Title of Project: UK Collaboration for the genetic Epidemiology of Stroke (ACES)

Amount awarded: £25,000

Role on the project: Principal Investigator (LMIC)

Start date: 01/07/2018

End date: 31/12/2019

# of hours spent on grant – 1hr/week

5. Awarding Body: Center for Global Health Pilot Grant, Medical University of South Carolina, USA.

Grant Holder: Prof Mayowa Owolabi

Title of Project: Stroke Information and Surveillance System Grant

Amount awarded: $20,000

Role on the project: Principal Investigator

Start date: 01/01/2017

End date: 31/12/2019

# of hours spent on grant – 0.5/week

6. Awarding Body: (College Research and Innovation Management Unit CRIM Grant CTR16A012)

Grant Holder: Dr Rufus Akinyemi

Title of Project: Ibadan Brain Bank (Dementia, Ageing and Neurodegeneration)

Amount awarded: 1,000,000 Naira

Role on the project: Co-Investigator

Start date: 01/1/2016

End date: 31/12/2018

# of hours spent on grant – 0.5/week

7. Awarding Body: NINDS, NIH; Consortium: Global Alliance for Chronic Diseases

Grant Holder: Prof Ovbiagele, B

Title of Project: Tailored Hospital-based Risk reduction to Impede Vascular Events after Stroke (THRIVES)

Amount awarded: $2,126,772

Role on the project: Co-Principal Investigator

Start date: 01/05/2012

End date: 30/04/2018

# of hours spent on grant – 8hrs/wk

8. Awarding Body: Mac Arthur Multidisciplinary Research Grant

Title of Project: Pattern and correlates of the metabolic syndrome among adult Nigerians

Amount awarded: $17,000

Role on the project: Co-Investigator

Start date: 01/01/2009

End date: 31/12/2015

9. Awarding Body: World Federation for Neurology/ World Stroke Organisation

Grant Holder: Dr Rufus O Akinyemi

Title of Project: Enhancing Capacity for Stroke Recognition, Documentation, Care and Prevention in Nigeria

Amount awarded: $40,000

Role on the project: Co-Investigator

Start date: 01/01/2013

End date: 31/12/2015

10. Awarding Body: MEPI-linked R25 grant from NIH (NINDS – R25NS080949)

Grant Holder: Prof Adesola Ogunniyi

Title of Project: Neurologic oUtcome Measurement in Research for Intervention and Care (NUMERIC)

Amount awarded: $541,507

Role on the project: Co-Investigator

Start date:01/01/2012

End date: 31/12/2014

11. Awarding Body: University of Ibadan Senate

Grant Holder: Prof Mayowa Owolabi

Title of Project: Stroke Inpatient Rehabilitation Reinforcement of ACTivity (SIRRACT) Research – Grant Number

SRG/FCS/2010/1B

Amount awarded: 2,000,000 Naira

Role on the project: Principal Investigator

Start date: 01/01/2010

End date: 31/12/2014

12. Awarding Body: Mac Arthur Foundation Research Grant

Grant Holder: Prof Mayowa Owolabi

Title of Project: Carotid Doppler ultrasound study in stroke patients to determine the pattern and associations of carotid atherosclerosis in stroke patients. Grant Number 800/406/54/01/D2008/2

Amount awarded: $17,000

Role on the project: Principal Investigator

Start date: 01/01/2008

End date: 31/12/2012

PUBLICATIONS

DISSERTATION AND THESIS

  1. Owolabi, M.O. Ibadan-Berlin bicultural study of HRQOL in stroke patients using a new instrument. “Ibadan-Berlin interkulturelle Vergleichstudie von Lebensqualität bei

Schlaganfallpatienten unter Nutzung eines neuen krankheitsspezifischen

Messinstrumentes (HRQOLISP)” Berlin: Charité University of Medicine, Free University and Humboldt’s University, Berlin. 2010. (Doctoral Thesis for Doctor medicinae degree)

  1.  Owolabi, M.O. Health-related quality of life (HRQOL) in stroke patients using a new instrument. Ibadan: National Postgraduate Medical College of Nigeria: 2005. (Part II FMCP Dissertation.

ARTICLES THAT HAVE ALREADY APPEARED IN REFEREED CONFERENCE PROCEEDINGS

  1. Owolabi, M.O. (2010). HRQOLISP is more valid than SF-36. Medimond International Proceedings: Proceedings of the 6th World Congress of Neurorehabilitation. Vienna, Austria, March 21 to 25, 2010. Editors: Homberg, V., Binder, H. ISBN:978-88-7587-556-5. pages 177-181.

PATENTS:

Owolabi MO et al. ACCESS AIM Clear Canvas Patent. Patent Registration Number: NG/PT/NC/2016/2007 Online Application ID : OAI/PT/201608241411499‐236786‐264476

FULL JOURNAL PUBLICATIONS

AS RESIDENT DOCTOR/ LECTURER I

  • Talabi, O.A., Owolabi, M.O., and Osotimehin, B.O. (2003): Autoimmune diseases in a Nigerian woman – a case report. West African Journal of Medicine, 22 (4):361-363.
  • Owolabi, M.O., and Ogunniyi, A. (2004): Gelineau Syndrome: Literature Review and Management of a Nigerian Teenager.  African Journal of Neurological Sciences, 23:51-57.
  • Owolabi, M.O. (2004).  The scientific model of man: Unity, Duality or United Duality.  Rapid response in: Blanke, O. Out of body experiences and their neural basis. British Medical Journal, 329:1414-1415.
  • Owolabi, M.O., and Otegbayo, J.A. (2005): Gastroesophageal Reflux Disease: An Overview. Postgraduate Doctor Caribbean, 21:49-54.
  • Otegbayo, J.A., Talabi, O.A., Akere, A., Owolabi, M.O., Owolabi, L.F., and Oguntoye, O.O. (2006): Gastrointestinal complications in stroke survivors. Tropical Gastroenterology, 27(3):127-130.
  • Owolabi, M.O., Okechukwu, S.O., and Ogunniyi, A. (2007): Episodic vertigo resulting from vascular risk factors, cervical spondylosis and head rotation: two case reports.  Neuropsychiatric Disease and Treatment, 3(5):675–678.
  • Owolabi, M.O., Bower, J.H., and Ogunniyi, A. (2007): Mapping Africa’s way into prominence in the field of neurology. Archives of Neurology, 64(12):1696-1700. 
  • Ugoya, S.O, Ugoya, T.A., Puepet, F.H., Owolabi, M.O., Echejoh G.O., and Ogunniyi, A. (2008): The association between body mass index and diabetic peripheral neuropathy. Hungarian Medical Journal, 2(1):63- 68. 
  • Owolabi, M.O., Platz, T. (2008): Proposing the stroke levity scale: a valid, reliable, simple and time-saving measure of stroke severity. European Journal of Neurology, 15(6):627-633. 
  • Akinyemi, R.O., Okubadejo, N., Akinyemi, J.O., Owolabi, M.O., Owolabi, L.F., Ogunniyi, A (2008): Cognitive dysfunction in Nigerians with Parkinson’s disease. Movement Disorders, 23(10):1378-1383. 
  • Owolabi, M.O. (2008): Determinants of health-related quality of life in Nigerian stroke survivors. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102 (12):1219-1225. 
  • Owolabi, M.O. (2008): Episodic vertigo resulting from head rotation, in the presence of vascular risk factors and cervical spondylosis: an intriguing quartet? African Journal of Neurological Sciences, 27(1):1-8.
  • Owolabi, M.O. (2008): Health-related quality of life (HRQOL) measures. There are still many unanswered questions about human life. The Scientific World Journal: (TSW) Holistic Health and Medicine, 8:357–363. 
  • Owolabi, M.O., Ugoya S., Platz, T. (2009): Racial disparity in stroke risk factors: The Berlin-Ibadan experience – a retrospective study. Acta Neurologica Scandinavica, 119 (2):81-87.
  • Owolabi, M.O., Ogunniyi, A. (2009): Profile of health-related quality of life in Nigerian stroke survivors. European Journal of Neurology, 16:54-62. 
  • Owolabi, M.O., Ogbole, G.I., Lagunju, I. (2008): Conservative management of Rasmussen’s encephalitis in a Nigerian girl. Journal of Pediatric Neurology, 6:389-394.
  • Owolabi, M.O. (2009): Health-related quality of life and the seed of life model. Journal of Alternative Medicine Research, 1 (4):375-382.
  • Owolabi, M.O. (2009): Comparative analysis of the seed of life model and the classical ancient philosophies: Understanding the purpose of life. Journal of Alternative Medicine Research, 1 (4):383-390. 
  • Owolabi, M.O. (2009): Application of the seed of life model: concept of quality of life and the disability paradox. Journal of Alternative Medicine Research, 1(4):401-408.
  • Owolabi, M.O. (2009): Comparative analysis of the seed of life model: Examining the mind-brain puzzle and programming. Journal of Alternative Medicine Research, 1(4):391-400.
  • Akinyemi, R., Owolabi, M.O., Makanjuola, V.A., Ogunsehinde, A.O., Ogunniyi, A. (2009): Frontotemporal dementia in a Nigerian woman: case report and brief review of the literature. African Journal of Medicine and the Medical Sciences, 38 (1):71-75.

PUBLICATIONS AS A SENIOR LECTURER

  • Owolabi, M.O. (2010): Optimization of blood pressure in stroke patients. Tropical Journal of Nephrology, 5 (2):87-96.
  • Owolabi, M.O., Ipadeola, A., Adeleye, J.O. (2010): Aggregate cardiovascular risk is a stronger statistical correlate of clinically evident diabetic peripheral neuropathy than HbA1c alone. Journal of the National Medical Association, 108 (2):707-712.
  • Owolabi, M.O. (2010): Which is more valid for stroke patients: generic or stroke-specific quality of life measures? Neuroepidemiology, 34 (1):8-12. (DOI: 10.1159/000255460).
  • Owolabi, M.O. (2010): What are the consistent predictors of generic and specific post-stroke   health-related quality of life? Cerebrovascular Diseases, 29 (2)105-110(DOI: 10.1159/000262305).
  • Dobkin, B.H., Plummer-D’Amato, P., Elashoff, R., Lee, J.; Owolabi, M.O. among SIRROWS Group. (2010): International Randomized Clinical Trial, Stroke Inpatient Rehabilitation with Reinforcement of Walking Speed (SIRROWS), Improves Outcomes. Neurorehabilitation and Neural Repair,24 (3):235-142.
  • O’Donnell,M., Xavier, D., Diener, C., Sacco, R., Lisheng, L., Zhang, H., Pias, P., Truelsen, T., Chin, S.L.,  Rangarajan, S., DeVilliers, L., Damasceno, A., Mondo, C., Lanas, F., Avezum, A., Diaz, R., Varigos, J., Hankey, G.,  Teal, P.,  Kapral, M., Ryglewicz, D. , Czlonkowska, A., Skowronska, M.,  Lopez-Jaramillo, P.,  Dans, T., Langhorne, P. , Yusuf S., Owolabi, M.O. among INTERSTROKE investigators. (2010). Rationale and Design of INTERSTROKE: A Global Case-Control Study of Risk Factors for Stroke. Neuroepidemiology, 35 (1):36-44.
  • O’Donnell, M.J., Xavier, D., Liu, L., Zhang, H., Chin, S.L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M.J., Mondo, C., Damasceno, A., Lopez-Jaramillo,P., Hankey, G.J., Dans, A.L., Yusoff , K., Truelsen, T., Diener, H.C., Sacco, R.L., Ryglewicz, D., Czlonkowska, A., Weimar, C., Wang, X., Yusuf, S. Owolabi, M.O. among INTERSTROKE investigators.(2010). Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet, 376 (9735):112-123.
  • Fawale, M.B., Owolabi, M.O., Ogunbode, O. (2010): Bell’s palsy in pregnancy and the puerperum: a report of five cases. African Journal of Medicine and the Medical Sciences, 39 (2):147 -151.
  • Owolabi, M.O. (2010): Psychometric properties of the HRQOLISP-40: a novel shortened multi-culturally valid holistic stroke measure. Neurorehabilitation and Neural Repair, 24 (9):814-825 DOI:10.1177/1545968310369113.
  • Owolabi, M.O., Hamzat, T.K. (2010): Rehabilitation of the patient with neurological deficits. Archives of Ibadan Medicine, 10 (1-2):65-70.
  • Owolabi, L.F., Akinyemi, R.O., Owolabi, M.O., Sani, U.M., Ogunniyi, A (2010): Profile of epilepsy in elderly Nigerians. Archives of Ibadan Medicine, 11 (2):47-50.
  • Owolabi, M.O., Ogun, S. (2010): Recent advances in stroke. Archives of Ibadan Medicine, 11 (2):56-62.
  • Owolabi, M.O. (2011): Taming the burgeoning stroke epidemic in Africa: stroke quadrangle to the rescue. West Indian Medical Journal, 60 (4):412-421.
  • Owolabi, M. O. (2011). Impact of stroke on health-related quality of life in diverse cultures: The Berlin-Ibadan multicenter international study. Health and Quality of Life Outcomes, 9 (81):1-11. DOI:10.1186/1477-7525-9-81.
  • Owolabi, M.O. (2011). HRQOLISP-26: a concise, multiculturally-valid, multidimensional, flexible and reliable stroke specific measure. International Scholarly Research Notes-Neurology, 2011:1-9 Article ID 295096, doi:10.5402/2011/295096. 
  • Fabian, U.A., Charles-Davies, M.A., Adebusuyi, J.R., Ebesunun, M.O., Ajobo, M.T., Hassan, O.O., Adigun, K., Owolabi, M.O., Oyewole, O.O., Olaniyi, J.A., Fasanmade, A.A., Akinlade, S.K., Arinola, O.G. and Agbedana, E.O. (2011): Leptin concentrations in African blacks with metabolic syndrome and type 2 diabetes mellitus. Journal of US-China Medical Science, 8 (8): 493-500.
  • Owolabi, M.O., Ipadeola, A. (2012): Total vascular risk as a stronger correlate of severity of Diabetic Peripheral Neuropathy in Nigerian Africans. Ethnicity & Diseases, 22 (2012):106 -112.
  • Charles-Davies, M.A., Arinola, O.G., Fasanmade, A.A., Olaniyi, J.A., Oyewole, O.O., Owolabi, M.O., Hassan, O.O., Ajobo, M.T., Adigun, K., Akinlade, S.K., Adebusuyi, J.R., Ebesunun, M.O., Popoola, O.O., Okunbolade, W., Fabian, U.A., Rahamon, S.K., Ogunlakin, M.A., Agbedana, E.O. (2012): Indices of metabolic syndrome in 534 apparently healthy Nigerian traders. Journal of US-China Medical Science, 9 (2): 91-100.
  • Adeleye, A., Owolabi, M.O., Rabiu T.B., Orimadegun, A. (2012). Physicians’ knowledge of the Glasgow Coma Scale in Nigeria’s foremost university hospital: is the simple GCS still too complex? Frontiers in Neurology, 3 (28): 1-7. doi: 10.3389/fneur.2012.00028.
  • Ogah, O.S., Owolabi, M.O., Akisanya, C.O. (2012): Cervical spine tuberculosis and retropharyngeal abscess in an adult Nigerian. Annals of Tropical Medicine and Public Health, 5 (6): 587-590.
  • Ogah OS, Owolabi MO (2012). Cervical TB case report. Annals of Tropical Medicine and Public Health, 5:587-90. Availablefrom: http://www.atmph.org/text.asp?2012/5/6/587/109286.
  • Owolabi MO, Agunloye AM (2013). Risk factors for stroke among black hypertensives. Journal of the Neurological Sciences; 325(1-2):51-6.
  • Ogbole, G.I., Owolabi, M.O., Yusuf, B.P., (2013): White Matter Changes on Magnetic Resonance Imaging: a risk factor for stroke in an African population?  Journal of Stroke and Cerebrovascular Diseases, 22 (7): e227-233. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.003.
  • Owolabi, M. O., Agunloye, A.M. (2013): Risk factors for stroke among patients with hypertension: a case-control study. Journal of the Neurological Sciences, 325 (1-2):51-56. doi: 10.1016/j.jns.2012.11.016.
  • Owolabi, M.O. (2013): Consistent determinants of post-stroke health-related quality of life across diverse cultures: Berlin-Ibadan study. Acta Neurologica Scandinavica, 128 (5): 311-320.
  • Owolabi, M.O. (2013): Psychometric properties of the German version of the HRQOLISP. NeuroRehabilitation, 33 (2): 241-250.
  • Ojagbemi, A., Owolabi M. O. (2013): Predictors of functional dependency after stroke among survivors in Nigeria. Journal of Stroke and Cerebrovascular Diseases, 22 (8): e381-387. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.015.
  • Owolabi, L.F., Akinyemi, R.O., Owolabi, M.O., Ogunniyi, A., Sani, M.U. (2013): Epilepsy profile in adult Nigerians with late onset epilepsy secondary to brain tumor. Neurology Asia, 18 (1): 23 – 27.
  • Owolabi, L.F., Akinyemi, R.O., Owolabi, M.O., Sani, M.U., Ogunniyi, A. (2013): Profile of stroke-related late onset epilepsy among Nigerians. Journal of Medicine in the Tropics, 15 (1): 29 -32.
  • Williams, U., Owolabi, M.O., Ogunniyi, A., Ezunu, E.O. (2013): Prevalence and pattern of neurocognitive impairment in Nigerians with stages 3 to 5 chronic kidney disease. International Scholarly Research Notes-Neurology, 2013: 1-6. Article ID 374890, doi.org/10.1155/2013/374890.
  • Olaleye, O., Hamzat, T.K., Owolabi, M.O. (2013): Development and evaluation of the primary health care physiotherapy intervention and its effects on selected indices of stroke recovery. International Journal of Therapy and Rehabilitation, 20 (9):443-449.
  • Ojagbemi, A., Owolabi, M.O., Atalabi, M., Baiyewu, O. (2013): Stroke lesions and post-stroke depression among stroke survivors in Ibadan, Nigeria. African Journal of Medicine and Medical Sciences, 42:245-251.
  • Owolabi, M.O., Agunloye, A.M. (2013): Which risk factors are more associated with ischemic rather than hemorrhagic stroke in black Africans? Clinical Neurology and Neurosurgery, 115 (10):2069-2074.
  • Charles-Davies, M.A., Fasanmade, A.A., Olaniyi, J.A., Oyewole, O.E., Owolabi, M.O., Adebusuyi, J.R., Hassan, O., Ajobo, M.T., Ebesunun, M.O., Adigun, K., Akinlade, K.S., Fabian, U.A., Popoola, O.O., Rahamon, S.K., Okunbolade, W.,  Ogunlakin, M.A., Arinola, O.G., Agbedana, E.O. A. (2013): Metabolic Alterations in Different Stages of Hypertension in an Apparently Healthy Nigerian Population. International Journal of Hypertension, 2013: 1-6. Article ID 351357. http://dx.doi.org/10.1155/2013/351357.
  • Owolabi, M.O., Agunloye, A., Ogunniyi, A. (2013): The relationship of flow velocities to vessel diameters differs between extracranial carotid and vertebral arteries of stroke patients. Journal of Clinical Ultrasound, 42 (1): 16-23.
  • Vincent-Onabajo, G. O., Owolabi, M.O., Hamzat, T.K. (2014): Sensitivity and responsiveness to change of the health-related quality of life in stroke patients-40 (HRQOLISP-40) scale. Disability and Rehabilitation, 36 (12): 1014-1019.
  • Olaleye, A., Hamzat, T. K., Owolabi, M.O. (2014): Stroke rehabilitation: should physiotherapy intervention be provided at a primary health care centre or the patients’ place of domicile? Disability and Rehabilitation, 36 (1): 49–54. DOI: 10.3109/09638288.2013.777804.
  • Vincent- Onabajo, G., Hamzat, T.K., Owolabi, M.O. (2014): Are there gender differences in longitudinal patterns of functioning in Nigerian stroke survivors during the first year after stroke? NeuroRehabilitation, 34 (2): 297-304.
  • Owolabi, M.O., Afolabi, A., Omigbodun, A. (2014): Performance of Residents Serving as Clinical Teachers: A Student-Based Assessment. Journal of Graduate Medical Education, 6  (1): 123-126.
  • Agunloye, A.M., Owolabi, M.O. (2014): Exploring carotid ultrasonographic parameters associated with stroke risk among hypertensive stroke patients compared to hypertensive controls.  Journal of Ultrasound in Medicine, 33 (6): 975–983.
  • Owolabi, M.O.  (2014): Development and psychometric characteristics of a new domain of the Stanford Faculty Development Program instrument. The Journal of Continuing Education in the Health Professions, 34 (1): 13–20.
  • Rahamon, S.K., Charles-Davies, M.A., Akinlade, K.S., Olaniyi, J.A., Fasanmade, A.A. , Oyewole, O.E., Owolabi, M.O., Adebusuyi, J.R., Hassan, O.O., Ajobo, B.M., Ebesunun, M.O., Adigun, K., Fabian, U.A., Popoola, O.O., Okunbolade, W., Arinola, O.G., Agbedana, E.O. (2014): Impact of dietary intervention on selected biochemical indices of inflammation and oxidative stress in Nigerians with metabolic syndrome: a pilot study. European Journal of Nutrition & Food Safety, 4 (2): 137-149.
  • Okunoye O, Asekomeh G, Owolabi MO, Onwuchekwa A, Ogunniyi A. (2014) Profile of generic and diseases-specific health-related quality of life among Nigerians with Parkinson’s disease. The Nigerian Health Journal, 14 (2):79-86.
  • Ogunbode AM, Adebusoye LA, Olowookere OO, Owolabi MO and Ogunniyi A (2014). Factors associated with insomnia among elderly patients attending a geriatric centre in Nigeria. Current Gerontology and Geriatrics Research,  2014:1-10. Article ID 780535. http://dx.doi.org/10.1155/2014/780535
  • Owolabi MO, Agunloye A, Ogunniyi A (2014). Flow Dynamics of the Extracranial Carotid and Vertebral Arteries in Nigerian Patients with Stroke. J Clinical USS,  42(1):16-23. doi: 10.1002/jcu.22053.
  • Saposnik, G. , Chow C.M., Gladstone, D., Cheung, D., Brawer, E., Thorpe, K.E., Saldanha, A., Dang, A., Bayley, M., Schweizer, T.A.; iHOME Research Team for the Stroke Outcomes Research Canada Working Group (Saposnik, G., Bayley, M., Black, S.E., Butcher, K., Côté, R., Coutts, S.B., Demchuk, A.M., Dowlatshahi, D., Dukelow, S., Fang, J., Gladstone, D.J., Hachinski, V., Hakim, A., Hart, R., Hill, M.D., Jeerakathil, T., Kapral, M.K., Macdonald, L., Mamdani, M., Penn, A., Phillips, S.J., Schweizer, T.A., Shuaib, A., Silver, F.L., Smith, E., Sposato, L.A., Tamayo, A., Al-Hassan, K., Ameriso, S., Barinagarrementeria, F., Béjot, Y., Bernhardt, J., Bornstein, N., Brainin, M., Bryer, A., Bushnell, C., Caso, V., Chaturvedi, S., Cordonnier, C., Cramer, S., Cohen, L.G., Davis, S., de los Rios, F., Feigin, V., Ferro, J., Fisher, M., Ford, G.A., Johnston, C., Kim, A., Lavados, P., Massaro, A., Meretoja, A., Michel, P., Mosquera, A., Moustafa, R.R., Nilanont, Y., Norving, B., Ntaios, G., O’Donnell, M., Ossou-Nguiet, P.M., Masjuan, J., Ovbiagele, B., Owolabi, M.O., Ozdemir, O., Pandian, J.D., Park, T.H., Rabinstein, A.A., Robles, A., Sacco, R.L., Shelliger, P.D., Shinohara, Y., Silver, B., Strbian, D., Tatlisumak, T., Vergouwen, M.D., Wong, L.(2014).iPad Technology for Home Rehabilitation after Stroke (iHOME): A proof-of-concept randomized trial. International Journal of Stroke, 9 (7): 956–962.  doi: 10.1111/ijs.12328. Epub 2014 Jul 7. 
  • Fawale, M.B., Owolabi, M.O., Ogunniyi, A. (2014): Effects of Seizure Severity and Seizure Freedom on the Health-Related Quality of Life of an African Population of People with Epilepsy. Epilepsy & Behaviour, 32: 9-14. DOI: 10.1016/j.yebeh.2013.12.026.
  • Owolabi MO, Akinyemi RO, Gebregziabher M, Olaniyan O, Salako BL, Arulogun O, Ovbiagele B (2014). Randomized controlled trial of a multipronged intervention to improve blood pressure control among stroke survivors in Nigeria. Int J Stroke, 9(8):1109-16. doi: 10.1111/ijs.12331. Epub 2014 Jul 18. PMID: 25042605.
  • Vincent- Onabajo, G., Hamzat, T. K., Owolabi, M.O. (2014): Trajectory of motor performance over twelve months in Nigerian stroke survivors. Brain Impairment, 15 (1): 43-50 doi:10.1017/BrImp.2014.3.
  • Eric, S., Owolabi, M.O., Bampoe, P., Aspelund, T., Gudnason, V. (2014): Community Awareness of stroke in Accra, Ghana. BioMed Central Public Health, 14 (196): 1-14 doi:10.1186/1471-2458-14-196.
  • Okunoye, O. C., Asekomeh, G. E., Owolabi, M. O., Otike-Odibi, B. I. (2014): Determinants of health-related quality of life among Nigerian-Africans with Parkinson’s disease Port Harcourt Medical Journal, 8 (1): 50-60.
  • Owolabi, M.O., Ovbiagele, B. (2014): Global clinical neuroscience: Journey of a thousand miles begins with a single step. Journal of the Neurological Sciences, 344, 223 doi: 10.1016/j.jns.2014.06.011.
  • Eric, S., Owolabi, M. O., Bampoe, P., Aspelund, T., Gudnason, V. (2014): Profile and health related quality of life of Ghanaian stroke survivors. Clinical Interventions in Aging, 9:1701-1708.
  • Hurst S, Arulogun O, Owolabi MO, Akinyemi RO, Uvere E, Warth S, Ovbiagele B. (2014). Pretesting Qualitative Data Collection Procedures to Facilitate Methodological Adherence and Team Building in Nigeria. IJQM, 14: 1609-4069http://ejournals.library.ualberta.ca/index.php/IJQM/index
  • H3Africa Consortium including Owolabi, M.O. (2014): Enabling the Genomic Revolution in Africa. Science, 344 (6190): 1346-1348.
  • Vincent Onabajo G, Hamzat T, Owolabi MO (2014). Trajectory of motor recovery in Nigerian stroke survivors over 12 months. Brain Impairment, 15(01): 43-50 doi:10.1017/BrImp.2014.3.
  • Akinyemi R; Allan LM; Owolabi MO; Akinyemi JO; Ogbole G; Ajani A; Firbank M; Ogunniyi A, Kalaria R (2014). Profile and Determinants of Vascular Cognitive Impairment  in African Stroke Survivors: The CogFAST – Nigeria Study. J Neurol Sci., 346 (1-2):241-9.doi: 10.1016/j.jns.2014.08.042. Epub 2014 Sep 1.
  • Owolabi, M.O., Agunloye, A.M., Umeh, E.O., Akpa, M. (2014): Can carotid intima media thickness serve as an indicator of both cardiovascular phenotype and risk among black Africans? European Journal of Preventive Cardiology, 0(00):1-10 DOI: 10.1177/2047487314547656.

PUBLICATIONS AS PROFESSOR

  • Charles-Davies, M.A., Fasanmade, A.A., Olaniyi, J.A., Oyewole, O.E., Owolabi, M.O., Adebusuyi, J.R., Hassan, O., Ajobo, M.T., Ebesunun, M.O., Adigun, K., Akinlade, K.S., Fabian, U.A., Popoola, O.O., Rahamon, S.K., Okunbolade, W.,  Ogunlakin, M.A., Arinola, O.G., Agbedana, E.O. (2014):Prevalent components of metabolic syndrome and their correlates in apparently healthy individuals in Sub-Saharan Africa. International Journal of Tropical Disease & Health, 4 (7): 740-752.
  • Sposato, L.A, Ovbiagele, B, Johnston, S.C., Fisher, M., Saposnik, G., Stroke Outcome Research Working Group(www.sorcan.ca). (Saposnik, G., Bayley, M., Black, S.E., Butcher, K., Corbett, D., Côté, R., Coutts, S.B., Demchuk, A.M., Dowlatshahi, D., Dukelow, S., Fang, J., Gladstone, D.J., Hachinski, V., Hakim, A., Hill, M.D., Jeerakathil, T., Kapral, M.K., Macdonald, L., Mamdani, M., Penn, A., Phillips, S.J., Schweizer, T.A., Shuaib, A., Silver, F.L., Smith, E., Sposato, L.A., Tamayo, A., Al-Hassan, K., Ameriso, S., Barinagarrementeria, F., Béjot, Y., Bernhardt, J., Bornstein, N., Brainin, M., Bryer, A., Bushnell, C., Caso, V., Chaturvedi, S., Cordonnier, C., Cramer, S., Cohen, L.G., Davis, S., de los Rios, F., Feigin, V., Ferro, J., Fisher, M., Ford, G.A., Johnston, C., Kim, A., Lavados, P., Massaro, A., Meretoja, A., Michel, P., Mosquera, A., Moustafa, R.R., Nilanont, Y., Norving, B., Ntaios, G., O’Donnell, M., Ossou-Nguiet, P.M., Masjuan, J., Ovbiagele, B., Owolabi, M.O., Ozdemir, O., Pandian, J.D., Park, T.H., Rabinstein, A.A., Robles, A., Sacco, R.L., Shelliger, P.D., Shinohara, Y., Silver, B., Strbian, D.,  Vergouwen, M.D., Wong, L.(2014). A peek behind the curtain: peer review and editorial decision making at Stroke. Annals of Neurology, 76: (2):151-158. doi: 10.1002/ana.24218. Epub 2014 Jul 16.
  • Owolabi MO, Mensah GA, Kimmel PL, Adu D, Ramsay M, Waddy SP, Ovbiagele B, Rabada-Diehl C, Rasooly R, Akarolo-Anthony SN, Rotimi C; H3Africa Consortium. (2014). Understanding the rise in cardiovascular diseases in Africa: harmonising H3Africa genomic epidemiological teams and tools. Cardiovasc J Afr., 25(3):134-6. doi: 10.5830/CVJA-2014-030.
  • Olaniyan O, Owolabi MO, Akinyemi RO, Salako BL, Hurst S, Arulogun O, Gebregziabher M, Uvere E, Ovbiagele B. (2015). Cost and cost-effectiveness analysis of a bundled intervention to enhance outcomes after stroke in Nigeria: Rationale and design. eNeurologicalSci., 1(2):38-45.
  • Farombi, T.H., Yaria, J.O., Owolabi, M.O., Ogunniyi, A. (2015). Cognitive impairment and fall rate in Parkinson’s disease (PD) in Nigeria

[abstract]

. Movement Disorders 2015;30 Suppl 1:867.

  • Akinyemi RO, Firbank M, Ogbole GI, Allan LM, Owolabi MO, Akinyemi JO, Yusuf BP, Ogunseyinde O, Ogunniyi A, Kalaria RN (2015). Medial temporal lobe atrophy, white matter hyperintensities and cognitive impairment among Nigerian African stroke survivors. BMC Res Notes, 8(1):625. doi: 10.1186/s13104-015-1552-7. PMID:2651915.
  • Ogunbode AM, Owolabi MO, Ogunniyi A, Ogunbode OO (2015). Weight control, Alcohol reduction, Smoking cessation, Health promotion, Exercise and Diet (WASHED)’: A mnemonic for lifestyle modification in obesity. Niger J Clin Pract, 18(6):831-2. doi: 10.4103/1119-3077.163276. PMID: 26289528.
  • Ogbole GI, Owolabi MO, Ogun O, Ogunseyinde OA, Ogunniyi A (2015). Time of presentation of stroke patients for CT imaging in a Nigerian tertiary hospital. Ann Ib Postgrad Med., 13(1):23-8. PMID:26807083.
  • Ogun OA, Ogbole G, Owolabi M. (2015). An ‘Uncommon” Headache at Our Doorsteps: Cerebral Venous Sinus Thrombosis From Combined Haemoglobinopathy and Protein S Deficiency, Presenting With Papilledema. Journal of Neurological Sciences, 32 (1):237-242.
  • Okorie CK, Ogbole GI, Owolabi MO, Ogun O, Adeyinka A, Ogunniyi A (2015). Role of Diffusion-weighted Imaging in Acute Stroke Management using Low-field Magnetic Resonance Imaging in Resource-limited Settings. West Afr J Radiol., 22(2):61-66.
  • Olatunji RB, Ogbole GI, Atalabi OM,  Adeyinka AO, Lagunju I,  Oyinlade A, Ogun O,  Owolabi MO,.Ogunseyinde OA, Ogunniyi A (2015). Role of transcranial colour-coded duplex sonography in stroke management. West African journal of Ultrasound, 16 (1):33-42.
  • Fawale MB, Owolabi MO, Mustapha AF, Komolafe MA, Ogunniyi A (2015). Time to treatment predicts seizure outcome in a high-treatment gap epilepsy population. International Journal of Epilepsy, 2:72-77. http://dx.doi.org/10.1016/j.ijep.2015.09.001.
  • Adebusoye LA, Owolabi MO, Kalula SZ, Ogunniyi A (2015). All-cause mortality among elderly patients admitted to the medical wards of hospitals in Africa: A systematic review. Niger J Health Sci., 15:45-51.
  • Vincent –Onabajo G., Hamzat TK, Owolabi MO (2015). Consistent determinants of health-related quality of life in the first 12 months after stroke:  a prospective study in Nigeria. Topics in stroke rehabilitation, 22 (2):127-133.
  • Ogbole, G.I., Adeleye, A.O., Owolabi, M.O., Olatunji, R.B., Yusuf, B.P. (2015): Incidental cranial CT findings in head injury patients in a Nigerian tertiary hospital. Journal of Emergencies, Trauma, and Shock, 8(2):77-82. doi: 10.4103/0974-2700.155499.
  • Owolabi MO, Agunloye AM, Akpa M, Umeh EO (2015). Can CIMT serve as an indicator of both cardiovascular phenotype and risk among among black Africans?Eur J Prev Cardiol.,  22(11):1442-51. doi: 10.1177/2047487314547656. Epub 2014 Aug 22.
  • Fabian U. A., Charles-Davies M. A, Fasanmade A. A, Olaniyi J. A, Oyewole O. E, Owolabi M. O, Adebusuyi J. R, Hassan O, Ajobo B.M, Ebesunun M. O, Adigun K, Akinlade K. S, Arinola O. G and Agbedana E. O. (2015). Sex Hormones and Their Relationship with Leptin and Cardiovascular Risk Factors in Pre and Post- Menopausal Nigerian Women with Metabolic Syndrome Cardiology and Angiology: An International Journal, 3(3):149-156, 2015, Article no.CA.2015.013 ISSN: 2347-520X.
  • Akinyemi RO, Ovbiagele B, Akpalu A, Jenkins C, Sagoe K, Owolabi L, Sarfo F, Obiako R, M Gebreziabher, E Melikam, S Warth, O Arulogun, D Lackland, A Ogunniyi, H Tiwari, RN Kalaria, D Arnett, Owolabi MO (2015). Stroke genomics in people of African ancestry: charting new paths for the SIREN investigators as members of the H3Africa Consortium. Cardiovasc J Afr., 26 (2 Suppl 1):S39-49. doi: 10.5830/CVJA-2015-039.
  • Dorsch AK, Thomas S, Xu X, Kaiser W, Dobkin BH, on behalf of the SIRRACT investigators (2015). Stroke Inpatient Rehabilitation Reinforcement of Activity (SIRRACT) Trial: Feedback about Walking Practice Enabled by Wireless Sensing. Neurorehabil Neural Repair., 29(5):407-15. doi: 10.1177/1545968314550369. Epub 2014 Sep 26.
  • Adeoye AM, Adebiyi A, Owolabi MO, Lackland DT, Ogedegbe G, Tayo BO. Sex Disparity in Blood Pressure Levels Among Nigerian Health Workers (2015). J Clin Hypertens (Greenwich). 2015 Nov 19. doi: 10.1111/jch.12735. [Epub ahead of print] PMID: 26582436.
  • Sarfo FS, Akassi J, Awuah D, Adamu S, Nkyi C, Owolabi M, Ovbiagele B (2015). Trends in stroke admission and mortality rates from 1983 to 2013 in central Ghana. J Neurol Sci., 357(1-2):240-5. doi: 10.1016/j.jns.2015.07.043. Epub 2015 Aug 4. PMID:26293417.
  • Owolabi MO, Akarolo-Anthony S, Akinyemi R, Arnett D, Gebregziabher M, Jenkins C, Tiwari H, Arulogun O, Akpalu A, Sarfo FS, Obiako R, Owolabi L, Sagoe K, Melikam S, Adeoye AM, Lackland D, Ovbiagele B; Members of the H3Africa Consortium (2015). The burden of stroke in Africa: a glance at the present and a glimpse into the future. Cardiovasc J Afr., 26 (2 Suppl 1):S27-38. doi: 10.5830/CVJA-2015-038. PMID: 25962945; PubMed Central PMCID: PMC4557491.
  • Akinyemi RO, Owolabi MO, Adebayo PB, Akinyemi JO, Otubogun FM, Uvere EO. (2015). Task-shifting training improves stroke literacy among Nigerian non-neurological health workers. Journal of the Neurological Sciences, 359 (1–2):112–116.
  • Akpalu A, Sarfo FS, Ovbiagele B, Akinyemi R, Gebregziabher M, Obiako R, Owolabi L, Sagoe K, Jenkins C, Arulogun O, Adamu S, Appiah LT, Adadey MA, Agyekum F, Quansah JA, Mensah YB, Adeoye AM, Singh A, Tosin AO, Ohifemen O, Sani AA, Tabi-Ajayi E, Phillip IO, Isah SY, Tabari NA, Mande A, Agunloye AM, Ogbole GI, Akinyemi JO, Akpa OM, Laryea R, Melikam SE, Adinku D, Uvere E, Burkett NS, Adekunle GF, Kehinde SI, Azuh PC, Dambatta AH, Ishaq NA, Arnett D, Tiwari HK, Lackland D, Owolabi MO; SIREN as part of the H3Africa Consortium. (2015). Phenotyping Stroke in sub-Saharan Africa: Stroke Investigative Research and Education Network (SIREN) Phenomics Protocol. Neuroepidemiology, 45(2):73-82. doi: 10.1159/000437372.
  • Owolabi MO, Miranda J.J, Yaria J, Ovbiagele B. (2016).Controlling cardiovascular diseases in low and middle income countries by placing proof in pragmatism. BMJ Glob Health;1(3). pii: e000105.
  • Laniyan D. O., Charles-Davies M. A., Fasanmade A. A., Olaniyi J. A., Oyewole O. E., Owolabi MO., Adebusuyi J. R, Hassan O., Ajobo B. M., Ebesunun M. O., Adigun K., Akinlade K. S., Okoli S. U., Arinola O. G. and Agbedana E. O (2016).. Inhibin B Levels in Relation to Obesity Measures and Lipids in Males with Different Numbers of Metabolic Syndrome Components. Journal of Scientific Research and Reports, 10(5): 1-12 DOI: 10.9734/JSRR/2016/24641.
  • O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, McQueen MJ, Rosengren A, Dehghan M, Hankey GJ, Dans AL, Elsayed A, Avezum A, Mondo C, Diener HC, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, Iqbal R, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Al HF, Magazi D, Nilanont Y, Ferguson J, Pare G, Yusuf S. (2016). INTERSTROKE Investigators (Owolabi MO) Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet, 388 (10046):761-75. doi: 10.1016/S0140-6736(16)30506-2.
  • Johnson W, Onuma O, Owolabi MO, Sachdev S. (2016). Stroke: a global response is needed. Bull World Health Organ,  94(9):634-634A.
  • Owolabi MO, Olowoyo P, Miranda JJ, Akinyemi R, Feng W, Yaria J, Makanjuola T, Yaya S, Kaczorowski J, Thabane L, Van Olmen J, Mathur P, Chow C, Kengne A, Saulson R, Thrift AG, Joshi R, Bloomfield GS, Gebregziabher M, Parker G, Agyemang C, Modesti PA, Norris S, Ogunjimi L, Farombi T, Melikam ES, Uvere E, Salako B, Ovbiagele B; COUNCIL Initiative. (). Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries: A Systematic Review. Hypertension,  2016 :68(6):1328-1337.
  • Farombi TH, Owolabi MO, Ogunniyi A. (2016).Falls and Their Associated Risks in Parkinson’s Disease Patients in Nigeria. J Mov Disord, 9(3):160-5. doi: 10.14802/jmd.16011.
  • Owolabi MO, Daniel T Lackland,  Mulugeta Gebregziabher,  Kevin S Armstrong, Fred S Sarfo, Rufus Akinyemi, Lukman Owolabi, Reginald Obiako, Albert Akpalu, Andrea D Boan, Sylvia Melikam, Raelle Saulson, and Bruce Ovbiagele (2016). International Stroke Conference Poster Abstracts – Community/Risk Factors Posters I Abstract WP206: A Tale of Blacks With Stroke on Two Continents and in Two Eras: Comparison of Baseline Risk Profiles in Black Africans and Black Americans. Stroke. 2016;47:AWP206.
  • Arulogun OS, Hurst S, Owolabi MO, Akinyemi RO, Uvere E, Saulson R, Ovbiagele B (2016). Experience of Using an Interdisciplinary Task Force to Develop a Culturally Sensitive Multipronged Tool to Improve Stroke Outcomes in Nigeria. eNeurologicalSci., 4:10-14.
  • Fabian UA, Charles-Davies MA, Fasanmade AA, Olaniyi JA, Oyewole OE, Owolabi MO, Adebusuyi JR, Hassan OO, Ajobo BM, Ebesunun MO, Adigun K, Akinlade KS, Arinola OG, Agbedana EO (2016). Male Sexual Dysfunction, Leptin, Pituitary and Gonadal Hormones in Nigerian Males with Metabolic Syndrome and Type 2 Diabetes Mellitus. J Reprod Infertil., 17(1):17-25. PMID:26962479.
  • GBD 2015 SDG Collaborators Owolabi MO. (2016). Measuring the health‐related Sustainable Development Goals in 188 countries: An analysis from the Global Burden of Disease Study 2015. Lancet; pii: S0140-6736(16)31467-2. doi: 10.1016/S0140-6736(16)31467-2.
  • Akinyemi RO, Owolabi MO, Oyeniyi T, Ovbiagele B, Arnett DK, Tiwari HK, Walker R, Ogunniyi A, Kalaria RN. (2016). Neurogenomics in Africa: Perspectives, Progress, Possibilities and Priorities. Journal of the Neurological Sciences, 366: 213–223 doi: 10.1016/j.jns.2016.05.006.
  • Olowoyo P, Owolabi MO, Fawale B, Ogunniyi A. (2016). Short term stroke outcome is worse among individuals with the Sickle Cell Trait.  eNeurologicalSci.,3: 64–68.
  • Peprah E, Wiley K, Troyer J, Rasooly R, Dwomoa A, Bongani M, Ramsay M, Motala A, Adebamowo C, Ovbiagele B, Owolabi M O of the H3Africa Cardiovascular Diseases Working Group and as members of the H3Africa Consortium, (2016). Commentary on the CVD Working Group discussion at the 6th H3Africa Consortium meeting in Zambia: Building a platform to enable non-communicable disease research to address population health in Africa. Global Heart, 11(1):165-70. doi: 10.1016/j.gheart.2015.11.002.
  • Sarfo FS, Gebregziabher M, Ovbiagele B, Akinyemi R, Owolabi L, Obiako R, Armstrong K, Arulogun O, Akpalu A, Melikam S, Saulson R, Jenkins C, Owolabi M; SIREN. (2016). Validation of the 8-Item Questionnaire for Verifying Stroke Free Status with and without Pictograms in Three West African Languages. eNeurological Science, 3: 75-79 http://dx.doi.org/10.1016/j.ensci.2016.03.004
  • Farombi T, Owolabi MO, Ogunniyi A (2016). Frequency and risk of falls in Parkinson’s disease in Ibadan. Parkinsonism and Related Disorders, 22 (Supplement 2): e5–e6.
  • Donkor ES, Akumwena A, Owolabi MO, Aspelund T and  Gudnason V (2016). Stroke related bacteriuria: a case-control study of stroke patients attending a physiotherapy clinic in Ghana. Therapeutics and Clinical Risk Management, 12:457–462.
  • Sarfo F, Gebregziabher M, Ovbiagele B, Akinyemi R, Owolabi L, Obiako R, Akpa O, Armstrong K, Akpalu A, Adamu S, Obese V, Boa-Antwi N, Appiah L, Arulogun O, Mensah Y, Adeoye A, Tosin A, Adeleye O, Tabi-Ajayi E, Phillip I, Sani A, Isah S, Tabari N, Mande A, Agunloye A, Ogbole G, Akinyemi J, Laryea R, Melikam S, Uvere E, Adekunle G, Kehinde S, Azuh P, Dambatta A, Ishaq N, Saulson R, Arnett D, Tiwari H, Jenkins C, Lackland D, Owolabi MO; Stroke Investigative Research Educational Networks. (2016). Multilingual Validation of the Questionnaire for Verifying Stroke-Free Status in West Africa. Stroke, 47(1):167-72. doi: 10.1161/STROKEAHA.115.010374. 
  • Jenkins C, Arulogun OS, Singh A, Mande AT, Ajayi E, Benedict CT, Ovbiagele B, Lackland DT, Sarfo FS, Akinyemi R, Akpalu A, Obiako R, Melikam ES, Laryea R, Shidali V, Sagoe K, Ibinaiye P, Fakunle AG, Owolabi LF, Owolabi MO; SIREN Team. (2016). Stroke Investigative Research and Education Network: Community Engagement and Outreach Within Phenomics Core. Health Educ Behav., 43(1 Suppl):82S-92S. doi: 10.1177/1090198116634082.
  • Ojagbemi A,Owolabi MO (2016).Do occupational therapy interventions improve Quality of life in Persons with Dementia? A Meta-analysis with implications for future directions.Psychogeriatrics Jun 24. doi: 10.1111/psyg.12201. [Epub ahead of print].
  • Tobe W.S.,  Attaran A., de Villiers A., Featherstone A., Forrest J., Kalyesubula R., Kamwesiga., Kengne A.P., Lopez P.C., Mills E., Mukasa B., Muldoon K., Tayari J.C., Yaya S., Kien K.N., Lopez P., Casas J.L., McCready T., McKee M., Ng E., Nieuwlaat R., Zainal A.O., Yusoff K., Yusuf S., Campbell N., Kilonzo K., Liu P., Marr M., Yeates K., Feng X., He F., Jan S., Li X., Lin C.P., Ma J., Ma Y., MacGregor G., Nowson C., Wang H., Wu Y., Yan L., Yuan J., Zhang J., Goudge J., Kabudula C., Limbani F., Masilela N., Myakayaka N., Thorogood M., Gómez-Olivé F.X., Arabshahi S., Chow C., Evans R., Joshi R., Kalyanram K., Kartik K., Mahal A., Maulik P., Oldenburg B., Riddell M., Srikanth V., Suresh O., Thankappan K., Thirunavukkarasu S., Thomas N., Thrift A.G., Varma R., Clifford G., Heritier S., Jan S., Joshi R., MacMahon S., Maulik P., Patel A., Peiris D., Prabhakaran D., Praveen D., Jan S., Maulik P., Patel A., Prabhakaran D., Rodgers A., Salam A., Thom S., Webster R., Johnson C., Krishnan A., Mohan S., Neal B., Prabhakaran D., Reddy K.S., Shivashankar R., Sudhir T., Faletoese S., Ieremia M., Moodie M., Neal B., Pillay A., Schultz J., Siitia J., Snowdon W., Sukhu A., Ulberg C., Viali S., Webster J., Bernabe-Ortiz A., Cárdenas M.K., Diez-Canseco F., Gilman R.H., Miranda J.J., Ponce-Lucero V., Sacksteder K., Apusiga K., Cooper R., Gyamfi J., Ntim M., Ogedegbe O., Plange-Rhule J., Binanay C., Bloomfield G., DeLong A., Finkelstein E., Fuster V., Hogan J., Kamano J.H., Horowitz C., Inui T., Kimaiyo S., Kofler C., Menya D., Naanyu V., Rotich J., Vedanthan R., Velazquez E., Were M., Augustovski F., Beratarrechea A., Chen J., Dolan J., He J., Irazola V., Krousel-Wood M., Mills K., Poggio R., Rubinstein A., Shi L., Webber L., Akinyemi R., Arulogun O., Gebregziabher M., Hurst S., Ovbiagele B., Owolabi M., Uvere E., Waddy S., Warth S (2016). The Global Alliance for Chronic Diseases Supports 15 Major Studies in Hypertension Prevention and Control in Low- and Middle-Income Countries. J Clin Hypertens (Greenwich), 18(7):600-5. doi: 10.1111/jch.12835. Epub 2016 Jun 1.
  • Vedanthan R, Bernabe-Ortiz A, Herasme OI, Joshi R, Lopez-Jaramillo P, Thrift AG, Webster J, Webster R, Yeates K, Gyamfi J, Ieremia M, Johnson C, Kamano JH, Lazo-Porras M, Limbani F, Liu P, McCready T, Miranda JJ, Mohan S, Ogedegbe O, Oldenburg B, Ovbiagele B, Owolabi M, Peiris D, Ponce-Lucero V, Praveen D, Pillay A, Schwalm JD, Tobe SW, Trieu K, Yusoff K, Fuster V. (2017). Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries. Cardiol Clin., 35(1):99-115. doi: 10.1016/j.ccl.2016.08.010.
  • GBD 2015 Healthcare Access and Quality Collaborators (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet, 6736 (17):30818-8.
  • Hurst S, Arulogun O, Owolabi MO, Akinyemi RO, Uvere E, Warth S, Fakunle G, Ovbiagele B (2017). The Use of Qualitative Methods in Developing Implementation Strategies in Prevention Research for Stroke Survivors in Nigeria. J Clin Hypertens (Greenwich); 18 (10):1015-1021. doi: 10.1111/jch.12817. 
  • Ojagbemi A, Owolabi M, Bello T, Baiyewu O (2017). Stroke severity predicts poststroke delirium and its association with dementia: Longitudinal observation from a low income setting. Journal of the Neurological Sciences, 375:376-381. doi: 10.1016/j.jns.2017.02.039.
  • Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, Alla F, Alvis-Guzman N, Amrock S, Ansari H, Ärnlöv J, Asayesh H, Atey TM, Avila-Burgos L, Awasthi A, Banerjee A, Barac A, Bärnighausen T, Barregard L, Bedi N, Belay Ketema E, Bennett D, Berhe G, Bhutta Z, Bitew S, Carapetis J, Carrero JJ, Malta DC, Castañeda-Orjuela CA, Castillo-Rivas J, Catalá-López F, Choi JY, Christensen H, Cirillo M, Cooper L Jr, Criqui M, Cundiff D, Damasceno A, Dandona L, Dandona R, Davletov K, Dharmaratne S, Dorairaj P, Dubey M, Ehrenkranz R, El Sayed Zaki M, Faraon EJA, Esteghamati A, Farid T, Farvid M, Feigin V, Ding EL, Fowkes G, Gebrehiwot T, Gillum R, Gold A, Gona P, Gupta R, Habtewold TD, Hafezi-Nejad N, Hailu T, Hailu GB, Hankey G, Hassen HY, Abate KH, Havmoeller R, Hay SI, Horino M, Hotez PJ, Jacobsen K, James S, Javanbakht M, Jeemon P, John D, Jonas J, Kalkonde Y, Karimkhani C, Kasaeian A, Khader Y, Khan A, Khang YH, Khera S, Khoja AT, Khubchandani J, Kim D, Kolte D, Kosen S, Krohn KJ, Kumar GA, Kwan G, Lal DK, Larsson A, Linn S, Lopez A, Lotufo PA, El Razek HMA, Malekzadeh R, Mazidi M, Meier T, Meles KG, Mensah G, Meretoja A, Mezgebe H, Miller T, Mirrakhimov E, Mohammed S, Moran AE, Musa KI, Narula J, Neal B, Ngalesoni F, Nguyen G, Obermeyer CM, Owolabi MO, Patton G, Pedro J, Qato D, Qorbani M, Rahimi K, Rai RK, Rawaf S, Ribeiro A, Safiri S, Salomon JA, Santos I, Santric Milicevic M, Sartorius B, Schutte A, Sepanlou S, Shaikh MA, Shin MJ, Shishehbor M, Shore H, Silva DAS, Sobngwi E, Stranges S, Swaminathan S, Tabarés-Seisdedos R, Tadele Atnafu N, Tesfay F, Thakur JS, Thrift A, Topor-Madry R, Truelsen T, Tyrovolas S, Ukwaja KN, Uthman O, Vasankari T, Vlassov V, Vollset SE, Wakayo T, Watkins D, Weintraub R, Werdecker A, Westerman R, Wiysonge CS, Wolfe C, Workicho A, Xu G, Yano Y, Yip P, Yonemoto N, Younis M, Yu C, Vos T, Naghavi M, Murray C. (2017). Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol., S0735-1097 (17):37244-3. doi: 10.1016/j.jacc.2017.04.052.
  • Wahab KW, Owolabi M, Akinyemi R, Jenkins C, Arulogun O, Akpa O, Gebregziabher M, Uvere E, Saulson R, Ovbiagele B. (2017). Short-term pilot feasibility study of a nurse-led intervention to improve blood pressure control after stroke in Nigeria. J Neurol Sci., 377:116-120. doi: 10.1016/j.jns.2017.04.005.
  • Global Burden of Disease Health Financing Collaborator Network. (2017). Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet, 389 (10083):2005-2030. doi: 10.1016/S0140-6736(17)30873-5. 
  • Global Burden of Disease Health Financing Collaborator Network. (2017).  Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet, 389 (10083):1981-2004. doi: 10.1016/S0140-6736(17)30874-7
  • Ojagbemi A, Owolabi MO, Akinyemi R, Arulogun O, Akinyemi J, Akpa O, Sarfo FS, Uvere E, Saulson R, Hurst S, Ovbiagele B. (2017). Prevalence and predictors of anxiety in an African sample of recent stroke survivors. Acta Neurol Scand. doi: 10.1111/ane.12766.
  • Adeoye AM, Ovbiagele B, Kolo P, Appiah L, Aje A, Adebayo O, Sarfo F, Akinyemi J, Adekunle G, Agyekum F, Shidali V, Ogah O, Lackland D, Gebregziabher M, Arnett D, Tiwari HK, Akinyemi R, Olagoke OO, Oguntade AS, Olunuga T, Uwanruochi K, Jenkins C, Adadey P, Iheonye H, Owolabi L, Obiako R, Akinjopo S, Armstrong K, Akpalu A, Fakunle A, Saulson R, Aridegbe M, Olowoyo P, Osaigbovo G, Akpalu J, Fawale B, Adebayo P, Arulogun O, Ibinaiye P, Agunloye A, Ishaq N, Wahab K, Akpa O, Adeleye O, Bock-Oruma A, Ogbole G, Melikam S, Yaria J, Ogunjimi L, Salaam A, Sunmonu T, Makanjuola A, Farombi T, Laryea R, Uvere E, Kehinde S, Chukwuonye I, Azuh P, Komolafe M, Akintunde A, Obiabo O, Areo O, Kehinde I, Amusa AG, Owolabi MO; SIREN Team as part of H3Africa Consortium. (2017). Exploring Overlaps Between the Genomic and Environmental Determinants of LVH and Stroke: A Multicenter Study in West Africa. Glob Heart. pii: S2211-8160 (17): 30001-7.
  • Adeoye AM, Ogah OS, Ovbiagele B, Akinyemi R, Shidali V, Agyekum F, Aje A, Adebayo O, Akinyemi JO, Kolo P, Appiah LT, Iheonye H, Kelechukwu U, Ganiyu A, Olunuga TO, Akpa O, Olagoke OO, Sarfo FS, Wahab K, Olowookere S, Fakunle A, Akpalu A, Adebayo PB, Nkromah K, Yaria J, Ibinaiye P, Ogbole G, Olumayowa A, Lakoh S, Calys-Tagoe B, Olowoyo P, Innocent C, Tiwari HK, Arnett D, Godwin O, Ayotunde B, Akpalu J, Obiora O, Joseph O, Omisore A, Jenkins C, Lackland D, Owolabi L, Isah S, Dambatta AH, Komolafe M, Bock-Oruma A, Melikam ES, Imoh LC, Sunmonu T, Gebregziabher M, Olabisi O, Armstrong K, Onyeonoro UU, Sanya E, Agunloye AM, Ogunjimi L, Arulogun O, Farombi TH, Obiabo O, Obiako R, Owolabi MO; SIREN Team as part of the H3Africa Consortium. (2017). Prevalence and Prognostic Features of ECG Abnormalities in Acute Stroke: Findings from the SIREN Study Among Africans. Glob Heart. pii: S2211-8160 (17):30002-9. doi: 10.1016/j.gheart.2017.01.002.
  • Riddell MA, Edwards N, Thompson SR, Bernabe-Ortiz A, Praveen D, Johnson C, Kengne AP, Liu P, McCready T, Ng E, Nieuwlaat R, Ovbiagele B, Owolabi M, Peiris D, Thrift AG, Tobe S, Yusoff K; GACD Hypertension Research Programme. (2017). Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program. Global Health, 13(1):17. doi: 10.1186/s12992-017-0242-8.
  • Sarfo FS, Gyamfi RA, Adamu S, Sarfo-Kantanka O, Owolabi M, Ovbiagele B. (2017). Administration of a pictorial questionnaire to screen for stroke among patients with hypertension or diabetes in rural Ghana. Journal of the Neurological Sciences, 373:289-294. doi: 10.1016/j.jns.2017.01.022.
  • Owolabi MO, Sarfo F, Howard VJ, Irvin MR, Gebregziabher M, Akinyemi R, Bennett A, Armstrong K, Tiwari HK, Akpalu A, Wahab KW, Owolabi L, Fawale B, Komolafe M, Obiako R, Adebayo P, Manly JM, Ogbole G, Melikam E, Laryea R, Saulson R, Jenkins C, Arnett DK, Lackland DT, Ovbiagele B, Howard G; SIREN-REGARDS Collaboration (Stroke Investigative Research and Educational Network–Reasons for Geographic and Racial Differences in Stroke). (2017). Stroke in Indigenous Africans, African Americans, and European Americans: Interplay of Racial and Geographic Factors. Stroke; 48(5):1169-1175. doi: 10.1161/STROKEAHA.116.015937.
  • Sarfo FS, Nichols M, Qanungo S, Teklehaimanot A, Singh A, Mensah N, Saulson R, Gebregziabher M, Ezinne U, Owolabi M, Jenkins C, Ovbiagele B. (2017). Stroke-related stigma among West Africans: Patterns and predictors. Journal of the Neurological Sciences 375:270-274. doi: 10.1016/j.jns.2017.02.018. 
  • Bayona H, Owolabi MO, Feng W, Olowoyo P, Yaria J, Akinyemi R, Sawers JR, Ovbiagele B. (2017). A systematic comparison of key features of ischemic stroke prevention guidelines in low- and middle-income vs. high-income countries. Journal of the Neurological Sciences, 375:360-366. doi: 10.1016/j.jns.2017.02.040.
  • Sarfo FS,  Jenkins C, Singh A, Owolabi MO, Ojagbemi A, Adusei N, Saulson R, Ovbiagele B. (2017). Post-stroke depression in Ghana: Characteristics and correlates. Journal of the Neurological Sciences. https://doi.org/10.1016/j.jns.2017.06.032.
  • GBD 2015 Healthcare Access and Quality Collaborators. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.  Lancet. 2017 May 18. pii: S0140-6736(17)30818-8. doi: 10.1016/S0140-6736(17)30818-8. [Epub ahead of print] PMID:28528753.
  • The GBD 2015 Obesity Collaborators. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. The New England Journal of Medicine. 2017 DOI: 10.1056/NEJMoa1614362.
  • Akinyemi RO, Arnett DK, Tiwari HK, Ovbiagele B, Sarfo F, Srinivasasainagendra V, Irvin MR, Adeoye A, Perry RT, Akpalu A, Jenkins C, Owolabi L, Obiako R, Wahab K, Sanya E, Komolafe M, Fawale, Adebayo P, Osaigbovo G, Sunmonu T, Olowoyo P, Chukwuonye I, Obiabo Y, Akpa O, Melikam S, Saulson R, Kalaria R, Ogunniyi A, Owolabi MO, for the SIREN Investigators. (2017). Interleukin–6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men. Journal of the Neurological Sciences, 379:229–235.
  • Olowoyo P, Akinyemi RO, Owolabi MO, Fawale B and Ogunniyi A (2017). Sickle Cell Trait Appears to Increase the Risk of Hemorrhagic Stroke in African Adults with Dyslipidaemia: A Pilot Study. Austin J Cerebrovasc Dis & Stroke,  4(4): 1067.
  • Singh A, Jenkins C, Calys-Tagoe B, Arulogun OS, Sarfo S, Ovbiagele B, Akpalu A, Melikam S, Uvere E, Owolabi MO for the SIREN Team of Investigators (2017). Stroke Investigative Research and Education Network: Public Outreach and Engagement. Journal of Community Med & Health Educ., 7:518 DOI: 10.4172/2161-0711.1000518.
  • GBD 2015 Neurological Disorders Collaborator Group (2017). Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol, 15. pii: S1474-4422(17)30299-5. doi: 10.1016/S1474-4422(17)30299-5.
  • GBD 2016 Risk Factors Collaborators (2017). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 16;390(10100):1345-1422. doi: 10.1016/S0140-6736(17)32366-8.
  • GBD 2016 DALYs and HALE Collaborators (2017). Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X.
  • GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.
  • GBD 2016 Mortality Collaborators (2017). Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0.
  • GBD 2016 SDG Collaborators (2017). Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet, 16;390(10100):1423-1459. doi: 10.1016/S0140-6736(17)32336-X.
  •  Owolabi MO, Olowoyo P, Popoola O, Lackland D, Jenkins C, Arulogun O, Akinyemi R,      Akinyemi J, Akpa O, Olaniyan O, Uvere E, Kehinde I, Selassie A, Gebregziabher M, Tagge R, Ovbiagele B. (2017).  The Epidemiology of Stroke in Africa: A Systematic Review of Existing Methods and New Approaches. J Clin Hypertens 2017; DOI: 10.1111/jch.13152.
  • Owolabi MO, Peprah E, Xuc H, Akinyemi R, Tiwari HK, Irvin MR, Wahab KW, Arnett D, Ovbiagele B (2017). Advancing stroke genomic research in the age of Trans-Omics big data science: Emerging priorities and opportunities. Journal of the Neurological Sciences, 382 18–28.
  • Uche EO, Shokunbi MT, Owolabi M, Atalabi O, Agunloye A. (2017). Symptomatic Vertebral Artery Occlusion in a Young Nigerian Male: A Case Report with Review of Current Literature. Journal of Clinical and Applied Neurosciences; 2 (1): 46-51.
  • Owolabi MO, Ogunniyi A, Hamzat TK, Platz T, Khan F (2017). Call for Papers: Neuro-rehabilitation in low and middle income countries: Adaptations and Innovations. eNeurologicalSci, 8 1.
  • Akinyemi R, Tiwari HK, Arnett DK, Ovbiagele B, Sarfo F, Srinivasasainagendra V, Irvin MR, Adeoye A, Perry RT, Akpalu A, Jenkins C, Owolabi L, Obiako RO, Wahab K, Sanya E, Komolafe A, Fawale M, Adebayo P, Osaigbovo G, Sunmonu T, Olowoyo P, Chukwuonye I, Obiabo Y, Akpa O, Melikam ES, Saulson R, Owolabi MO, (2018). SIREN. APOL1, CDKN2A/CDKN2B and HDAC9 polymorphisms and small vessel ischemic stroke. Acta Neurologica Scandinavica.. 2018 Jan;137(1):133-141. doi: 10.1111/ane.12847. Epub 2017 Oct 3. PMID:28975602
  • Rahamon SK, Fabian UA, Charles-Davies MA, Olaniyi JA, Fasanmade AA, Akinlade KS, Oyewole OE, Owolabi MO, Adebusuyi JR, Hassan OO, Ajobo BM, Ebesunun MO, Adigun K, Popoola OO, Omiyale W, Arinola OG, Agbedana EO.(2017). Changes in mediators of inflammation and pro-thrombosis after 12 months of dietary modification in adults with metabolic syndrome. Afr Health Sci. Jun;17(2):453-462. doi: 10.4314/ahs.v17i2.20.
  •  Mulder N, Adebamowo CA, Adebamowo SN, Adebayo O, Adeleye O, Alibi M, Baichoo S, Benkahla A,  Fadlelmola FM, Ghazal H, Ghedira K, Matimba A,  Moussa A, Mungloo-Dilmohamud Z, Owolabi MO, Radouani F, Rotimi CN, Stein DJ and Souiai O, as members of the H3Africa Consortium . (2017). Genomic Research Data Generation, Analysis and Sharing – Challenges in the African Setting. Data Science Journal, 16, p.49. pp. 1–15 DOI: http://doi.org/10.5334/dsj-2017-049,
  • Sarfo FS, Owusu D, Adamu S, Awuah D, Appiah L, Amamoo M, Loglo A, Owolabi M, Ovbiagele B. (2017). Plasma Glial Fibrillary Acidic Protein, Copeptin, and Matrix Metalloproteinase-9 Concentrations among West African Stroke Subjects Compared with Stroke-Free Controls. J Stroke Cerebrovasc Dis. Oct 23. pii: S1052-3057(17)30519-0. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.035.
  • Ojagbemi A, Owolabi M, Akinyemi J, Ovbiagele B. (2017). Criterion Validity of the “HRQOLISP-E”: A New Context-Specific Screening Tool for Poststroke Depression. Behav Neurol. 2017:6515769. doi: 10.1155/2017/6515769. Epub 2017 Oct 11.
  • Ojagbemi A, Owolabi M, Ovbiagele B. (2017). Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability.eNeurologicalSci. Dec;9:14-18. doi: 10.1016/j.ensci.2017.10.002. Epub 2017 Oct 31.
  • Adeoye AM, Adebayo O, Nwosu M, Adebiyi A, Owolabi MO, Tayo BO, Salako BL, Ogunniyi A, and Cooper RS. (2017). Assessment of Measures of Adiposity that Correlate with Blood Pressure among Hypertensive Africans. Ann Ibd. Pg. Med. Vol.15, No.2 82-87.
  • Owolabi M. Sarfo F, Akinyemi R, Gebregziabher M, Akpa O, Akpalu A, Wahab K, Obiako R, Owolabi L, Ovbiagele B on behalf of SIREN Team as part of H3Africa Consortium. (2018).Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study. The Lancet Global Health, 2018 Apr;6(4):e436-e446. doi: 10.1016/S2214-109X(18)30002-0. http://dx.doi.org/10.1016/S2214-109X(18)30002-0
  • Owolabi MO, Yaria J.,  Daivadanam M, Makanjuola A, Parker G, Oldenburg B, Vedanthan R,  Norris S, Oguntoye A, Osundina M, Herasme O,  Lakoh S, Ogunjimi L, Abraham S,  Olowoyo P, Jenkins C, Feng W, Bayona H, Mohan S, Joshi R, Webster R,  Kengne A,  Trofor A, Lotrean LM, Praveen D,  Zafra-Tanaka JM, Porras ML, Bobrow K, Riddell M, Makrilakis K, Manios Y, Ovbiagele B for the †COUNCIL Initiative et al (2018). Gaps in Guidelines for the Management of Diabetes Mellitus in Low and Middle Income vs. High Income Countries – A Systematic Review.. Diabetes Care; 2018 May;41(5):1097-1105. doi: 10.2337/dc17-1795.
  • Adebayo P. Taiwo FT, Owolabi MO, Ogunremi OA,(2018). Knowledge of electromyography (EMG) among sub-Saharan African patients – a pilot survey. Ann Med Health Sci Res. 2018; 8: 69-73.
  • Adebayo P. Taiwo FT, Ogunremi OA, Owolabi MO, (2018). EMG Indications and Findings in a sub-Saharan African Neurorehabilitation Centre.Clinical Neurophysiology Practice 3 ; 99–103.
  • Owolabi M, Ojagbemi A, Kalaria R,Sarfo FS, Akinyemi R. (2018). Behavioural and Cognitive Effects of Cerebrovascular Diseases. Behav. Neurol. Volume 2018, Article ID 7516032, https://doi.org/10.1155/2018/7516032
  • Khan F, Amatya B, De Groote W, Owolabi MO, Syed IM, Hajjoui A, Babur MN, Sayed TM, Frizzell Y, Naicker AS, Fourtassi M, Elmalik A,  Galea MP. (2018). Capacity-Building in Clinical Skills of Rehabilitation Workforce in Low- and Middle-Income Countries. J Rehabil Med; 50. doi: 10.2340/16501977-231310.2340/16501977-2276.
  • Akinyemi RO, Akinwande K,  Diala S, Adeleye O, Ajose A, Issa K, Owusu D, Boamah I,  Yahaya IS, Jimoh AO,  Imoh L, Fakunle G, Akpalu A, Sarfo F, Wahab K, Sanya E, Owolabi L, Obiako R, Osaigbovo G, Komolafe M, Fawale M, Adebayo P,  Olowoyo P, Obiabo Y, Sunmonu T, Chukwuonye I, Balogun O,  Adeoye B, Oladele F, Olowoniyi P, Adeyemi F, Lezzi A, Falayi A, Fasanya M, Ogunwale K, Adeola O, Olomu O, Aridegbe O, Laryea R, Uvere E, Faniyan M, Melikam E, Tagge R, Akpa O, Akinyemi J,  Arulogun O,  Tiwari HK, Ovbiagele B, Owolabi M for the SIREN Investigators as members of the H3 Africa Consortium (2018)Biobanking in a Challenging African Environment: Unique Experience from the SIREN Project. Biopreservation and Biobanking 2018 Jun 1; 16(3): 217–232. doi: 10.1089/bio.2017.0113.
  • Sarfo F, Ovbiagele B, Gebregziabher M,  Wahab K, Akinyemi R, Akpalu A,  Akpa O,  Obiako R, Owolabi L, Jenkins C, Owolabi M, on behalf of SIREN (2018). Stroke Among Young West Africans: Evidence from the SIREN Large Multi-site Case-Control Study. Stroke. 2018 May;49(5):1116-1122. . doi: 10.1161/STROKEAHA.118.020783. [Epub ahead of print] PMID: 29618553
  •  Global Burden of Cardiovascular Diseases Collaboration, Roth GA, Johnson CO, Abate KH, Abd-Allah F, Ahmed M, Alam K, Alam T, Alvis-Guzman N, Ansari H, Ärnlöv J, Atey TM, Awasthi A, Awoke T, Barac A, Bärnighausen T, Bedi N, Bennett D, Bensenor I, Biadgilign S, Castañeda-Orjuela C, Catalá-López F, Davletov K, Dharmaratne S, Ding EL, Dubey M, Faraon EJA, Farid T, Farvid MS, Feigin V, Fernandes J, Frostad J, Gebru A, Geleijnse JM, Gona PN, Griswold M, Hailu GB, Hankey GJ, Hassen HY, Havmoeller R, Hay S, Heckbert SR, Irvine CMS, James SL, Jara D, Kasaeian A, Khan AR, Khera S, Khoja AT, Khubchandani J, Kim D, Kolte D, Lal D, Larsson A, Linn S, Lotufo PA, Magdy Abd El Razek H, Mazidi M, Meier T, Mendoza W, Mensah GA, Meretoja A, Mezgebe HB, Mirrakhimov E, Mohammed S, Moran AE, Nguyen G, Nguyen M, Ong KL, Owolabi M, Pletcher M, Pourmalek F, Purcell CA, Qorbani M, Rahman M, Rai RK, Ram U, Reitsma MB, Renzaho AMN, Rios-Blancas MJ, Safiri S, Salomon JA, Sartorius B, Sepanlou SG, Shaikh MA, Silva D, Stranges S, Tabarés-Seisdedos R, Tadele Atnafu N, Thakur JS, Topor-Madry R, Truelsen T, Tuzcu EM, Tyrovolas S, Ukwaja KN, Vasankari T, Vlassov V, Vollset SE, Wakayo T, Weintraub R, Wolfe C, Workicho A, Xu G, Yadgir S, Yano Y, Yip P, Yonemoto N, Younis M, Yu C, Zaidi Z, Zaki MES, Zipkin B, Afshin A, Gakidou E, Lim SS, Mokdad AH, Naghavi M, Vos T, Murray CJL. (2018) The Burden of Cardiovascular Diseases Among US States, 1990-2016. JAMA Cardiol. 2018 Apr 11. doi: 10.1001/jamacardio.2018.0385. [Epub ahead of print] PMID:29641820
  • Adeoye AM, Tayo BO, Owolabi MO, Adebiyi AA, Lackland DT, Cooper R, Ojo A,  Ogedegbe G. (2018) Ambulatory blood pressure threshold for black Africans: more questions than answers. Journal of Clinical Hypertension. DOI: 10.1111/jch.13287
  • Global Burden of Disease Health Financing Collaborator Network. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015. Lancet. 2018 Apr 17. pii: S0140-6736(18)30698-6. doi: 10.1016/S0140-6736(18)30698-6. PMID: 29678342
  • Global Burden of Disease Health Financing Collaborator Network. Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016-40 Lancet. 2018 Apr 17. pii: S0140-6736(18)30697-4. doi: 10.1016/S0140-6736(18)30697-4. PMID:29678341
  • Akinyemi RO, Owolabi MO, Ihara M, Damascebo A, Ogunniyi A, Dotchin C, Paddick S-M, Ogeng’o J, Walker R, and Kalaria RN Stroke, Cerebrovascular Diseases and Vascular Cognitive Impairment in Africa. Brain Research Bulletin . May 25. pii: S0361-9230(18)30281-8. doi: 10.1016/j.brainresbull.2018.05.018. [Epub ahead of print] PMID:    29807146
  • Akinyemi RO, Sarfo FS,  Akinyemi J,  Singh A, Akpa O,  Akpalu A, Owolabi L , Adeoye AM, Obiako R,  Wahab K, Sanya E, Komolafe M, Ogbole G, Fawale M, Adebayo P, Osaigbovo G, Sunmonu T, Olowoyo P, Chukwuonye P, Obiabo Y,  Adeniji O,  Fakunle A, Melikam E, Saulson R,  Yaria J, Uwanruochi K, Ibinaiye P, Amusa GA, Yahaya IS, Dambatta AH, Faniyan M, Olowoniyi P, Bock-Oruma A,  Joseph OC, Oguntade A, Kolo P, Laryea A, Lakoh S, Uvere E, Farombi T, Akpalu J, Oyinloye O, Appiah L, Calys-Tagoe B, Shidali V,  Tabari NA, Adebayo O, Efidi R, Adeleye O, Owusu D, Ogunjimi L, Aridegbe  O, Imoh CL, Sanni T, Gebreziabher M, Tiwari H, Arulogun O, Ogunniyi A, Jenkins C, Owolabi M,  Ovbiagele B for the SIREN  Investigators Knowledge, Attitudes and Practices of West Africans on Genetic Studies of Stroke: Evidence from the SIREN Study. International Journal of Stroke 2018. Int J Stroke. 2018 Jul 24:1747493018790059. doi: 10.1177/1747493018790059. [Epub ahead of print] PMID: 30040054
  • Adams RJ, Akinyemi RO, Owolabi MO, Lackland DL, Ovbiagele B. New approaches to genetic predisposition for hemorrhagic stroke in sickle cell disease. J Clin Hypertens (Greenwich). 2018 May 27. doi: 10.1111/jch.13306. [Epub ahead of print] No abstract available. PMID:    29806147
  • Munirudeen I, Charles-Davies M.A, Fabian U.A, Fasanmade A.A, Olaniyi J.A, Oyewole O.E, Owolabi M.O, Adebusuyi J.R, Hassan O, Ajobo B.M, Ebesunun M.O, Adigun K, Akinlade K.S, Okoli S.U, Arinola O.G and Agbedana E.O Reproductive Endocrinopathies in Nigerian Males with Zero and Three or More Metabolic Syndrome Components Arch. Bas. App. Med. 5 (2017) 109 – 118
  • Adebusoye LA, Owolabi M, Ogunniyi A. Predictors of mortality among older patients in the medical wards of a tertiary hospital in Nigeria. Aging Clin Exp Res. 2018 Jul 6. doi: 10.1007/s40520-018-0997-7. [Epub ahead of print]
  •  Owolabi M, Johnson W, Khan T, Feigin V, for Operations Committee of the Lancet Neurology on Stroke . Effectively Combating Stroke in Low- and Middle-Income Countries: Placing Proof in Pragmatism -The Lancet Neurology Commission. Journal of Stroke Medicine 1(1) 65-67, 2018 DOI: 10.1177/2516608518776706
  • GBD 2016 Alcohol Collaborators Owolabi MO . Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.  Lancet 2018.:August 23, 2018 DOI:https://doi.org/10.1016/S0140-6736(18)31310-2
  • Akinyemi R, Coker M, Ojagbemi A,  Salami A, Akinyemi J, Olopade F, Farombi T, Nweke M, Arulogun O, Jegede A, Owolabi M,  Kalaria R,  Ogunniyi A. Brain Banking in Low- and Middle – Income Countries: Raison D’être for the Ibadan Brain Ageing, Dementia And Neurodegeneration (IBADAN) Brain Bank Project. Brain Research Bulletin 2018 Aug 24. pii: S0361-9230(18)30338-1. doi: 10.1016/j.brainresbull.2018.08.014. [Epub ahead of print]
  • Sarfo F, Opare-Sema O, Agyeia M, Akassia J, Owusu D, Owolabi M, Ovbiagele B.  Risk Factors for Stroke Occurrence in a low HIV endemic West African Country: a case-control study. Journal of the Neurological Sciences Journal of the Neurological Sciences 395 (2018) 8–16
  • Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, Ansha MG, Brayne C, Choi JJ, Collado-Mateo D, Dahodwala N, Do HP, Edessa D, Endres M, Fereshtehnejad SM, Foreman KJ, Gankpe FG, Gupta R, Hankey GJ, Hay SI, Hegazy MI, Hibstu DT, Kasaeian A, Khader Y, Khalil I, Khang YH, Kim YJ, Kokubo Y, Logroscino G, Massano J, Mohamed Ibrahim N, Mohammed MA, Mohammadi A, Moradi-Lakeh M, Naghavi M, Nguyen BT, Nirayo YL, Ogbo FA, Owolabi MO, Pereira DM, Postma MJ, Qorbani M, Rahman MA, Roba KT, Safari H, Safiri S, Satpathy M, Sawhney M, Shafieesabet A, Shiferaw MS, Smith M, Szoeke CEI, Tabarés-Seisdedos R, Truong NT, Ukwaja KN, Venketasubramanian N, Villafaina S, Weldegwergs KG, Westerman R, Wijeratne T, Winkler AS, Xuan BT, Yonemoto N, Feigin VL, Vos T, Murray CJL. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.
  • The GBD 2016 Lifetime Risk of Stroke Collaborators including Owolabi MO. Global, Regional, and Country-Specific Lifetime Risk of Stroke, 1990–2016 N Engl J Med. 2018 Dec 20;379(25):2429-2437. doi: 10.1056/NEJMoa1804492.PMID:30575491
  • Jenkins C, Ovbiagele B, Arulogun O, Singh A,   Calys-Tagoe B,  Akinyemi R, Mande A, Melikam ES, Akpalu A, Wahab K,Sarfo FS,  Sanni T, Osaigbovo G,  Tiwari HK, Obiako R, Shidali V,  Ibinaiye P, Akpalu J, Ogbole G, Owolabi L, Uvere E, Taggae R, Adeoye AM, Gebregziabher M, Akintunde A, Adebayo O, Oguntade A, Bisi A,  Ohagwu K, Laryea R, Olowoniyi P, Yahaya IS. Olowookere S,  Adeyemi F, Komolafe M,  Fawale MB, Sunmonu T,  Onyeonoro U, Imoh LC, Oguike W, Olunuga T, Kolo PM, Ogah OS, Efidi R, Chukwuonye I, Bock-Oruma A, Owusu D, Odo CJ, Faniyan M, Ohnifeman OA, Ajose O, Ogunjimi L, Johnson S, Ganiyu A,  Olowoyo P, Fakunle AG, Tolulope A, FarombiT, Obiabo MO, Owolabi M. Knowledge, attitudes and practices related to stroke in Ghana and Nigeria:  a SIREN call to action.  PLoS ONE 13(11): e0206548.  https://doi.org/10.1371/journal.pone.0206548
  • Owolabi M, Akpa OM, Made F, Adebamowo SN, Ojo A, Adu D, Motala AA, Mayosi BM, Ovbiagele B, Adebamowo C, Tayo B, Rotimi C, Mensah G,  Akinyemi R,  Gebregziabher M, Sarfo F, Wahab KW,  Parekh RS, Waddy S, Peprah E, Wiley K,  Troyer J,  Ramsay M, as members of the CVD Working Group of the H3Africa Consortium Data Resource Profile: Cardiovascular H3Africa Innovation Resource (CHAIR). International Journal of Epidemiology 2018, 1–9 doi: 10.1093/ije/dyy261
  • GBD 2017 DALYs and HALE Collaborators including Owolabi MO. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3. PMID:30415748
  • GBD 2016 Meningitis Collaborators (including Owolabi M.O.) Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Dec;17(12):1061-1082. doi: 10.1016/S1474-4422(18)30387-9. Epub 2018 Nov 13.
  •  GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators (including Owolabi M.O.)Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov 26. pii: S1474-4422(18)30415-0. doi: 10.1016/S1474-4422(18)30415-0. [Epub ahead of print]
  • GBD 2016 Dementia Collaborators (including Owolabi M.O.) Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov 26. pii: S1474-4422(18)30403-4. doi: 10.1016/S1474-4422(18)30403-4. [Epub ahead of print]
  • GBD 2017 SDG Collaborators. (including Owolabi M.O.) Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):2091-2138. doi: 10.1016/S0140-6736(18)32281-5. Epub 2018 Nov 8.
  • GBD 2017 Population and Fertility Collaborators. (including Owolabi M.O.) Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018 Nov 10;392(10159):1995-2051. doi: 10.1016/S0140-6736(18)32278-5. Epub 2018 Nov 8.
  • GBD 2017 Risk Factor Collaborators. (including Owolabi M.O.) Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
  • GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. (including Owolabi M.O.) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
  • GBD 2017 Causes of Death Collaborators. (including Owolabi M.O.) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
  • GBD 2017 Mortality Collaborators. (including Owolabi M.O.) Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9. Epub 2018 Nov 8.
  • GBD 2016 Epilepsy Collaborators (Owolabi M). Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Feb 14. pii: S1474-4422(18)30454-X. doi: 10.1016/S1474-4422(18)30454-X. [Epub ahead of print] PMID:30773428
  •  GBD 2016 Stroke Collaborators Owolabi MO. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Mar 11. pii: S1474-4422(19)30034-1. doi: 10.1016/S1474-4422(19)30034-1. [Epub ahead of print PMID:30871944
  • Adeoye AM, Adebiyi AO, Adebayo OM, Owolabi MO.Medication adherence and 24-h blood pressure in apparently uncontrolled hypertensive Nigerian patients. Niger Postgrad Med J. 2019 Jan-Mar;26(1):18-24. doi: 10.4103/npmj.npmj_147_18. PMID: 30860195
  • Azarpazhooh MR, Mandzia JL, Thrift AG, Sposato LA, Morovatdar N, Amiri A, Kapral MK, Yassi N, Bahit C, Kaul S, Alladi S, Nilanont Y, Coppola M, Nucera A, Silver B, Werring D, Simister R, Swartz RH, Owolabi MO, Ovbiagele B, Hachinski V; ASSESS investigators. Age, sex, and setting in the etiology of stroke study (ASSESS): Study design and protocol. J Neurol Sci. 2019 Feb 14;399:209-213. doi: 10.1016/j.jns.2019.02.024. [Epub ahead of print] PMID:30851659
  • GBD 2016 Neurology Collaborators (Owolabi MO). Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Mar 14. pii: S1474-4422(18)30499-X. doi: 10.1016/S1474-4422(18)30499-X. [Epub ahead of print] PMID:30879893
  • Akpalu A, Gebregziabher M, Ovbiagele B, Sarfo F, Iheonye H, Akinyemi R, Akpa O, Tiwari HK, Arnett D, Wahab K, Lackland D, Abiodun A, Ogbole G, Jenkins C, Arulogun O, Akpalu J, Obiako R, Olowoyo P, Fawale M, Komolafe M, Osaigbovo G, Obiabo Y, Chukwuonye I, Owolabi L, Adebayo P, Sunmonu T, Owolabi M. Differential Impact of Risk Factors on Stroke Occurrence Among Men Versus Women in West Africa. Stroke. 2019 Mar 18:STROKEAHA118022786. doi: 10.1161/STROKEAHA.118.022786. [Epub ahead of print] PMID:30879432
  • Breet Y, Lackland DT, Ovbiagele B, Owolabi MO, Ogedegbe G, Kruger IM, Schutte AE. Is the cardiovascular health of South Africans today comparable with African Americans 45 years ago? J Hypertens. 2019 Apr 3. doi: 10.1097/HJH.0000000000002082
  • Daivadanam M, Ingram M, Sidney Annerstedt K, Parker G, Bobrow K, Dolovich L, Gould G, Riddell M, Vedanthan R, Webster J, Absetz P, Mölsted Alvesson H, Androutsos O, Chavannes N, Cortez B, Devarasetty P, Fottrell E, Gonzalez-Salazar F, Goudge J, Herasme O, Jennings H, Kapoor D, Kamano J, Kasteleyn MJ, Kyriakos C, Manios Y, Mogulluru K, Owolabi M, Lazo-Porras M, Silva W, Thrift A, Uvere E, Webster R, van der Kleij R, van Olmen J, Vardavas C, Zhang P; GACD Concepts and Contexts working group.PLoS One. 2019 Apr 8;14(4):e0214454. doi: 10.1371/journal.pone.0214454. eCollection 2019. PMID: 30958868
  • Adebusoye LA, Owolabi MO & Ogunniyi A (2019): Biomarkers, shock index and modified early warning score among older medical hospital inpatients in Nigeria, South African Family Practice April : https://doi.org/10.1080/20786190.2018.1554304
  •  Owolabi MO, Sarfo FS, Akinyemi R, Ovbiagele B. The Sub-Saharan Africa Conference on Stroke (SSACS): An idea whose time has come. Journal of the Neurological Sciences.Volume 400, 15 May 2019, Pages 194-198 https://doi.org/10.1016/j.jns.2019.03.026
  • Akinyemi R, Ojagbemi A, Akinyemi J, Salami A, Olopade F, Farombi T, Nweke M, Uvere E, Aridegbe M, Balogun J, Ogbole G, Jegede A, Kalaria R, Ogunniyi A, Owolabi M, Arulogun O. Gender differential in inclination to donate brain for research among Nigerians: the IBADAN Brain Bank Project. Cell Tissue Bank. 2019 Apr 26. Volume 400, 15 May 2019, Pages 194-198doi: 10.1007/s10561-019-09769-4. [Epub ahead of print] PMID:31028517
  • Jacobs MS, van Hulst M, Adeoye AM, Tieleman RG, Postma MJ, Owolabi MO.Atrial Fibrillation in Africa-An Underreported and Unrecognized Risk Factor for Stroke: A Systematic Review.Glob Heart. 2019 May 15. pii: S2211-8160(19)30067-5. doi: 10.1016/j.gheart.2019.04.003. [Epub ahead of print] Review. PMID:31103399
  • Adeoye AM, Ovbiagele B, Akinyemi JO, Ogah OS, Akinyemi R, Gebregziabher M, Wahab K, Fakunle AG, Akintunde A, Adebayo O, Aje A, Tiwari HK, Arnett D, Agyekum F, Appiah LT, Amusa G, Olunuga TO, Onoja A, Sarfo FS, Akpalu A, Jenkins C, Lackland D, Owolabi L, Komolafe M, Faniyan MM, Arulogun O, Obiako R, Owolabi M. Echocardiographic Abnormalities and Determinants of 1-Month Outcome of Stroke Among West Africans in the SIREN Study. J Am Heart Assoc. 2019 Jun 4;8(11):e010814. doi: 10.1161/JAHA.118.010814. Epub 2019 May 30. PMID:31142178
  • Ogunbode AM, Owolabi MO, Ogunbode OO, Ogunniyi A. What’s in your hands? A systematic review of dietary assessment methods and estimation of food sizes in a Primary Care Clinic. J Med Trop 2018;20:93-103. DOI: 10.4103/jomt.jomt_22_18
  • Akpabio AA, Owolabi MO, Umoh VA, Adelowo OO. Evaluation of rheumatology lectures by clinical students in a Nigerian medical school: learning from the learners.  Afr J Rheumatol 2019; Vol. 7(2): 57 – 62  
  • Naghavi M; Global Burden of Disease Self-Harm Collaborators. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016. BMJ. 2019 Feb 6;364:l94. doi: 10.1136/bmj.l94. PMID: 31339847
  • Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I, Abdulle ASM, Abebe ND, Abraha HN, Abu-Raddad LJ, Abualhasan A, Adedeji IA, Advani SM, Afarideh M, Afshari M, Aghaali M, Agius D, Agrawal S, Ahmadi A, Ahmadian E, Ahmadpour E, Ahmed MB, Akbari ME, Akinyemiju T, Al-Aly Z, AlAbdulKader AM, Alahdab F, Alam T, Alamene GM, Alemnew BTT, Alene KA, Alinia C, Alipour V, Aljunid SM, Bakeshei FA, Almadi MAH, Almasi-Hashiani A, Alsharif U, Alsowaidi S, Alvis-Guzman N, Amini E, Amini S, Amoako YA, Anbari Z, Anber NH, Andrei CL, Anjomshoa M, Ansari F, Ansariadi A, Appiah SCY, Arab-Zozani M, Arabloo J, Arefi Z, Aremu O, Areri HA, Artaman A, Asayesh H, Asfaw ET, Ashagre AF, Assadi R, Ataeinia B, Atalay HT, Ataro Z, Atique S, Ausloos M, Avila-Burgos L, Avokpaho EFGA, Awasthi A, Awoke N, Ayala Quintanilla BP, Ayanore MA, Ayele HT, Babaee E, Bacha U, Badawi A, Bagherzadeh M, Bagli E, Balakrishnan S, Balouchi A, Bärnighausen TW, Battista RJ, Behzadifar M, Behzadifar M, Bekele BB, Belay YB, Belayneh YM, Berfield KKS, Berhane A, Bernabe E, Beuran M, Bhakta N, Bhattacharyya K, Biadgo B, Bijani A, Bin Sayeed MS, Birungi C, Bisignano C, Bitew H, Bjørge T, Bleyer A, Bogale KA, Bojia HA, Borzì AM, Bosetti C, Bou-Orm IR, Brenner H, Brewer JD, Briko AN, Briko NI, Bustamante-Teixeira MT, Butt ZA, Carreras G, Carrero JJ, Carvalho F, Castro C, Castro F, Catalá-López F, Cerin E, Chaiah Y, Chanie WF, Chattu VK, Chaturvedi P, Chauhan NS, Chehrazi M, Chiang PP, Chichiabellu TY, Chido-Amajuoyi OG, Chimed-Ochir O, Choi JJ, Christopher DJ, Chu DT, Constantin MM, Costa VM, Crocetti E, Crowe CS, Curado MP, Dahlawi SMA, Damiani G, Darwish AH, Daryani A, das Neves J, Demeke FM, Demis AB, Demissie BW, Demoz GT, Denova-Gutiérrez E, Derakhshani A, Deribe KS, Desai R, Desalegn BB, Desta M, Dey S, Dharmaratne SD, Dhimal M, Diaz D, Dinberu MTT, Djalalinia S, Doku DT, Drake TM, Dubey M, Dubljanin E, Duken EE, Ebrahimi H, Effiong A, Eftekhari A, El Sayed I, Zaki MES, El-Jaafary SI, El-Khatib Z, Elemineh DA, Elkout H, Ellenbogen RG, Elsharkawy A, Emamian MH, Endalew DA, Endries AY, Eshrati B, Fadhil I, Fallah V, Faramarzi M, Farhangi MA, Farioli A, Farzadfar F, Fentahun N, Fernandes E, Feyissa GT, Filip I, Fischer F, Fisher JL, Force LM, Foroutan M, Freitas M, Fukumoto T, Futran ND, Gallus S, Gankpe FG, Gayesa RT, Gebrehiwot TT, Gebremeskel GG, Gedefaw GA, Gelaw BK, Geta B, Getachew S, Gezae KE, Ghafourifard M, Ghajar A, Ghashghaee A, Gholamian A, Gill PS, Ginindza TTG, Girmay A, Gizaw M, Gomez RS, Gopalani SV, Gorini G, Goulart BNG, Grada A, Ribeiro Guerra M, Guimaraes ALS, Gupta PC, Gupta R, Hadkhale K, Haj-Mirzaian A, Haj-Mirzaian A, Hamadeh RR, Hamidi S, Hanfore LK, Haro JM, Hasankhani M, Hasanzadeh A, Hassen HY, Hay RJ, Hay SI, Henok A, Henry NJ, Herteliu C, Hidru HD, Hoang CL, Hole MK, Hoogar P, Horita N, Hosgood HD, Hosseini M, Hosseinzadeh M, Hostiuc M, Hostiuc S, Househ M, Hussen MM, Ileanu B, Ilic MD, Innos K, Irvani SSN, Iseh KR, Islam SMS, Islami F, Jafari Balalami N, Jafarinia M, Jahangiry L, Jahani MA, Jahanmehr N, Jakovljevic M, James SL, Javanbakht M, Jayaraman S, Jee SH, Jenabi E, Jha RP, Jonas JB, Jonnagaddala J, Joo T, Jungari SB, Jürisson M, Kabir A, Kamangar F, Karch A, Karimi N, Karimian A, Kasaeian A, Kasahun GG, Kassa B, Kassa TD, Kassaw MW, Kaul A, Keiyoro PN, Kelbore AG, Kerbo AA, Khader YS, Khalilarjmandi M, Khan EA, Khan G, Khang YH, Khatab K, Khater A, Khayamzadeh M, Khazaee-Pool M, Khazaei S, Khoja AT, Khosravi MH, Khubchandani J, Kianipour N, Kim D, Kim YJ, Kisa A, Kisa S, Kissimova-Skarbek K, Komaki H, Koyanagi A, Krohn KJ, Bicer BK, Kugbey N, Kumar V, Kuupiel D, La Vecchia C, Lad DP, Lake EA, Lakew AM, Lal DK, Lami FH, Lan Q, Lasrado S, Lauriola P, Lazarus JV, Leigh J, Leshargie CT, Liao Y, Limenih MA, Listl S, Lopez AD, Lopukhov PD, Lunevicius R, Madadin M, Magdeldin S, El Razek HMA, Majeed A, Maleki A, Malekzadeh R, Manafi A, Manafi N, Manamo WA, Mansourian M, Mansournia MA, Mantovani LG, Maroufizadeh S, Martini SMS, Mashamba-Thompson TP, Massenburg BB, Maswabi MT, Mathur MR, McAlinden C, McKee M, Meheretu HAA, Mehrotra R, Mehta V, Meier T, Melaku YA, Meles GG, Meles HG, Melese A, Melku M, Memiah PTN, Mendoza W, Menezes RG, Merat S, Meretoja TJ, Mestrovic T, Miazgowski B, Miazgowski T, Mihretie KMM, Miller TR, Mills EJ, Mir SM, Mirzaei H, Mirzaei HR, Mishra R, Moazen B, Mohammad DK, Mohammad KA, Mohammad Y, Darwesh AM, Mohammadbeigi A, Mohammadi H, Mohammadi M, Mohammadian M, Mohammadian-Hafshejani A, Mohammadoo-Khorasani M, Mohammadpourhodki R, Mohammed AS, Mohammed JA, Mohammed S, Mohebi F, Mokdad AH, Monasta L, Moodley Y, Moosazadeh M, Moossavi M, Moradi G, Moradi-Joo M, Moradi-Lakeh M, Moradpour F, Morawska L, Morgado-da-Costa J, Morisaki N, Morrison SD, Mosapour A, Mousavi SM, Muche AA, Muhammed OSS, Musa J, Nabhan AR, Naderi M, Nagarajan AJ, Nagel G, Nahvijou A, Naik G, Najafi F, Naldi L, Nam HS, Nasiri N, Nazari J, Negoi I, Neupane S, Newcomb PA, Nggada HA, Ngunjiri JW, Nguyen CT, Nikniaz L, Ningrum DNA, Nirayo YL, Nixon MR, Nnaji CA, Nojomi M, Nosratnejad S, Shiadeh MN, Obsa MS, Ofori-Asenso R, Ogbo FA, Oh IH, Olagunju AT, Olagunju TO, Oluwasanu MM, Omonisi AE, Onwujekwe OE, Oommen AM, Oren E, Ortega-Altamirano DDV, Ota E, Otstavnov SS, Owolabi MO, P A M, Padubidri JR, Pakhale S, Pakpour AH, Pana A, Park EK, Parsian H, Pashaei T, Patel S, Patil ST, Pennini A, Pereira DM, Piccinelli C, Pillay JD, Pirestani M, Pishgar F, Postma MJ, Pourjafar H, Pourmalek F, Pourshams A, Prakash S, Prasad N, Qorbani M, Rabiee M, Rabiee N, Radfar A, Rafiei A, Rahim F, Rahimi M, Rahman MA, Rajati F, Rana SM, Raoofi S, Rath GK, Rawaf DL, Rawaf S, Reiner RC, Renzaho AMN, Rezaei N, Rezapour A, Ribeiro AI, Ribeiro D, Ronfani L, Roro EM, Roshandel G, Rostami A, Saad RS, Sabbagh P, Sabour S, Saddik B, Safiri S, Sahebkar A, Salahshoor MR, Salehi F, Salem H, Salem MR, Salimzadeh H, Salomon JA, Samy AM, Sanabria J, Santric Milicevic MM, Sartorius B, Sarveazad A, Sathian B, Satpathy M, Savic M, Sawhney M, Sayyah M, Schneider IJC, Schöttker B, Sekerija M, Sepanlou SG, Sepehrimanesh M, Seyedmousavi S, Shaahmadi F, Shabaninejad H, Shahbaz M, Shaikh MA, Shamshirian A, Shamsizadeh M, Sharafi H, Sharafi Z, Sharif M, Sharifi A, Sharifi H, Sharma R, Sheikh A, Shirkoohi R, Shukla SR, Si S, Siabani S, Silva DAS, Silveira DGA, Singh A, Singh JA, Sisay S, Sitas F, Sobngwi E, Soofi M, Soriano JB, Stathopoulou V, Sufiyan MB, Tabarés-Seisdedos R, Tabuchi T, Takahashi K, Tamtaji OR, Tarawneh MR, Tassew SG, Taymoori P, Tehrani-Banihashemi A, Temsah MH, Temsah O, Tesfay BE, Tesfay FH, Teshale MY, Tessema GA, Thapa S, Tlaye KG, Topor-Madry R, Tovani-Palone MR, Traini E, Tran BX, Tran KB, Tsadik AG, Ullah I, Uthman OA, Vacante M, Vaezi M, Varona Pérez P, Veisani Y, Vidale S, Violante FS, Vlassov V, Vollset SE, Vos T, Vosoughi K, Vu GT, Vujcic IS, Wabinga H, Wachamo TM, Wagnew FS, Waheed Y, Weldegebreal F, Weldesamuel GT, Wijeratne T, Wondafrash DZ, Wonde TE, Wondmieneh AB, Workie HM, Yadav R, Yadegar A, Yadollahpour A, Yaseri M, Yazdi-Feyzabadi V, Yeshaneh A, Yimam MA, Yimer EM, Yisma E, Yonemoto N, Younis MZ, Yousefi B, Yousefifard M, Yu C, Zabeh E, Zadnik V, Moghadam TZ, Zaidi Z, Zamani M, Zandian H, Zangeneh A, Zaki L, Zendehdel K, Zenebe ZM, Zewale TA, Ziapour A, Zodpey S, Murray CJL. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.JAMA Oncol. 2019 Sep 27. doi: 10.1001/jamaoncol.2019.2996. [Epub ahead of print] PMD 31560378
  • Adebusoye LA, Cadmus EO, Owolabi MO and Ogunniyi A . Frailty and mortality among older patients in a tertiary hospital in Nigeria Ghana Med J 2019; 53(3):210-216 doi: http://dx.doi.org/10.4314/gmj.v53i3.5
  •  Burstein R, Henry NJ, Collison ML, Marczak LB, Sligar A, Watson S, Marquez N, Abbasalizad-Farhangi M, Abbasi M, Abd-Allah F, Abdoli A, Abdollahi M, Abdollahpour I, Abdulkader RS, Abrigo MRM, Acharya D, Adebayo OM, Adekanmbi V, Adham D, Afshari M, Aghaali M, Ahmadi K, Ahmadi M, Ahmadpour E, Ahmed R, Akal CG, Akinyemi JO, Alahdab F, Alam N, Alamene GM, Alene KA, Alijanzadeh M, Alinia C, Alipour V, Aljunid SM, Almalki MJ, Al-Mekhlafi HM, Altirkawi K, Alvis-Guzman N, Amegah AK, Amini S, Amit AML, Anbari Z, Androudi S, Anjomshoa M, Ansari F, Antonio CAT, Arabloo J, Arefi Z, Aremu O, Armoon B, Arora A, Artaman A, Asadi A, Asadi-Aliabadi M, Ashraf-Ganjouei A, Assadi R, Ataeinia B, Atre SR, Quintanilla BPA, Ayanore MA, Azari S, Babaee E, Babazadeh A, Badawi A, Bagheri S, Bagherzadeh M, Baheiraei N, Balouchi A, Barac A, Bassat Q, Baune BT, Bayati M, Bedi N, Beghi E, Behzadifar M, Behzadifar M, Belay YB, Bell B, Bell ML, Berbada DA, Bernstein RS, Bhattacharjee NV, Bhattarai S, Bhutta ZA, Bijani A, Bohlouli S, Breitborde NJK, Britton G, Browne AJ, Nagaraja SB, Busse R, Butt ZA, Car J, Cárdenas R, Castañeda-Orjuela CA, Cerin E, Chanie WF, Chatterjee P, Chu DT, Cooper C, Costa VM, Dalal K, Dandona L, Dandona R, Daoud F, Daryani A, Das Gupta R, Davis I, Davis Weaver N, Davitoiu DV, De Neve JW, Demeke FM, Demoz GT, Deribe K, Desai R, Deshpande A, Desyibelew HD, Dey S, Dharmaratne SD, Dhimal M, Diaz D, Doshmangir L, Duraes AR, Dwyer-Lindgren L, Earl L, Ebrahimi R, Ebrahimpour S, Effiong A, Eftekhari A, Ehsani-Chimeh E, El Sayed I, El Sayed Zaki M, El Tantawi M, El-Khatib Z, Emamian MH, Enany S, Eskandarieh S, Eyawo O, Ezalarab M, Faramarzi M, Fareed M, Faridnia R, Faro A, Fazaeli AA, Fazlzadeh M, Fentahun N, Fereshtehnejad SM, Fernandes JC, Filip I, Fischer F, Foigt NA, Foroutan M, Francis JM, Fukumoto T, Fullman N, Gallus S, Gebre DG, Gebrehiwot TT, Gebremeskel GG, Gessner BD, Geta B, Gething PW, Ghadimi R, Ghadiri K, Ghajarzadeh M, Ghashghaee A, Gill PS, Gill TK, Golding N, Gomes NGM, Gona PN, Gopalani SV, Gorini G, Goulart BNG, Graetz N, Greaves F, Green MS, Guo Y, Haj-Mirzaian A, Haj-Mirzaian A, Hall BJ, Hamidi S, Haririan H, Haro JM, Hasankhani M, Hasanpoor E, Hasanzadeh A, Hassankhani H, Hassen HY, Hegazy MI, Hendrie D, Heydarpour F, Hird TR, Hoang CL, Hollerich G, Rad EH, Hoseini-Ghahfarokhi M, Hossain N, Hosseini M, Hosseinzadeh M, Hostiuc M, Hostiuc S, Househ M, Hsairi M, Ilesanmi OS, Imani-Nasab MH, Iqbal U, Irvani SSN, Islam N, Islam SMS, Jürisson M, Balalami NJ, Jalali A, Javidnia J, Jayatilleke AU, Jenabi E, Ji JS, Jobanputra YB, Johnson K, Jonas JB, Shushtari ZJ, Jozwiak JJ, Kabir A, Kahsay A, Kalani H, Kalhor R, Karami M, Karki S, Kasaeian A, Kassebaum NJ, Keiyoro PN, Kemp GR, Khabiri R, Khader YS, Khafaie MA, Khan EA, Khan J, Khan MS, Khang YH, Khatab K, Khater A, Khater MM, Khatony A, Khazaei M, Khazaei S, Khazaei-Pool M, Khubchandani J, Kianipour N, Kim YJ, Kimokoti RW, Kinyoki DK, Kisa A, Kisa S, Kolola T, Kosen S, Koul PA, Koyanagi A, Kraemer MUG, Krishan K, Krohn KJ, Kugbey N, Kumar GA, Kumar M, Kumar P, Kuupiel D, Lacey B, Lad SD, Lami FH, Larsson AO, Lee PH, Leili M, Levine AJ, Li S, Lim LL, Listl S, Longbottom J, Lopez JCF, Lorkowski S, Magdeldin S, Abd El Razek HM, Abd El Razek MM, Majeed A, Maleki A, Malekzadeh R, Malta DC, Mamun AA, Manafi N, Manda AL, Mansourian M, Martins-Melo FR, Masaka A, Massenburg BB, Maulik PK, Mayala BK, Mazidi M, McKee M, Mehrotra R, Mehta KM, Meles GG, Mendoza W, Menezes RG, Meretoja A, Meretoja TJ, Mestrovic T, Miller TR, Miller-Petrie MK, Mills EJ, Milne GJ, Mini GK, Mir SM, Mirjalali H, Mirrakhimov EM, Mohamadi E, Mohammad DK, Darwesh AM, Mezerji NMG, Mohammed AS, Mohammed S, Mokdad AH, Molokhia M, Monasta L, Moodley Y, Moosazadeh M, Moradi G, Moradi M, Moradi Y, Moradi-Lakeh M, Moradinazar M, Moraga P, Morawska L, Mosapour A, Mousavi SM, Mueller UO, Muluneh AG, Mustafa G, Nabavizadeh B, Naderi M, Nagarajan AJ, Nahvijou A, Najafi F, Nangia V, Ndwandwe DE, Neamati N, Negoi I, Negoi RI, Ngunjiri JW, Thi Nguyen HL, Nguyen LH, Nguyen SH, Nielsen KR, Ningrum DNA, Nirayo YL, Nixon MR, Nnaji CA, Nojomi M, Noroozi M, Nosratnejad S, Noubiap JJ, Motlagh SN, Ofori-Asenso R, Ogbo FA, Oladimeji KE, Olagunju AT, Olfatifar M, Olum S, Olusanya BO, Oluwasanu MM, Onwujekwe OE, Oren E, Ortega-Altamirano DDV, Ortiz A, Osarenotor O, Osei FB, Osgood-Zimmerman AE, Otstavnov SS, Owolabi MO, P A M, Pagheh AS, Pakhale S, Panda-Jonas S, Pandey A, Park EK, Parsian H, Pashaei T, Patel SK, Pepito VCF, Pereira A, Perkins S, Pickering BV, Pilgrim T, Pirestani M, Piroozi B, Pirsaheb M, Plana-Ripoll O, Pourjafar H, Puri P, Qorbani M, Quintana H, Rabiee M, Rabiee N, Radfar A, Rafiei A, Rahim F, Rahimi Z, Rahimi-Movaghar V, Rahimzadeh S, Rajati F, Raju SB, Ramezankhani A, Ranabhat CL, Rasella D, Rashedi V, Rawal L, Reiner RC Jr, Renzaho AMN, Rezaei S, Rezapour A, Riahi SM, Ribeiro AI, Roever L, Roro EM, Roser M, Roshandel G, Roshani D, Rostami A, Rubagotti E, Rubino S, Sabour S, Sadat N, Sadeghi E, Saeedi R, Safari Y, Safari-Faramani R, Safdarian M, Sahebkar A, Salahshoor MR, Salam N, Salamati P, Salehi F, Zahabi SS, Salimi Y, Salimzadeh H, Salomon JA, Sambala EZ, Samy AM, Santric Milicevic MM, Jose BPS, Saraswathy SYI, Sarmiento-Suárez R, Sartorius B, Sathian B, Saxena S, Sbarra AN, Schaeffer LE, Schwebel DC, Sepanlou SG, Seyedmousavi S, Shaahmadi F, Shaikh MA, Shams-Beyranvand M, Shamshirian A, Shamsizadeh M, Sharafi K, Sharif M, Sharif-Alhoseini M, Sharifi H, Sharma J, Sharma R, Sheikh A, Shields C, Shigematsu M, Shiri R, Shiue I, Shuval K, Siddiqi TJ, Silva JP, Singh JA, Sinha DN, Sisay MM, Sisay S, Sliwa K, Smith DL, Somayaji R, Soofi M, Soriano JB, Sreeramareddy CT, Sudaryanto A, Sufiyan MB, Sykes BL, Sylaja PN, Tabarés-Seisdedos R, Tabb KM, Tabuchi T, Taveira N, Temsah MH, Terkawi AS, Tessema ZT, Thankappan KR, Thirunavukkarasu S, To QG, Tovani-Palone MR, Tran BX, Tran KB, Ullah I, Usman MS, Uthman OA, Vahedian-Azimi A, Valdez PR, van Boven JFM, Vasankari TJ, Vasseghian Y, Veisani Y, Venketasubramanian N, Violante FS, Vladimirov SK, Vlassov V, Vos T, Vu GT, Vujcic IS, Waheed Y, Wakefield J, Wang H, Wang Y, Wang YP, Ward JL, Weintraub RG, Weldegwergs KG, Weldesamuel GT, Westerman R, Wiysonge CS, Wondafrash DZ, Woyczynski L, Wu AM, Xu G, Yadegar A, Yamada T, Yazdi-Feyzabadi V, Yilgwan CS, Yip P, Yonemoto N, Lebni JY, Younis MZ, Yousefifard M, Yousof HSA, Yu C, Yusefzadeh H, Zabeh E, Moghadam TZ, Bin Zaman S, Zamani M, Zandian H, Zangeneh A, Zerfu TA, Zhang Y, Ziapour A, Zodpey S, Murray CJL, Hay SI. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017. Nature. 2019 Oct;574 (7778):353-358. doi: 10.1038/s41586-019-1545-0. Epub 2019 Oct 16. PMID:31619795
  • Wahab KW, Tiwari HK, Ovbiagele B, Sarfo F, Akinyemi R, Traylor M, Rotimi C, Markus HS, Owolabi M Genetic risk of Spontaneous intracerebral hemorrhage: Systematic review and future directions. Journal of the Neurological Sciences 407 (2019) 116526 https://doi.org/10.1016/j.jns.2019.116526
  • Ekker M, Jacob M, van Dongen M, Aarnio K, Annamalai A, Arauz A, Arnold M, Barboza M, Bolognese M, Brouns R, Chuluun B, Chuluunbaatar E, Dagvajantsan B, Debette S, Don A, Enzinger C, Ekizoglu E, Fandler-Höfler S, Fazekas F, Fromm A, Gattringer T, Gulli G, Hoffmann M, Hora T, Jern C, Jood K, Kamouchi M, Kim YS, Kitazono T, Kittner S, Kleinig T, Klijn K, Korv J, Lee TH, Leys D, Maaijwee N, Martinez-Majander N, Marto JP, Mehndiratta M, Mifsud V, Montanaro V, Owolabi MO, Patel V, Phillips M, Piechowski-Iozwiak B, Pikula A, Ruiz-Sandoval JL, Sarnowski B, Schreuder F, Swartz R, Tan KS, Tanne D, Tatlisumak T, Thijs V, Tuladhar A, Viana-Baptista M, Vibo R, Wu T, Yesilot N, Waje-Andreassen U, Pezzini A, Putaala J, de Leeuw FE. Global Outcome Assessment Life-long after stroke in young adults initiative-the GOAL initiative: study protocol and rationale of a multicentre retrospective individual patient data meta-analysis. BMJ Open. 2019 Nov 14;9(11):e031144. doi: 10.1136/bmjopen-2019-031144. PMID:1727655
  • Webster R, Parker G, Heritier S, Joshi R, Yeates K, Lopez-Jaramillo P, Miranda JJ, Oldenburg B, Ovbiagele B, Owolabi M, Peiris D, Praveen D, Salam A, Schwalm JD, Thankappan KR, Thomas N, Tobe S, Vedanthan R. Strategic, Successful, and Sustained Synergy: The Global Alliance for Chronic Diseases Hypertension Program.Glob Heart. 2019 Dec;14(4):391-394. doi: 10.1016/j.gheart.2019.09.003.. PMID: 31727270
  • Campbell NRC, Schutte AE, Varghese CV, Ordunez P, Zhang XH, Khan T, Sharman JE, Whelton PK, Parati G, Weber MA, Orías M, Jaffe MG, Moran AE, Liane Plavnik F, Ram VS, Brainin M, Owolabi MO, Ramirez AJ, Barbosa E, Bortolotto LA, Lackland DT. São Paulo call to action for the prevention and control of high blood pressure: 2020. J Clin Hypertens (Greenwich). 2019 Nov 25. doi: 10.1111/jch.13741. [Epub ahead of print].PMID:31769155
  • Owolabi MO, Gebregziabher M, Akinyemi RO, Akinyemi JO, Akpa O,  Olaniyan O.,  Salako BL, Arulogun O,  Tagge R,  Uvere E, Fakunle A., Ovbiagele B.Randomized Trial of an Intervention to Improve Blood Pressure Control in Stroke Survivors.Circulation: Cardiovascular Quality and Outcomes. 2019;12:e005904. DOI: 10.1161/CIRCOUTCOMES.119.005904
  •  Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, Deuschl G, Parmar P, Brainin M, Murray C. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2019 Dec 5. pii: S1474-4422(19)30411-9. doi: 10.1016/S1474-4422(19)30411-9. PMID:31813850
  •  Kim J., Thayabaranathan T., Donnan GA, Howard G, Howard VJ, Rothwel PM, Feigin V, Norrving B, Owolabi M, Pandian J, Liu L, Cadilhac DA, Thrift AG. Global Stroke Statistics 2019. International Journal of Stroke.2020. Mar 9:1747493020909545. doi: 10.1177/1747493020909545. Online ahead of print.PMID: 32146867
  • Sarfo FS,Ovbiagele B,Gebregziabher M,   Akpa A, Akpalu A, Wahab K,  Ogbole G, Akinyemi R, Obiako R, Komolafe M,  Owolabi L, Lackland D, Arnett D, Tiwari H,  Markus HS, Akinyemi J, Oguntade A, Fawale B, Adeoye A, Olugbo O, Ogunjimi L, Osaigbovo G, Jenkins C, Chukwuonye I, Ajose O, Oyinloye L, Mutiso F, Laryea R, Calys-Tagoe B,  Salaam A, Amusa G, Olowookere S, Imoh C, Mande A, Arulogun O, Adekunle F, Appiah L, Balogun O, Singh A, Adeleye O, Ogah O, Makanjuola A, Owusu D, Kolo P, Adebayo O, Agunloye A, Shidali V, Faniyan M, Lakoh S, Diala S, Iheonye H, Efidi C, Sanya E, Sunmonu T, Akintunde A, Owolabi M,  on behalf of SIREN. Unraveling the Risk factors for Spontaneous Intracerebral Hemorrhage and its Severity among West Africans. Neurology 2020;94:e1-e15. doi:10.1212/WNL.0000000000009056
  • Akinyemi R, Sarfo F, Abd-Allah F, Ogun Y, Belo M, Francis P, Mateus MB, Bateman K, Naidoo P, Charway-Felli A, Akpalu A, Wahab K, Napon C, Arulogun O, Ebenezer AA, Ekeng G, Scola G, Hamzat K, Zimba S, Ossou-Nguiet PM, Ademokoya J, Adebayo P, Ayele BA, Vaz DC, Ogbole G, Barasukan P, Melifonwu R, Onwuekwe I, Belson S, Damasceno A, Okubadejo N, Njamnshi AK, Ogeng’o J, Walker RW, Diop AG, Ogunniyi A, Kalaria R, Sandercock P, Davis S, Brainin M, Ovbiagele B, Owolabi M, Conceptual framework for establishing the African Stroke Organization. Int J Stroke. 2020 Feb 6:1747493019897871. doi: 10.1177/1747493019897871. [Epub ahead of print]
  • Frewen P, Schroeter ML, Riva G, Cipresso P, Fairfield B, Padulo C, Kemp AH, Palaniyappan L, Owolabi M, Kusi-Mensah K, Polyakova M, Fehertoi N, D’Andrea W, Lowe L, Northoff G.Neuroimaging the Consciousness of Self: Review, and Conceptual-Methodological Framework  Neurosci Biobehav Rev. 2020 Jan 26. pii: S0149-7634(19)30262-3. doi: 10.1016/j.neubiorev.2020.01.023.
  • Feigin V, Brainin M, Norrving B,  Gorelick PB,  Dichgans M, Wang W, Pandian JD,  Martins S,  Owolabi MO,  Wood DA, Hankey GJ, What Is the Best Mix of Population-Wide and High-Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention? J Am Heart Assoc. 2020;9:e014494. DOI: 10.1161/JAHA.119.014494.
  • Ogunbode AM, Owolabi MO, Ogunbode OO, Ogunniyi A. Factors associated with obesity and weight reduction among people with obesity: a systematic review. Journal of Molecular Pathophysiology, 2020 Vol 9, No. 1, Page 1–13
  • 10.5455/Jmp.20190717044204
  • Akpa OM, Made F, Ojo A, Ovbiagele B, Adu D,  Motala AA, Mayosi BM, Adebamowo SN, Engel ME, Tayo B, Rotimi C, Salako B, Akinyemi R, Gebregziabher M, Sarfo F, Wahab K, Agongo G, Alberts M, Ali SA, Asiki G, Boua RP, Gómez-Olivé FX, Mashinya F, Micklesfield L, Mohamed SF, Nonterah EA, Norris SA,  Sorgho H, Tollman S, Parekh RS, Chishala C, Ekuro K, Waddy SP, Peprah E, Mensah GA, Wiley K, Troyer J, Ramsay M, Owolabi MO, as members of the CVD Working Group of the H3Africa Consortium . Regional Patterns and Association Between Obesity and Hypertension in Africa :Evidence From the H3Africa CHAIRStudy Hypertension. 2020;75:1167–1178. OI:10.1161/HYPERTENSIONAHA.119.14147
  • Sarfo FS, Akinyemi R, Howard G,  Howard VJ, Wahab K, Cushman M, Levine DA, Ogunniyi A, Unverzagt F, Owolabi M, Ovbiagele B. Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke. Journal of the Neurological Sciences, 2020 DOI: https://doi.org/10.1016/j.jns.2020.116754
  • GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
  • Lancet. 2020 Feb 13. pii: S0140-6736(20)30045-3. doi: 10.1016/S0140-6736(20)30045-3
  • Li J, Ogbole G, Aribisala B, Affini M,  Yaria J, Adekunle F; Kehinde I;  Rahman A, Banjo R,  Faniyan M; Owolabi M, Sammet S, Association between White Matter Hyperintensities and Stroke in a West African Patient Population: Evidence from the Stroke Investigative Research and Educational Network Study Neuroimage. 2020 Apr 7:116789. doi: 10.1016/j.neuroimage.2020.116789. [Epub ahead of print] PMID:32276063
  •  Croxton T, Agala N, Jonathan E, Balogun O, Ozumba PJ, Onyemata E, Lawal S, Mamven M, Ajayi S, Melikam SE, Owolabi M, Ovbiagele B, Adu D, Ojo A, Beiswanger CM, Abimiku A. H3Africa partnerships to empower clinical research sites to generate high-quality biological samples. Afr J Lab Med. 2020 Mar 18;9(1):935. doi: 10.4102/ajlm.v9i1.935. eCollection 2020.PMID: 32284923A
  • Global Burden of Disease Health Financing Collaborator Network. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3. Lancet. 2020 Apr 23. pii: S0140-6736(20)30608-5. doi: 10.1016/S0140-6736(20)30608-5. [Epub ahead of print] PMID: 32334655
  •  LBD Double Burden of Malnutrition Collaborators including Owolabi MO. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017. Nat Med. 2020 May;26(5):750-759. doi: 10.1038/s41591-020-0807-6. Epub 2020 Apr 20.PMID: 32313249 
  • Ezunu EO, Owolabi M, Ogunniyi A, Williams U. Epilepsy Care in Nigeria: Factors Influencing Default. Natl J Community Med 2020;11(4):160-165
  • LBD Double Burden of Malnutrition Collaborators including Owolabi MO. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017. Nat Med. 2020 May;26(5):750-759. doi: 10.1038/s41591-020-0807-6. Epub 2020 Apr 20.PMID: 32313249 
  • GBD Chronic Respiratory Disease Collaborators including Owolabi MO. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. .Lancet Respir Med. 2020 Jun;8(6):585-596. doi: 10.1016/S2213-2600(20)30105-3.PMID: 32526187 
  • Local Burden of Disease Diarrhoea Collaborators Owolabi MO Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: analysis for the Global Burden of Disease Study 2017. .Lancet. 2020 Jun 6;395(10239):1779-1801. doi: 10.1016/S0140-6736(20)30114-8. Epub 2020 May 6.PMID: 32513411 
  • Ojagbemi A, Akinyemi J, Owolabi M, Akinyemi R, Arulogun O, Gebregziabher M, Akpa O, Olaniyan O, Salako B, Ovbiagele B. Predictors and prognoses of new onset post-stroke anxiety at one year in black Africans.J  Stroke Cerebrovasc Dis. 2020 Sep;29(9):105082. doi: 10.1016/j.jstrokecerebrovasdis.2020.105082. Epub 2020 Jul 3.PMID: 32807479
  •  Local Burden of Disease Diarrhoea Collaborators Owolabi MO. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17. Lancet Glob Health. 2020 Aug;8(8):e1038-e1060. doi: 10.1016/S2214-109X(20)30230-8.PMID: 32710861 
  • Ojagbemi A, Bello T, Owolabi M, Baiyewu O. Cognitive, Functional, and Mortality Outcomes of Attenuated Delirium Syndrome in Stroke Survivors. J Geriatr Psychiatry Neurol. 2020 Aug 6:891988720944234. doi: 10.1177/0891988720944234. Online ahead of print.PMID: 32757844
  • Gebreyohanns M, Akinyemi RA, Owolabi MO, Sarfo FS, Tagge R, Ovbiagele B. The Inaugural African Stroke Organization Conference J Neurol Sci. 2020 Aug 10;418:117089. doi: 10.1016/j.jns.2020.117089. Online ahead of print. PMID: 32805439 No abstract available.
  • GBD 2019 Universal Health Coverage Collaborators including Owolabi MO. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Aug 27:S0140-6736(20)30750-9. doi: 10.1016/S0140-6736(20)30750-9. Online ahead of print. PMID: 32861314 
  • Local Burden of Disease WaSH Collaborators Oowlabi MO. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17. Lancet Glob Health. 2020 Sep;8(9):e1162-e1185. doi: 10.1016/S2214-109X(20)30278-3. PMID: 32827479
  • Hurst JR, Agarwal G, van Boven JFM, Daivadanam M, Gould GS, Wan-Chun Huang E, Maulik PK, Miranda JJ, Owolabi MO, Premji SS, Soriano JB, Vedanthan R, Yan L, Levitt N; GACD Multi-Morbidity Working Group. Critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the Global Alliance for Chronic Diseases (GACD) researchers. BMJ Open. 2020 Sep 6;10(9):e037079. doi: 10.1136/bmjopen-2020-037079.PMID: 32895277 
  • Sarfo FS, Ovbiagele B, Matthew OA, Akpalu A, Wahab K, Obiako R, Owolabi L, Asowata O, Ogbole G, Komolafe M, Akinyemi R, Owolabi M; SIREN. Antecedent febrile illness and occurrence of stroke in West Africa: The SIREN study. J Neurol Sci. 2020 Sep 28;418:117158. doi: 10.1016/j.jns.2020.117158. Online ahead of print. PMID: 33002758
  • Ekechukwu END, Olowoyo P, Nwankwo KO, Olaleye OA, Ogbodo VE, Hamzat TK, Owolabi MO. Front Neurol. 2020 Jun 25;11:337. doi: 10.3389/fneur.2020.00337. eCollection 2020 Pragmatic Solutions for Stroke Recovery and Improved Quality of Life in Low- and Middle-Income Countries-A Systematic Review. .PMID: 32695058
  • Ojagbemi A, Akinyemi J, Wahab K, Owolabi L, Arulogun O, Akpalu J, Akpalu A, Ogbole G, Akinsanya C, Wasiu A, Tito-Ilori M, Adekunle F, Lyrea R, Akpa O, Akinyemi R, Sarfo F, Owolabi M, Ovbiagele B. Pre-Stroke Depression in Ghana and Nigeria: Prevalence, Predictors and Association With Poststroke Depression. J Geriatr Psychiatry Neurol. 2020 Oct 19:891988720968274. doi: 10.1177/0891988720968274.
  •  GBD 2019 Viewpoint Collaborators , Owolabi MO. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1135-1159. doi: 10.1016/S0140-6736(20)31404-5. PMID: 33069324 Review.
  • Balogun WO, Uloko AE, Owolabi MO Atypical Diabetes Presentations in Sub-Saharan Africa Classification Puzzle and Possible Role of Precision Medicine. .West Afr J Med. 2020 Oct;37(5):574-582.PMID: 33058135
  • GBD 2019 Risk Factors Collaborators, Owolabi MO. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.PMID: 33069327 
  •  GBD 2019 Demographics Collaborators, Owolabi MO. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. .Lancet. 2020 Oct 17;396(10258):1160-1203. doi: 10.1016/S0140-6736(20)30977-6. PMID: 33069325 
  • GBD 2019 Diseases and Injuries Collaborators , Owolabi MO.Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9. PMID: 33069326 
  • Lee Y, Brietzke E, Cao B, Chen Y, Linnaranta O, Mansur RB, Cortes P, Kösters M, Majeed A, Tamura JK, Lui LMW, Vinberg M, Keinänen J, Kisely S, Naveed S, Barbui C, Parker G, Owolabi M, Nishi D, Lee J, Srisurapanont M, Gill H, Guo L, Balanzá-Martínez V, Partonen T, Nolen WA, Lee JH, Kim JH, Chavannes NH, Ewais T, Atienza-Carbonell B, Silven AV, Yasuma N, Gil A, Novikov A, Lacey C, Versluis A, von Malortie S, Chan LF, Waqas A, Purgato M, Aardoom JJ, Ly-Uson JT, Sim K, Tuineag M, van der Kleij RMJJ, van Luenen S, Suttajit S, Hajek T, Lee YW, Porter RJ, Alsuwaidan M, Rosenblat JD, Ravindran AV, Lam RW, McIntyre RS; Global Alliance for Chronic Diseases (GACD) Mental Health Guidelines Working Group. Development and implementation of guidelines for the management of depression: a systematic review Bull World Health Organ. 2020 Oct 1;98(10):683-697H. doi: 10.2471/BLT.20.251405. Epub 2020 Aug 27.PMID: 33177758 
  •  GBD 2019 Blindness and Vision Impairment Collaborators, Owolabi MO; Vision Loss Expert Group of the Global Burden of Disease Study.Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2020 Dec 1:S2214-109X(20)30489-7. doi: 10.1016/S2214-109X(20)30489-7. Online ahead of print. PMID: 33275949 
  •  Mulder N, Lombard Z, Owolabi MO, Ofori-Acquah SF. Editorial: The Genetic and Environmental Basis for Diseases in Understudied Populations. Front Genet. 2020 Sep 23;11:559956. doi: 10.3389/fgene.2020.559956. eCollection 2020.PMID: 33173534
  • Ojagbemi A, Bello T, Elugbadebo O, Owolabi M, Baiyewu O. Different Cognitive and Functional Outcomes in Attenuated and Full Delirium Syndromes Among Recent Stroke Survivors. J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105251. doi: 10.1016/j.jstrokecerebrovasdis.2020.105251. Epub 2020 Aug 25.PMID: 33066941
  • Owolabi MO, Platz T, Good D, Dobkin BH, Ekechukwu END and Li L (2020) Editorial: Translating Innovations in Stroke Rehabilitation to Improve Recovery and Quality of Life Across the Globe. Front. Neurol. 11:630830. doi: 10.3389/fneur.2020.630830
  • Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 Dec 3:S0735-1097(20)37775-5. doi: 10.1016/j.jacc.2020.11.010. Online ahead of print. PMID: 33309175 
  • Local Burden of Disease Vaccine Coverage Collaborators Owolabi MO. Mapping routine measles vaccination in low- and middle-income countries. Nature. 2020 Dec 16. doi: 10.1038/s41586-020-03043-4. Online ahead of print.PMID: 33328634
  • Akpa OM, Okekunle AP, Ovbiagele B, Sarfo FS, Akinyemi RO, Akpalu A, Wahab KW, Komolafe M, Obiako R, Owolabi LF, Ogbole G, Fawale B, Fakunle A, Asaleye CM, Akisanya CO, Hamisu DA, Ogunjimi L, Adeoye A, Ogah O, Lackland D, Uvere EO, Faniyan MM, Asowata OJ, Adeleye O, Aridegbe M, Olunuga T, Yahaya IS, Olaleye A, Calys-Tagoe B, Owolabi MO; SIREN Study as part of the H3Africa Consortium. J Clin Hypertens. 2021;00:1–12. https://doi.org/10.1111/jch.141832021 Jan 23. doi: 10.1111/jch.14183. Online ahead of print.PMID: 33484599
  • Ojagbemi A, Bello T, Owolabi M, Baiyewu O.  The Independent Association of Prestroke Psychiatric Symptoms and Acute Phase Delirium with Poststroke Mortality at One Year in Nigeria.J. Stroke Cerebrovasc Dis. 2021 Jan 23;30(4):105622. doi: 10.1016/j.jstrokecerebrovasdis.2021.105622. Online ahead of print.PMID: 33497933
  • Ojagbemi A, Bello T, Owolabi M, Baiyewu O. Prevalence, predictors, and prognoses of prestroke neuropsychiatric symptoms at 3 months poststroke. Int Psychogeriatr. 2020 Dec 30:1-8. doi: 10.1017/S1041610220003816. Online ahead of print.PMID: 33375951

BOOK CHAPTERS

  • Owolabi MO (2011).Rasmussen Encephalitis: An Overview. In Hayasaka, D. (Ed.): Pathogenesis of Encephalitis, Published by Intech ISBN: 978-953-307-741-3. Chapter 9, 235-  254. DOI: 10.5772/20599.
  •  Owolabi MO (2011).The association between dyslipidemia and neuropathy. In Acimovic Z. (Ed): Dyslipidemia. Published by NOVA Science Publishers, Inc. New York. ISBN: 978-1-62100-917-7 Chapter 7. 165-177.
  • Ogunniyi A, Sanya E, Owolabi M, Akinyemi RO. (2015) Medical Research  in Nigeria with Special focus on the Neurosciences: a historical review.  In Oyebode F, Adeyoju AAB, Editors : Medical Research Principles and Practice. Ibadan Medical Specialist Group. Bookbuilders. Ibadan. ISBN 978 978 921 122 7. pages 19-60 
  • https://doi.org/10.1007/978-3-030-58505-1261


List of some of my published work (out of over 280 publications) available at ResearchGate

https://www.researchgate.net/profile/Mayowa_Owolabi/3

https://www.ncbi.nlm.nih.gov/sites/myncbi/mayowa.owolabi.1/bibliography/46357736/public/?sort=date&direction=ascending.

https://scholar.google.com/citations?user=76K2iYgAAAAJ&hl=en

INVITED SPEAKER/ CHAIR AT UNIVERSITIES AND INTERNATIONAL CONFERENCES

ICH Neurology

ICH JNS

THRIVES

Stroke in people of African ancestry. Stroke Journal. Commissioned article

Adetola Morenikeji Ogunbode, Mayowa Ojo Owolabi, Olayinka Oladunjoye Ogunbode, Adesola Ogunniyi, “Factors associated with obesity and weight reduction among people with obesity: a systematic review” (Manuscript Number: JMP-2019-07-010 was accepted for publication in the Journal of Molecular Pathophysiology.

  Akpa A, Akpalu A, Wahab K,  Ogbole G, Akinyemi R, Obiako R, Komolafe M,  Owolabi L, Lackland D, Arnett D, Tiwari H,  Markus HS, Akinyemi J, Oguntade A, Fawale B, Adeoye A, Olugbo O, Ogunjimi L, Osaigbovo G, Jenkins C, Chukwuonye I, Ajose O, Oyinloye L, Mutiso F, Laryea R, Calys-Tagoe B,  Salaam A, Amusa G, Olowookere S, Imoh C, Mande A, Arulogun O, Adekunle F, Appiah L, Balogun O, Singh A, Adeleye O, Ogah O, Makanjuola A, Owusu D, Kolo P, Adebayo O,

Naghavi M; Global Burden of Disease Self-Harm Collaborators. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016. BMJ. 2019 Feb 6;364:l94. doi: 10.1136/bmj.l94. PMID: 31339847

Prof. Valery L. Feigin, MD; Prof. Theo Vos, MD; Dr Emma Nichols, PhD; Prof. Mayowa O. Owolabi, MD; Prof. William M. Carroll, MD; Prof. Martin Dichgans, MD; Prof. Gunther Deuschl, MD; Dr Priya Parmar, PhD; Prof. Michael Brainin, MD; Prof. Christopher Murray, MD. A ROADMAP TO TACKLE THE BURDEN OF NEUROLOGICAL DISORDERS WORLDWIDE. Lancet Neurology

Valery Owolabi  et al THE GLOBAL BURDEN OF NEUROLOGICAL DISORDERS: TRANSLATING EVIDENCE INTO POLICY : Lancet Neurology

Valery  Owolabi  Stroke Prevention . JAHA

Julie Bernhardt Stroke Rehab Lancet

GBD Chronic Respiratory Diseases

Green leafy vegetables systematic review

Frontiers Systematic Review NeuroRehab

CIMT manuscript

ICH genetics systematic review

ICH manuscript in Neurology Journal

WHO Lancet manuscript

Stroke in people of African ancestry: Scientific Statement

 For Stroke Journal

Lancet Neurology commission on Racial and ethnic disparities in neurologic disease: opportunities and challenges[LA1]  Towfighi

Owolabi MO, Sarfo FS, Akinyemi R, Ovbiagele B. The Sub-Saharan Africa Conference on Stroke (SSACS): An idea whose time has come. Journal of the Neurological Sciences.Volume 400, 15 May 2019, Pages 194-198 https://doi.org/10.1016/j.jns.2019.03.026

Jacobs MS, van Hulst M, Adeoye AM, Tieleman RG, Postma MJ, Owolabi MO.Atrial Fibrillation in Africa-An Underreported and Unrecognized Risk Factor for Stroke: A Systematic Review.

Glob Heart. 2019 May 15. pii: S2211-8160(19)30067-5. doi: 10.1016/j.gheart.2019.04.003. [Epub ahead of print] Review. PMID:31103399

Adeoye AM, Ovbiagele B, Akinyemi JO, Ogah OS, Akinyemi R, Gebregziabher M, Wahab K, Fakunle AG, Akintunde A, Adebayo O, Aje A, Tiwari HK, Arnett D, Agyekum F, Appiah LT, Amusa G, Olunuga TO, Onoja A, Sarfo FS, Akpalu A, Jenkins C, Lackland D, Owolabi L, Komolafe M, Faniyan MM, Arulogun O, Obiako R, Owolabi M. Echocardiographic Abnormalities and Determinants of 1-Month Outcome of Stroke Among West Africans in the SIREN Study. J Am Heart Assoc. 2019 Jun 4;8(11):e010814. doi: 10.1161/JAHA.118.010814. Epub 2019 May 30. PMID:31142178

In Process

Owolabi MO THRIVES

Kumuthini J, Zass L, Olowoyo P, Owolabi MO”Proposed Guideline for Minimum Information Stroke Research and Clinical Data Reporting” Data Science Journal.

Akinyemi RO….. Owolabi MO, Gender differential in inclination to donate brain for research among Nigerians – the IBADAN Brain Bank Project, Cell and Tissue Banking

JH-D-18-01005  Journal of Hypertension

Is the cardiovascular health of South Africans today

comparablewith African Americans 45 years ago?

Gbenga Ogedegbee, Iolanthe` M. Krugerf, and Aletta E. Schuttea,g

Yolandi Breeta,g, Daniel T. Lacklandb, Bruce Ovbiagelec, Mayowa O. Owolabid

Owolabi et al SSACS

SICH Genomics review

GBD Neurology interpretation and impact

GBD Cancer

GBD Air pollution

GBD COPD

Global Stroke Statitics… Thrift and Dominique

Policy View Paper ; Lancet; Valery Feigin

GBD Diarroea

In the Pipeline

Nature Genetics Special issue on genetics in Africa

NEUBIOREV_2019_233_R2
Submission title:

Professor Paul Frewen Professor Matthias Schroeter,  Professor Giuseppe Riva,  Dr Pietro Cipresso, Dr Beth Fairfield, Miss Caterina Padulo, Dr Andrew Kemp, Dr LENA PALANIYAPPAN, Dr. Mayowa OWOLABI,
Dr Kwabena Kusi-Mensah, Dr. Maryna Polyakova, Dr Nicholas Fehertoi, Dr Wendy D’Andrea,
Dr Leroy Lowe, Professor Georg Northoff Neuroimaging the Consciousness of Self: Review, and Conceptual-Methodological Framework Neuroscience and Behavior Reviews


Mahmoud Reza Azarpazhooh, Amanda Thrift, Luciano Sposato, Negar Morovatdar, amin amiri, M. Cecilia Bahit, Mariano Coppola, Jennifer Mandzia, Nawaf Yassi, Yongchai Nilanont, Antonia Nucera, Subhash Kaul, Suvarna Alladi, Moira Kapral, Brian Silver, David Werring, Robert Simister, Richard Swartz, Mayowa Owolabi, Bruce Ovbiagele, and Vladimir Hachinski AGE, SEX, AND SETTING IN THE ETIOLOGY OF STROKE STUDY (ASSESS) Journal of Neurological Sciences

Adebusoye LA, Owolabi M, Ogunniyi A. Predictors of mortality among older patients in the medical wards of a tertiary hospital in Nigeria. Aging Clin Exp Res. 2018 Jul 6. doi: 10.1007/s40520-018-0997-7. [Epub ahead of print]

Owolabi M, Johnson W,  Khan T, Feigin V, for Operations Committee of the Lancet Neurology on Stroke Effectively Combating Stroke in Low- and Middle-Income Countries: Placing Proof in Pragmatism—The Lancet Neurology Commission. Journal of Stroke Medicine 1(1) 65-67, 2018 DOI: 10.1177/2516608518776706

Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 GBD 2016 Alcohol Collaborators Owolabi MO . Lancet 2018.:August 23, 2018 DOI:https://doi.org/10.1016/S0140-6736(18)31310-2

Munirudeen I, Charles-Davies M.A, Fabian U.A, Fasanmade A.A, Olaniyi J.A, Oyewole O.E, Owolabi M.O, Adebusuyi J.R, Hassan O, Ajobo B.M, Ebesunun M.O, Adigun K, Akinlade K.S, Okoli S.U, Arinola O.G and Agbedana E.O Reproductive Endocrinopathies in Nigerian Males with Zero and Three or More Metabolic Syndrome Components Arch. Bas. App. Med. 5 (2017) 109 – 118

Langhorne P1, O’Donnell MJ2, Chin SL3, Zhang H4, Xavier D5, Avezum A6, Mathur N5, Turner M7, MacLeod MJ7, Lopez-Jaramillo P8, Damasceno A9, Hankey GJ10, Dans AL11, Elsayed A12, Mondo C13, Wasay M14, Czlonkowska A15, Weimar C16, Yusufali AH17, Hussain FA18, Lisheng L19, Diener HC16, Ryglewicz D15, Pogosova N20, Iqbal R14, Diaz R21, Yusoff K22, Oguz A23, Wang X4, Penaherrera E24, Lanas F25, Ogah OS26, Ogunniyi A27, Iversen HK28, Malaga G29, Rumboldt Z30, Magazi D31, Nilanont Y32, Rosengren A33, Oveisgharan S34, Yusuf S3; INTERSTROKE collaborators.

Collaborators (334)

Send to

Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, Ansha MG, Brayne C, Choi JJ, Collado-Mateo D, Dahodwala N, Do HP, Edessa D, Endres M, Fereshtehnejad SM, Foreman KJ, Gankpe FG, Gupta R, Hankey GJ, Hay SI, Hegazy MI, Hibstu DT, Kasaeian A, Khader Y, Khalil I, Khang YH, Kim YJ, Kokubo Y, Logroscino G, Massano J, Mohamed Ibrahim N, Mohammed MA, Mohammadi A, Moradi-Lakeh M, Naghavi M, Nguyen BT, Nirayo YL, Ogbo FA, Owolabi MO, Pereira DM, Postma MJ, Qorbani M, Rahman MA, Roba KT, Safari H, Safiri S, Satpathy M, Sawhney M, Shafieesabet A, Shiferaw MS, Smith M, Szoeke CEI, Tabarés-Seisdedos R, Truong NT, Ukwaja KN, Venketasubramanian N, Villafaina S, Weldegwergs KG, Westerman R, Wijeratne T, Winkler AS, Xuan BT, Yonemoto N, Feigin VL, Vos T, Murray CJL. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.

Collaborators (66)

Clinical Neurophysiology Practice

Title: EMG Indications and Findings in a sub-Saharan African Neurorehabilitation Centre

Authors: Philip B. Adebayo1,2 Funmilola T. Taiwo3 Olufemi A. Ogunremi4 Mayowa O. Owolabi2,5

Ref.:  Ms. No. CNP-D-17-106R2

EMG Indications and Findings in a sub-Saharan African Neurorehabilitation Centre,

Consulting editor eNeurologicalSci


Yolandi Breet (PhD)a, Daniel T Lackland (DrPH)b, Bruce Ovbiagele (MD),c Mayowa O Owolabi (MBBS, MWACP,FMCP)d Iolanthè M Kruger (PhD)e, Aletta E Schutte (PhD)af Is the cardiovascular health of modern-day South Africans comparable to African-Americans 45 years ago??

Owolabi, Ojagbemi, ….BCEC Editorial

SIREN brain volume variables

Meena GACD Bulletin of the WHO . MS ID#: BLT/2018/216192

MS TITLE: The role of context in implementation research for non- communicable diseases: answering the ‘how-to’ dilemma

Stroke and cognitive dx in Africa: Akinyemi, Raj Kalaria

ECG and metab syndrome… Adeoye et al

Blossom manuscript

Mac Arthur Charles Davies manuscript

Biomarkers, shock index and modified early warning score among medical in-hospital older patients in Nigeria Adebusoye, Owolabi, Ogunniyi

IBADAN Brain bank: willingness to donate brain

Brain Research Bulletin Title: Brain Banking in Low- and Middle – Income Countries: Raison D’être for the Ibadan Brain Ageing, Dementia And Neurodegeneration (IBADAN) Brain Bank Project. Corresponding Author: Rufus AkinyemiCo-Authors: motunrayo Coker, akinsola ojagbemi, Ayodeji Salami, Joshua Akinyemi, Funmi Olopade, TEMITOPE FAROMBI, Michael Nweke, Oyedunni Arulogun, Ayodele Jegede, Mayowa OWOLABI, Raj Kalaria, Adesola Ogunniyi

Journal: Journal of the Neurological Sciences

Title:  The Contribution of HIV to Stroke Occurrence in a low HIV endemic West African Country: a case-control study

Corresponding Author:  Fred Sarfo

Co-Authors:  Ohene Opare-Sem; Martin Agyei; John Akassi; Dorcas Owusu; Mayowa Owolabi; Bruce Ovbiagele

ASSESS

GOAL

 Akpabio Peters

SIREN  FGD

SIREN Echo

SIREN CIMT

SIREN Gender and stroke

GBD –

    Stroke

Motor neurone disease

   MSclerosis

    SDG

  Epilepsy

    Dementias

    DALY

     Injury

   Risk factors

     YLD

    SCI/TBI

   Parkinson’s disease

    mortality.

   Brain cancer

Meningitis

   COD 2017 capstone

    Population and Fertility

               – FGH Prospective Paper  Financing

                                  – HIV retrospective financing

          – Lifetime stroke risk

        -HAQ trend

Alcohol

COUNCIL DM commentary

COUNCIL stroke

WHO Lancet Stroke Commission …Journal of Stroke Medicine commentary

Adeoye ambulatory BP

Brain Research Bulletin Title: Brain Banking in Low- and Middle – Income Countries: Raison D’être for the Ibadan Brain Ageing, Dementia And Neurodegeneration (IBADAN) Brain Bank Project. Corresponding Author: Rufus AkinyemiCo-Authors: motunrayo Coker, akinsola ojagbemi, Ayodeji Salami, Joshua Akinyemi, Funmi Olopade, TEMITOPE FAROMBI, Michael Nweke, Oyedunni Arulogun, Ayodele Jegede, Mayowa OWOLABI, Raj Kalaria, Adesola Ogunniyi

Adebayo P. Taiwo FT, Owolabi MO, Ogunremi OA, Knowledge of electromyography (EMG) among sub-Saharan African patients – a pilot survey. Annals of Medical and Health Sciences Research. In Press

Adebayo P. Taiwo FT, Ogunremi OA, Owolabi MO, EMG Indications and Findings in a sub-Saharan African Neurorehabilitation Centre. Clinical Neurophysiology Practice.In Press

Blossom Center manuscript

SIREN Publications (CIMT, Stroke in the Young, Stroke by Gender, FGD, Echo in stroke, KAP stroke genetics, SIREN Biorep , Precision stroke, etc)

THRIVES (Main results; Secondary/ Tertiary outcomes, Cost effectiveness, Text messaging)

Atrial fibrillation in Africa – an underreported and unrecognized risk factor for stroke: a systematic review M.S. Jacobs1,2, PharmD; M. van Hulst1,2, PhD; A.M. Adeoye3, MD; R.G. Tieleman4,5, MD; M. Postma2,6,7, Prof.; M.O. Owoloabi3, Prof.

COUNCIL DM, Obesity, Anticoagulants

COUNCIL DM commentary

Mac Arthur manuscript on cognitive impairment

GACD multimorbidity statement

Contextualization paper GACD The role of context in implementation research for non-communicable diseases: answering the ‘how-to’ dilemma

BCEC editorial. Behavioural Neurology

CHAIR Proof of Concept

Lancet Neurology Commission

Frontiers in Neurology Special issue

Ibadan brain bank X2

 Rationale paper in BRB

Poster at AAN 2018. Stroke.

INVITED SPEAKER AT UNIVERSITIES AND INTERNATIONAL CONFERENCES

“Evaluation of Rheumatology Lectures By Clinical Students in a Nigerian Medical School: Learning from the Learners” for presentation at the 2018 ACR/ARHP Annual Meeting, to be held in Chicago, Illinois, October 19-24.

ABSTRACT ACCEPTANCE INFORMATION
Abstract ID: 74801
Abstract Title: Evaluation of Rheumatology Lectures By Clinical Students in a Nigerian Medical School: Learning from the Learners
Presenting Author: Akpabio Akpabio
Program Type: ACR
Presentation Type: Poster
Session Title: Education Poster
Session Date/Time: Sunday, October 21, 2018; 9:00 AM – 11:00 AM*

INVITED SPEAKER/ CHAIR AT UNIVERSITIES AND INTERNATIONAL CONFERENCES

  1. #521 Stroke Prevention Strategies in Africa. International Stroke Conference, March 17 – 19, 2021 , Virtual Conference. (Invited Speaker)
  • Owolabi MO. #6162 Stroke Investigative Research and Education Network: Public Outreach & Engagement . International Stroke Conference, March 17 – 19, 2021 , Virtual Conference. (Invited Speaker)
  • Sarfo………….MO Owolabi  #5097, Characterization of the Associations Between Pre-Diabetes and Diabetes With Occurrence of Stroke by Its Types, Subtypes and Outcomes Among West Africans, , International Stroke Conference, March 17 – 19, 2021,  Virtual Conference
  • Sarfo………….MO Owolabi  #5097, Effect Sizes of Vascular Risk Factors for Stroke Occurrence by Age Among West Africans, International Stroke Conference, March 17 – 19, 2021 , Virtual Conference
  • Owolabi MO Leveraging Precision Medicine and Mobile Technology to control Non-Communicable Diseases in Africa. Toward a Successful Trilateral collaboration:4th Kyoto-Bordeaux Joint Symposium (Feb. 18 and 19, 2021)
  • Owolabi MO,. Gemeinsame Jahrestagung der Deutschen Gesellschaft für Neurorehabilitation e. V. und der Deutschen Gesellschaft für Neurotraumatologie und Klinische Neurorehabilitation e. V. December 10-12th, 2020. National plans for neurorehabilitation. Perspectives from Africa – Invited Speaker
  • Owolabi MO Reducing the global burden of stroke in resource limited settings: Mitigating the barriers, Amplifying the Facilitators (an ASA and World Health Organization Joint Symposium). International Stroke Conference, Los Angeles California, 2020 (Invited Moderator)
  • NHLBI Data Science Africa Initiative Symposium:

 Innovations in Health Metrics Sciences: Measuring, Mapping, and Monitoring Morbidity and Mortality at the Regional, National, and Local Levels in Africa” scheduled for Wednesday October 21, 2020  at 10:30 am EDT | 5:30 pm EAT

  • Grantsmanship : How to make an impression on Funders… UNILAG 2020
  • COVID Experiences in Neurorehabilitation: WFNR 2020
  • Owolabi MO COVID Experiences in Neurorehabilitation- Africa experience WCNR SOFMER  October 6-10 ,2020 :
  • Wasti SA, Owolabi MO Healthcare settings for rehabilitation after stroke, WCNR SOFMER October  6 to 10, 2020:
  • Platz T, Owolabi MO, : Clinical Pathways in Stroke Rehabilitation, Background, Scope and Methods. WCNR SOFMER October  6 to 10, 2020
  • Owolabi MO:Session  Chair,  Disorders of Consciousness, WCNR SOFMER October  6 to 10, 2020
  • Owolabi MO, Moderator, Nigerian Academy of Sciences in collaboration with Academies of Scinces in West Africa: Symposium on COVID 19. October 15, 2020
  • Owolabi MO World Hypertension Day Global HEARTS Hypertension control projects and planed/ongoing activities in Africa. October 17 2020
  • ISC VCI abstract 2020
  • ISC Ischemic stroke abstract 2020
  • Owolabi MO. Preventing Stroke In Low- And Middle-Income Countries – Barriers And Potential Solutions. European Stroke Organization World Stroke Organization Conference 7-9 November 2020 Virtual Conference Invited Speaker
  • Owolabi MO. Stroke Prevention. Society of Family Physicians Of Nigeria (SOFPON) Conference. 28 November 2020 Virtual Conference Invited Speaker
  • WHO WSO Lancet Neurology Conference Bellagio Conference Chair
  • AAN 2020 Abstract : Echo and stroke outcome
  • AAN 2020 Abstract : ICH abstract American Academy of Neurology Annual Meeting, April 25 to May 1, 2020 in Toronto, ON, Canada. You will be presenting your work at the world’s largest gathering of neurological professionals. We are pleased to inform you that your scientific abstract number 1606 entitled “Echocardiographic Abnormalities and Determinants of 1-month Outcome of Stroke Among West Africans in the SIREN Study” has been accepted for an oral presentation.
  • American Academy of Neurology Annual Meeting, April 25 to May 1, 2020 in Toronto, ON, Canada. You will be presenting your work at the world’s largest gathering of neurological professionals. We are pleased to inform you that your scientific abstract number 1564 entitled “Unraveling the Risk factors for Spontaneous Intracerebral Hemorrhage and its Severity among West Africans” ha
  • Owolabi MO . The Role of Context in Implementation Research. International Stroke Conference. 2019 . Honolulu, Hawaii, USA (Invited Speaker)
  • Owolabi MO .. Cost Effective Stroke Interventions in Low and Middle Income Countries (an AHA/ASAand World Health Organization Joint Symposium) International Stroke Conference. 2019 . Honolulu, Hawaii, USA (Session Moderator/Chair)
  • Akpabio A, Owolabi MO “Evaluation of Rheumatology Lectures By Clinical Students in a Nigerian Medical School: Learning from the Learners” for presentation at the 2018 ACR/ARHP Annual Meeting, to be held in Chicago, Illinois, October 19-24.
  • Owolabi MO. Integrating pillars of the stroke quadrangle into stroke rehabilitation: risk factors identification and secondary prevention: Invited Speaker, SANRA /SASCA Johannesburg, South Africa, August 23 to 25, 2018
  • Owolabi MO. Quality of life in stroke patients: measurements, profile and predictors .Invited Speaker, SANRA /SASCA Johannesburg, South Africa, August 23 to 25, 2018
  • Owolabi MO. Concepts of improving access to NeuroRehabilitation care in Africai: Invited Speaker, SANRA /SASCA Johannesburg, South Africa, August 23 to 25, 2018
  • R. Akinyemi, H.K. Tiwari, D.K. Arnett, B. Ovbiagele, M.R. Irvin, K. Wahab, F. Sarfo, V. Srinivasasainagendra, A. Adeoye, R.T. Perry, A. Akpalu, C. Jenkins, O. Arulogun, M. Gebregziabher, L. Owolabi, R. Obiako, E. Sanya, M. Komolafe, M. Fawale, P. Adebayo, G. Osaigbovo, T. Sunmonu, P. Olowoyo, I. Chukwuonye, Y. Obiabo, O. Akpa, J. Akinyemi, G. Ogbole, S. Melikam, R. Saulson, and M. Owolabi, Unraveling the Genetic Architecture of Stroke in Africans: Updates from the SIREN project For the SIREN Investigators . Proceedings of the 22nd International Stroke Genetics Consortium Workshops. Neurol Genet 2018;4:e235. doi:10.1212/NXG.0000000000000235
  • Owolabi MO. “The Lancet Neurology Commission on Stroke in Low and Middle-Income Countries”. Reducing Global Burden of Stroke. Dates: 20th October, 2018. World Stroke Congress, Canada.
  • Owolabi MO. “Controlling Stroke Epidemic in Low and Middle-Income Countries: Experience from Africa”. WSO-WHO Joint Session: Global Epidemiology & Policies. Dates: 17th October, 2018 World Stroke Congress, Canada.
  • Owolabi MO. Chair Leave No-one Behind: Putting People Living with Stroke and NCDs at the Centre of Healthcare 19th October, 2018. World Stroke Congress, Montreal, Canada.
  •  Owolabi MO, Stroke burden in Africa. Practical aspects. Global Brain Summit .November 27 to 28, 2018, Auckland, New Zealand
  • Owolabi MO, Speaker: Blossom Centre for Neurorehabilitation – A Model Centre in a Developing Country.10th World Congress for Neurorehabilitation Renaissance Mumbai Convention Centre Hotel, Powai in Mumbai, India February 7 – 10, 2018.
  • Owolabi MO, Chair: Outreach Programmes in Developing Countries. 10th World Congress for Neurorehabilitation Renaissance Mumbai Convention Centre Hotel, Powai in Mumbai, India February 7 – 10, 2018.
  • Owolabi MO, Chair: Low Cost Model of Rehabilitation in Africa. 10th World Congress for Neurorehabilitation Renaissance Mumbai Convention Centre Hotel, Powai in Mumbai, India February 7 – 10, 2018.
  • Owolabi MO. Chair/ Moderator: First WFNR /ASA Joint Session on Neurorehabilation, Translating Innovations in Stroke Rehabilitation to Improve Recovery and Quality of Life across the Globe (an AHA/ASA and World Federation for Neurorehabilitation Joint Session). International Stroke Conference, ISC January 2018. Los Angeles, USA
  • Owolabi MO. Chair/Speaker: First WHO Lancet Commission Session on Stroke in LMIC, Tackling stroke in low and middle income countries- placing proof in pragmatism; a WHO-Lancet Commission on Stroke in Low and Middle Income Countries (an AHA/ASA and World Health Organization Joint Symposium) International Stroke Conference, ISC January 2018. Los Angeles, USA 137.
  • Owolabi MO, Akinyemi RO, Gebregziabher M, Armstrong K, Akinyemi O,  Akpa O, Olaniyan O,Salako BL,  Arulogun O,  Tagge R , Uvere E,  Fakunle K,Ovbiagele B Randomized Controlled Trial of a Multipronged Intervention to Improve Blood Pressure Control among Stroke Survivors. THRIVES Poster ISC
  • Owolabi MO, Sarfo F, Ovbiagele B, Gebregziabher M, Akpa OM,  Wahab K. International Stroke Conference Moderated Poster Abstracts Session Title: Community/Risk Factors Moderated Poster Tour II Abstract TMP53: Risk Profile of Stroke Among Young Africans: Evidence From the SIREN Study Stroke.2018; 49:ATMP53 . International Stroke Conference, Los Angeles, USA. January 24-26; 2018.
  • Owolabi MO, Sarfo F, International Stroke Conference Oral Abstracts Session Title: Community/Risk Factors Oral Abstracts II Abstract 183: Determinants of Hypertension-related Intracerebral Hemorrhage in West Africans: Findings from the SIREN Study.Stroke. 2018;49: A183 International Stroke Conference, Los Angeles, USA. January 24-26; 2018.
  • Owolabi MO. Invited Lecture Unravelling Stroke and Cardiovascular diseases in Africa:
  •  Charting new Paths. New York University. 29 January 2018.
  • Owolabi MO., — Unravelling Stroke among People of African Ancestry. African Research Universities Alliance (ARUA) Launch. Research in Africa Rising” Dates: 3-4 April 2017. Venue: ISSER, University of Ghana.
  • Owolabi MO et al 69th Annual Meeting of the American Academy of Neurology, Boston, USA, April 21-27 2017. Oral Presentation titled, ‘Stroke risk factors, post stroke anxiety and neurocognitive function.’
  • Owolabi MO, Lackland DT,  Gebregziabher M,  Armstrong KS, Sarfo FS, Akinyemi R, et al. International Stroke Conference Poster Abstracts – Community/Risk Factors Posters I Abstract WP206: A Tale of Blacks With Stroke on Two Continents and in Two Eras: Comparison of Baseline Risk Profiles in Black Africans and Black Americans. Stroke. 2016;47:AWP206
  • Owolabi M, Akinyemi R, Arnett D, Ovbiagele B, Irvin M, Tiwari H, SIREN..Defining the genetic architecture of stroke in people of black ancestry. Oral presentation . 18th Workshop of the International Stroke Genetics Consortium (ISGC) . 18th Workshop of the International Stroke Genetics Consortium (ISGC); 2015 October; Barcelona, Spain.
  • Owolabi M, Akinyemi R, Arnett D, Tiwari H, Ovbiagele B, SIREN. Is Genetics Important for Stroke in Africa?  Invited Oral presentation. 10th World Stroke Congress.; 2016 October 26-29, Hyderabad India.
  • Ovbiagele B. Addressing the Growing Burden of Stroke in Africa: The Journey So Far. Expanding the Scope of Research in Global Health: A Symposium Honoring the Leadership of Dr. Francis S. Collins. Bethesda, Maryland  October 14, 2016
  • Singh A, Jenkins C, Arulogun OS, Owolabi MO, Sarfo FS, Ovbiagele B Community Engagement: Experience from the SIREN Study in Sub-Saharan Africa .Oral presentation as well as inclusion in the conference proceedings of the ICCHHP 2017: 19th International Conference on Community Health and Health Promotion to be held in Zurich, Switzerland during January, 13-14, 2017.
  • Owolabi MO, Sarfo FS, Akpa O, Gebregziabher M, Akinyemi R, Armstrong K, Akpalu A, Tiwari H, Arnett D, Obiako R, Owolabi L, Wahab K, Melikam ES, Saulson R, Lackland D,  Jenkins C,  Arulogun O,  Ovbiagele, B. SIREN . The Topmost Modifiable Risk Factors for Stroke among People of African Ancestry Moderated Poster Session. Poster Number: TP166 International Stroke Conference, February 22-24, 2017, Texas, USA
  • Owolabi M, Howard G, Gebregziabher M, Sarfo F, Irvin R, Armstrong K,  Akinyemi R, Tiwari H, Lackland D, Bennett A, Arnett D, Howard V,  Ovbiagele B. Interplay Of Racial And Geographical Differences In Stroke Type And Risk Factors Among Indigenous West Africans; African Americans And European Americans. Moderated Poster Session. Poster Board Number: TMP59 International Stroke Conference, February 22-24, 2017, Texas, USA.
  • Owolabi M., SIREN. State of Clinical Research in Stroke in Africa. Invited Oral Presentation. Stroke Risk and Outcomes in People of African Ancestry (an American Heart/American Stroke Association and Nigerian Stroke Society Joint Session) International Stroke Conference, February 22-24, 2017, Texas, USA.
  • Akinyemi R., SIREN. Burden of Stroke, Vascular Risk Factors, and Care Gaps in Africa. Invited Oral Presentation. Stroke Risk and Outcomes in People of African Ancestry (an American Heart/American Stroke Association and Nigerian Stroke Society Joint Session) International Stroke Conference, February 22-24, 2017, Texas, USA.
  • Howard G,  Gebregziabher M,  Ovbiagele B,  Owolabi M,  Howard V. Insights on black-white disparities in cardiovascular risk potentially offered by international comparisons of stroke-free populations. Global Health Symposium. Novemnber 10, 2016. Medical University of South Carolina. Charleston, USA.
  • Ojagbemi, Owolabi, M. Delirium In The First Week After Stroke In Survivors Managed In A Poorly-resourced World Psychiatry Association International Congress in Cape Town, November 2016 (oral presentation) .
  • Howard G., Gebregziabher M., Ovbiagele B., Owolabi M., Howard V. 2016. Insights on black-white disparities in cardiovascular risk potentially offered by international comparisons of stroke-free populations. Global Health Symposium. November 10, 2016. Medical University of South Carolina. Charleston, USA.
  • Nwankwo K.O, Adejare O.A and Owolabi M.O. Profile of Critically Ill Neurological Patients Referred for Physiotherapy In a Tertiary Hospital In Southwest Nigeria. Presentation at the 9th WCNR 10-13 May Philadelphia, USA. 2016.
  • Nwankwo K.O, Adejare O.A and Owolabi M.O. Inverse Relationship between Depression, Anxiety, Stress and Functional Independence among Stroke Survivors In Nigeria. Presentation at the 9th WCNR 10-13 May Philadelphia, USA. 2016.
  • Ovbiagele, B., Owolabi, M., Saulson, R., Uvere, E., Arulogun, O. 2016. THRIVES Investigators. Tailored Hospital-Based Risk Reduction to Impede Vascular Events after Stroke (THRIVES) study. Platform presentation at the International Stroke Conference, (ISC) February 17-19 2016 at Los Angeles CA, USA.
  • Ovbiagele, B., Owolabi, M., Akinyemi, R., Hurst, S., Arulogun, O., Gebregziabher, M., Uvere, E., Saulson, R., THRIVES team. 2016. Tailored Hospital-Based Risk Reduction to Impede Vascular Events after Stroke (THRIVES) study. Platform presentation at the 5th Annual Joint Technical Steering Committee Meeting, Sydney, Australia, October 17 2016.
  • Ovbiagele B. 2016. Addressing the Growing Burden of Stroke in Africa: The Journey So Far. Expanding the Scope of Research in Global Health: A Symposium Honoring the Leadership of Dr. Francis S. Collins. Bethesda, Maryland  October 14, 2016
  • Owolabi M.O., Lackland D.T., Gebregziabher M., Armstrong K.S., Sarfo F.S., Akinyemi R., et al. 2016. International Stroke Conference Poster Abstracts – Community/Risk Factors Posters I Abstract WP206: A Tale of Blacks With Stroke on Two Continents and in Two Eras: Comparison of Baseline Risk Profiles in Black Africans and Black Americans. Stroke. 2016;47: AWP206 PUBLISHED in Stroke
  • Owolabi M., Akinyemi R., Arnett D., Tiwari H., Ovbiagele B., SIREN. 2016. Is Genetics Important for Stroke in Africa? Oral presentation. 10th World Stroke Congress.; 2016 October 26-29, Hyderabad India.
  • Philip, B.A., Owolabi, M.O., Olufemi, A. Ogunremi, A., Uvere, E. 2016. Electromyography referral pattern: report from the first Centre for Neurorehabilitation in East, West and Central Africa. Presentation at the 9th WCNR 10-13 May Philadelphia, USA. 2016.
  • Nwankwo K.O, Adejare O.A and Owolabi M.O. Profile of Critically Ill Neurological Patients Referred for Physiotherapy In a Tertiary Hospital In Southwest Nigeria. Presentation at the 9th WCNR 10-13 May Philadelphia, USA. 2016.
  • Nwankwo K.O, Adejare O.A and Owolabi M.O. Inverse Relationship between Depression, Anxiety, Stress and Functional Independence among Stroke Survivors In Nigeria. Presentation at the 9th WCNR 10-13 May Philadelphia, USA. 2016.
  • Owolabi MO et al. ‘Profile of Patients seeking Neurorehabilitation in a developing country: report from the First Center for Neurorehabilitation in East, West and Central Africa’. Presentation at the 9th WCNR 10-13 May Philadelphia, USA. 2016.
  • Philip B. Adebayo, Owolabi MO, Olufemi A. Ogunremi, Ezinne Uvere. Electromyography referral pattern: report from the first Centre for Neurorehabilitation in East, West and Central Africa. Presentation at the 9th WCNR 10-13 May Philadelphia, USA. 2016.
  • Owolabi MO et al. SIREN presentation in H3Africa Consortium Meeting, Washington DC, Oct 2015
  • Owolabi MO et al. Consensus presentation to NIH at NIH Campus on behalf of the CVD group, Washington DC, Oct 2015
  • Ovbiagele B, Owolabi MO, Saulson R, Uvere E, Arulogun O. Tailored Hospital-Based Risk Reduction to Impede Vascular Events After Stroke (THRIVES). THRIVES Investigators. ISC Poster ISC, Feb 17-19 2016 Los Angeles CA.
  • Owolabi MO et al. SIREN: defining the genetic architecture of stroke in people of black ancestry. Oral presentation at theInternational Stroke Genetics Consortium (ISGC) Barcelona Spain 2015.
  • Owolabi MO. Presentation at the Annual GACD COUNCIL meeting Mexico City November 2015
  • Ojagbemi A, Owolabi MO. Ibadan Delirium study presented at the Joint meeting of the British Geriatric Society and the European Delirium Association between the 3rd and 4th of September, 2015
  • NSNS Meeting Presentation at Nnewi, South East Nigeria, 2015
  • Owolabi MO, Tamer E, Vincent-Onabajo GO, Awoniyi E, Olukolade O, Moranti K, Uvere E, Nwankwo KO. Changing Trend in need for Neurorehabilitation in Africa- a SCOTA analysis. Abstract presented at the Istanbul WCNR 2014
  • Owolabi MO, Vincent-Onabajo GO, Awoniyi E, Olukolade O, Moranti K and Uvere E. New developments in Neurorehabilitation: applicability of the evidence in developing countries. Abstract presented at the Istanbul WCNR 2014
  • Owolabi MO, Awoniyi E, Olukolade O, Moranti K, Uvere E. Assessment of Quality of Life in Patients with Neurological Diseases. Abstract presented at the Istanbul WCNR 2014
  • Owolabi MO Welcome Address. Cardiovascular Workshop. Fourth H3Africa Consortium Meeting Spier, Cape Town South Africa. May 30 to June 2. 2014
  • Owolabi MO Stroke in Africa: the burden, the gaps and the future. Cardiovascular Workshop. Fourth H3Africa Consortium Meeting Spier, Cape Town South Africa. May 30 to June 2. 2014
  • Owolabi MO. H3Africa 2014 Cape Town, Spier Hotel Stellenbosch. May 29 to June 2, 2014. Co-chair of session on harmonization of H3Africa teams and tools
  • Owolabi MO, Atinuke M. Agunloye AAN. Risk factors more associated with ischemic rather than hemorrhagic stroke in black Africans: implications for epidemiologic transition. 66th Conference of the American Academy of Neurology. April 26 to May 3, 2014. Pennsylvania Convention Center, Philadelphia USA. 2014 CNN paper
  • Owolabi MO. Diagnosis and Treatment Cerebrovascular Diseases. Workshop On Neurological And Mental Disorders In Older Adults Taking Place At The Neuropsychiatric Hospital, Yaba, Lagos. July 15-16. 2014.
  • Akinyemi RO, Allan L, Owolabi MO, Akinyemi JO, Ajani A, Ogunniyi A, Kalaria RN. Profile and Predictors of Vascular Cognitive Impairment in African Stroke Survivors: The CogFAST –Nigeria study. VasCOG 2013 Conference in Toronto Canada, 25 -28 June 2013.
  • Owolabi MO et al, SIREN. Third H3 Africa Consortium Meeting. Oct 3 to 5, 2013. Sandton, South Africa.
  • Owolabi MO. IDEAS Interventions Designed to Eliminate & Solve Stroke Disparities Novemnber 20-21 2013, Bethesda, Double Tree Hotel. USA
  • Owolabi MO. Challenges of Neurorehabilitation in SubSaharan Africa: we must set forth at dawn. [Platform] 7th World Congress for Neurorehabilitation, May 16 to 19, 2012, Melbourne Australia.
  • Owolabi MO. Impact of stroke on health-related quality of life in diverse cultures: the Berlin-Ibadan multicenter international study. [Platform].7th World Congress for Neurorehabilitation, May 16 to 19, 2012, Melbourne Australia.
  • Owolabi MO. Psychometric Properties of the HRQOLISP-40: a novel, shortened multi-culturally valid holistic stroke measure. [Poster]. 7th World Congress for Neurorehabilitation, May 16 to 19, 2012, Melbourne Australia.
  • Ezunu EO, Ogunniyi A, Owolabi MO. Epilepsy care in Nigeria: Factors influencing default. 15th Congress of the European Federation of Neurological Societies, Budapest, Hungary, from 10-14 September, 2011.
  • Owolabi MO. Summative Cardiovascular Risk Load Correlates Better to the Severity of Diabetic Peripheral Neuropathy than HbA1c” 63rd Annual Meeting of the American Academy of Neurology April 10 to 16, 2011, Hawaii, USA. Not physically present.
  • Owolabi MO, Ipadeola A, Adeleye J. Is Clinically Diagnosed Diabetic Peripheral Neuropathy Predominantly Metabolic or Vascular in Origin? 62nd Annual Meeting of the American Academy of Neurology. April 10 to April 17, 2010. Toronto, Canada. Not physically present
  • Owolabi MO. HRQOLISP is more valid than SF-36 for stroke. 6th World Congress for Neurorehabilitation. March 21 to 25, 2010. Vienna, Austria.
  • Owolabi MO. Determinants of specific and generic post-stroke HRQOL. 6th World Congress for Neurorehabilitation. March 21 to 25, 2010. Vienna, Austria.
  • Fawale MB, Owolabi MO, Ogunniyi A. Seizure status and health-related quality of life. 19th World Congress of Neurology October 24th to 30th, 2009. BITEC, Bangkok, Thailand.
  • Shokunbi WA, Iwara KU, Owolabi MO. IgA myeloma: a case report. Ibadan 2009. 18th to 21st August, 2009. 37th Scientific and Annual General Meeting of the Nigerian Society for Hematology and Blood transfusion.
  • Shokunbi WA, Iwara KU, Owolabi MO. Transverse sinus thrombosis and bilateral internal jugular jugular vein thrombosis in a 65 year old man. Ibadan 2009. 18th to 21st August, 2009. 37th Scientific and Annual General Meeting of the Nigerian Society for Hematology and Blood transfusion.
  • Owolabi MO. Comparative analysis of the seed of life model and the philosophies of Descartes, Spinoza and Leibniz: examining the mind-brain puzzle and programming. Neuroscience 2008. November 15 to 19, 2008. Washington Convention Center Hall. Washington DC.
  • Owolabi, M.O. Racial disparity in stroke risk factors: the Berlin-Ibadan experience. Ehrlich II – 2nd World Conference on Magic Bullets October 3 – 5, 2008. Nurnberg, Germany.
  • Owolabi, M.O. Modelling QOL measures after the model of life: presenting the ‘egg of life’ model.”  4thInternational Conference on Holistic Health and Medicine, hosted in Lexington, Kentucky USA. Wednesday, September 24, 2008. [oral]
  • Owolabi, M.O. Comparative analysis of the egg of life model and the classical ancient philosophies: The Purpose of life. 4thInternational Conference on Holistic Health and Medicine, hosted in Lexington, Kentucky USA. Thursday, September 25, 2008. [poster]
  • Owolabi, M.O. Comparative analysis of the egg of life model and the philosophies of Des Cartes, Spinoza and Leibniz: The Mind-brain puzzle and programming. 4thInternational Conference on Holistic Health and Medicine, hosted in Lexington, Kentucky USA. Thursday, September 25, 2008. [poster]
  • Owolabi, M.O. An application of the egg of life model (EOLM): addressing conceptual difficulties in quality of life (QOL) and explaining the ‘disability paradox’. 4th International Conference on Holistic Health and Medicine, hosted in Lexington, Kentucky USA. Thursday, September 25, 2008.

[poster]

  • Akinyemi RO, Owolabi LF, Owolabi MO, Akinyemi JO, Ogunniyi A Perception of Stroke among a sample Of Urban Dwellers in southwestern Nigeria: A Preliminary Report. 60th AAN Meeting, Chicago Illinois. 12 to 20th April, 2008. [poster]
  • Owolabi MO, Ogbole GI, Lagunju I. Rasmussen Encephalitis in a Nigerian girl. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Ogun OA, Adeyinka A, Agunloye AM, Owolabi MO, Shokunbi MT. Visual assessment in a patient with dominant parietal lobe haematoma from a ruptured arteovenous malformation. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Uche EO, Owolabi MO, Agunloye AO, Atalabi MA, Shokunbi MT. Vertebral artery occlusion in a young Nigerian male: A case report. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Owolabi MO, Taiwo FT, Ogun OA, Oluwole OSA. A 16-year-old Nigerian girl with leuko-encephalopathy: differential diagnosis. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Owolabi MO, Ogunniyi A. Episodic vertigo resulting from head rotation in the presence of vascular risk factors and cervical spondylosis. An intriguing quartet? 40thScientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Akinyemi RO, Okubadejo NU, Owolabi LF, Akinyemi JO, Owolabi MO, Oluwole OS, Ogunniyi A. Non-motor manifestations in Nigerian patients with Parkinson’s disease. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Owolabi MO, Akinyemi RO, Owolabi LF. Racial impact of stroke risk factors: the Berlin-Ibadan comparative study of stroke patients. A pilot study. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Owolabi MO, Akinyemi RO. Proposing the stroke levity scale: a valid, reliable, simple and time-saving measure of stroke severity. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Owolabi LF, Akinyemi RO, Owolabi MO, Fadare J, Ogunniyi A. Post stroke epilepsy in Nigeria 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Akinyemi RO, Okubadejo NU, Owolabi MO, Akinyemi JO, Owolabi LF, Ogunniyi A. Cognitive dysfunction in Nigerian patients with Parkinson’s disease. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Owolabi MO, Taiwo FT, Shokunbi WA. The full neuropsychiatric spectrum of vitamin B12 deficiency in a 48-year-old woman. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008.

[oral]

  • Owolabi MO, Taiwo FT, Ogun OA, Oluwole OSA. A 16-year-old Nigerian girl with leukoencephalopathy: differential diagnosis. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Fawale MB, Owolabi MO. Bell’s palsy in pregnancy and the pueperium: a report of 5 cases. 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Fawale MB, Owolabi MO. Can a subject’s handedness be validly assessed through a proxy? 40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008. [oral]
  • Fawale MB, Owolabi MO. Agreement between self-reported and questionnaire-determined handedness.  40th Scientific Conference of the Nigerian Society of Neurological Sciences, March 26 to 29th, 2008.

[oral]

  • Owolabi MO General medical problems in the elderly. 2nd Training workshop of African Gerontological Society (AGES) titled ‘Geriatric Care and Management’. Sept 05-08, 2007. [oral]
  • Owolabi MO. Stroke in the elderly. 2nd Training workshop of African Gerontological Society (AGES) titled ‘Geriatric Care and Management’. Sept 05-08, 2007. [oral]
  • Owolabi MO, Ogunniyi A, Akinyemi R. Hypertension and Cerebrovascular Disease. Presented at the Nigerian Hypertension Society Conference, Ile-Ife. 17th to 20th July 2007 [invited lecture].
  • Owolabi MO, Akinyemi RO, Ogunniyi A. Binswanger’s disease co-existing with possible Normal Pressure Hydrocephalus: Report of a case in a female Nigerian. Poster to be presented at the 3rd Congress of the International Society for Vascular, Cognitive and Behavioural Disorders. Texas, USA, July 2007.
  • Akinyemi RO, Owolabi MO, Owolabi LF, Ogunniyi A. Perception of stroke among a sample of urban dwellers in southwestern Nigeria: A preliminary report. Poster to be presented at the 3rd Congress of the International Society for Vascular, Cognitive and Behavioural Disorders. Texas, USA, July 2007.
  • Owolabi MO, OgunniyiA. Mapping Africa’s way into prominence in the world map of Neurology. Presented at the Pan African Association of Neurological Sciences (PAANS) Conference, Lagos, Nigeria 2006 [oral].   
  • Owolabi MO, Akinyemi RO, Owolabi LF, Ogunniyi A. Spinocerebellar ataxia in a family lineage from Southwestern Nigeria. Presented at the PAANS Conference, Lagos, Nigeria 2006

[poster]

  • Akinyemi RO, Owolabi MO, Owolabi LF, Ogunniyi A. Frontotemporal Dementia in a female Nigerian. Presented at the PAANS Conference, Lagos, Nigeria 2006 [poster]
  • Owolabi MO, Ogunniyi A, Akang EU, Ogun, Spontaneous Intracerebral Hemorrhage: Vasculitis or DIC? Presented at the PAANS Conference, Cotonou, Republic of Benin. 2004.

COMMUNITY SERVICES

CONTRIBUTIONS TO SERVICE

  • ACUTE CARE STROKE SERVICES: He has promoted the delivery of expert services for acute care of stroke in the Neurology Unit of the University College Hospital Ibadan, where he also trains medical students and resident doctors.
  • NEURO- REHABILITATION: He pioneered the establishment of the first neurorehabilitation center in East West and Central Africa. The Center has treated over 500 patients with neurological disabilities in the subregion. http://www.blossom.org.ng/
  • STROKE ADVOCACY: Al Jazeera Interview: Aljazeera conducted a Special Focused Interview Documentary on SIREN detailing the ground-breaking work being undertaken in illuminating the contributions of genetic factors to stroke causation among African subjects and capacity building of emerging scientists from Africa. Footage of the interview by Colin Baker producer and cameraman from Al Jazeera TV on Stroke and Genetics was aired on the 25/12/2016. This was facilitated by H3Africa/NIH who made the link. The process of SIREN phenomics and genomics and the usefulness of genetic studies in relation to stroke was discussed. A patient was followed from recruitment phase through sample collection, physiotherapy and family education. A lively discussion ensued discussing the sites, personnel, numbers of cases and controls and funding agencies NIH/ H3 Africa as well as the implications of our results and capacity building. The feedback has been encouraging and we consider this as one of the broader impacts SIREN has made through community engagement and advocacy, now on a global scene. We thank the NIH for facilitating this wonderful opportunity.
  • STROKE LITERACY AND SCREENING FOR RISK FACTORS THROUGH COMMUNITY SERVICES:: The Community Engagement (CE) within SIREN has focused on three-pronged activities – constitution and interaction with Community Advisory Board (CABs), conducting Focus Group Discussions (n=27) and community education and outreach programs (n=88). Over 10 000 individuals have received education on cardiovascular risk factors and over 8,000 have been screened for cardiovascular risk factors during the outreaches thus far. The CABs provided stakeholder input into SIREN activities and facilitated collaborations among investigators, community members and stakeholders. The CE core within SIREN is a first-of-its kind public outreach engagement initiative to evaluate and address perceptions about stroke and genomics by patients, caregivers, and local leaders in SSA and has implications as a model for assessment in other high stroke risk populations.

Stroke Dance Video: Entertaining award-winning SIREN dance describing some features of stroke which he uses to educate youths on how to recognize symptoms of stroke.

  • SECONDARY STROKE PREVENTION : He pioneered the use of text messaging, stroke educational videos (3 different languages) for secondary stroke prevention. This is based on the knowledge of barriers and facilitators of risk factor control, obtained from the qualitative phase of the THRIVES study . He has also conducted workshops to train non-neurologist health workers on the identification, emergency care and referral of stroke patients using the educational video which also has sections on stroke recognition and care systems.
  • COORDINATED SERVICES FOR STROKE: THE STROKE QUADRANGLE . His contributions to knowledge of stroke epidemiology include the identification of risk factors for stroke and post-stroke cognitive disorder among Africans. The knowledge of the established risk factors as well as the new ones he has unravelled is being used to design stroke prevention programs for the continent. As a solution to the escalating burden of stroke on the continent he proposed and is leading the implementation of  the stroke quadrangle comprising stroke epidemiological surveillance and research network, prevention, acute care and rehabilitation.
  • STROKE PREVENTION AND CONTROL BILL.  He is engaging the Oyo State House of Assembly to faciltate research uptake and policies to improve stroke control in Nigeria. The bill will be presented to the House in July 2018. The bill covers all aspects of the stroke quadrangle and will improve stroke services in the country.
  • PUBLIC COMMUNICATION : He has consistently published and disseminated cardiovascular health and preventive messages using social, print, electronic, audio visual channels. Highlighted below are some of his publications on cardiovascular health and advocacy on neurorehabilitation.  Below are some of the print media publications
Stakeholders solicit for establishment of rehabilitation services

http://www.ngrguardiannews.com/index.php?option=com_content&view=article&id=87712:first-centre-for-neuro-rehabilitation-in-east-west-and-central-africa&catid=93:science&Itemid=608

http://tribune.com.ng/index.php/your-health/37613-neuro-rehabilitation-boosting-quality-of-life-in-epilepsy-stroke

http://tribune.com.ng/index.php/health-news/38458-expert-makes-case-for-stroke-victims-rehabilitation

http://tribune.com.ng/news2013/en/health-news/item/13641-centre-to-boost-quality-of-life-of-stroke-patients.html

http://tribune.com.ng/health-news/item/8947-don-t-take-early-warning-signs-of-stroke-lightly-experts/8947-don-t-take-early-warning-signs-of-stroke-lightly-experts

http://www.tribune.com.ng/news2013/index.php/en/health-news/item/22465-study-to-unveil-best-way-to-prevent-stroke-in-nigeria.html

Daily intake of green leafy vegetable prevents stroke —Expert

OLD VERSION

  • I have concentrated my research efforts on vascular neurology and neuro-rehabilitation now expanding into community-based genomic epidemiology of stroke and vascular risk factors in Africa and beyond. As a solution to the escalating burden of stroke on the continent I proposed the stroke quadrangle comprising stroke epidemiological surveillance and research network, prevention, acute care and rehabilitation. My contributions to knowledge of stroke epidemiology include the evaluation of risk factors for stroke and post-stroke cognitive disorder among Africans. In addition to other factors including hypertension, we found white matter hyperintensities and increased common carotid diameter to be independent risk factors for stroke among African patients.
  • Al Jazeera Interview: Aljazeera conducted a Special Focused Interview Documentary on SIREN detailing the ground-breaking work being undertaken in illuminating the contributions of genetic factors to stroke causation among African subjects and capacity building of emerging scientists from Africa. Footage of the interview by Colin Baker producer and cameraman from Al Jazeera TV on Stroke and Genetics was aired on the 25/12/2016. This was facilitated by H3Africa/NIH who made the link. The process of SIREN phenomics and genomics and the usefulness of genetic studies in relation to stroke was discussed. A patient was followed from recruitment phase through sample collection, physiotherapy and family education. A lively discussion ensued discussing the sites, personnel, numbers of cases and controls and funding agencies NIH/ H3 Africa as well as the implications of our results and capacity building. The feedback has been encouraging and we consider this as one of the broader impacts SIREN has made through community engagement and advocacy, now on a global scene. We thank the NIH for facilitating this wonderful opportunity.
  • Community Engagement in SIREN: The Community Engagement (CE) within SIREN has focused on three-pronged activities – constitution and interaction with Community Advisory Board (CABs), conducting Focus Group Discussions (n=27) and community education and outreach programs (n=88). FGDs and outreach programs indicate that knowledge of stroke, as well as risk factors and follow-up evidence-based care is limited and often late. Almost all indicated that genetic testing could help health providers better treat stroke and help scientists better understand the causes of stroke. Over 7000 individuals have received education on cardiovascular risk factors and over 5,000 have been screened for cardiovascular risk factors during the outreaches thus far. The CABs provided stakeholder input into SIREN activities and facilitated collaborations among investigators, community members and stakeholders. The CE core within SIREN is a first-of-its kind public outreach engagement initiative to evaluate and address perceptions about stroke and genomics by patients, caregivers, and local leaders in SSA and has implications as a model for assessment in other high stroke risk populations.
  • Singh A, Jenkins C, Calys-Tagoe B, Arulogun OS, Sarfo S, Ovbiagele B, Akpalu A, Melikam S, Uvere E, Owolabi MO for the SIREN Team of Investigators (2017). Stroke Investigative Research and Education Network: Public Outreach and Engagement. Journal of Community Med & Health Educ., 7:518 DOI: 10.4172/2161-0711.1000518
    • Jenkins C, Arulogun OS, Singh A, Mande AT, Ajayi E, Benedict CT, et al 2016. Stroke Investigative Research and Education Network: Community Engagement and Outreach within Phenomics Core. Health Education and Behavior 2016 Apr;43(1 suppl):82S-92S.
    • Entertaining award-winning SIREN dance describing some features of stroke which will educate youths on how to recognize symptoms of stroke.
  • ACCESS Stroke Phenotyping Software Patent and Manuscript: Acceptance letter of the ACCESS Patent has been received. The certificate backing up the patent is awaiting signature by the President of Nigeria. The certificate would be presented to the Vice Chancellor of the University, who will in turn present it to the SIREN team. The manuscript Development and Validation of a User-friendly Multicenter Phenotyping Application for Hemorrhagic and Ischemic Stroke is currently under review by the International Journal of Stroke.
  • Owolabi M, Salaam K, Ogunniyi A, Ogbole G, Akinyemi R, Mongkolwat P, Omisore A, Agunloye A, Makanjuola A, et al, SIREN; AIM on Clear Canvas Enriched Stroke phenotyping Software (ACCESS). 2016.PATENT NG/PT/NC/2016/2007.

Examples:

Stakeholders solicit for establishment of rehabilitation services

http://www.ngrguardiannews.com/index.php?option=com_content&view=article&id=87712:first-centre-for-neuro-rehabilitation-in-east-west-and-central-africa&catid=93:science&Itemid=608

http://tribune.com.ng/index.php/your-health/37613-neuro-rehabilitation-boosting-quality-of-life-in-epilepsy-stroke

http://tribune.com.ng/index.php/health-news/38458-expert-makes-case-for-stroke-victims-rehabilitation

http://tribune.com.ng/news2013/en/health-news/item/13641-centre-to-boost-quality-of-life-of-stroke-patients.html

http://tribune.com.ng/health-news/item/8947-don-t-take-early-warning-signs-of-stroke-lightly-experts/8947-don-t-take-early-warning-signs-of-stroke-lightly-experts

http://www.tribune.com.ng/news2013/index.php/en/health-news/item/22465-study-to-unveil-best-way-to-prevent-stroke-in-nigeria.html

KEY SCIENTIFIC ACHIEVEMENTS

He is an innovative scientist with several inventions and innovative concepts (theories) including the stroke levity scale, the stroke recovery cycle, the stroke quadrangle, the cardiovascular quadrangle, guidelines implementation cycle, the Seed of Life Model, and the health-related quality of life in stroke patients questionnaire, HRQOLISP, a quality of life measure, in use across the world including Spain, Jamaica, Germany, Nigeria, and Ghana. He also pioneered the development of a stroke phenotyping software with patent (Reg.#:NG/PT/NC/2016/2007). He has made over94 international scientific presentations and has over 173 publications in peer-reviewed journals including The Lancet,  Science, and New England Journal of Medicine.

Prof. Owolabi is a recognized global leader in science covering neurology, neuro-rehabilitation, and community-based genomic epidemiology of stroke in Africa. He discovered novel risk factors for stroke on the continent  and is the first to discover an association between apolipoprotein-1 (APOL-1) and stroke.  He leads the largest study of stroke in Africa (U54 grant $4,236,930 ) and has identified 11 potentially modifiable factors which account for over 90% of strokes on the continent. This includes novel factors such as stress regular meat intake, and protective factors such as green leafy vegetables in Africa.

He leads several global reserach consortia including the largest study of cardiovascular diseases in Africa (H3Africa-CVD WG with >55 000 subjects was pioneer chair), Joint Publications Comiittee, Global Alliance for Chronic Diseases (as Co-Chair), WHO- World Stroke Organization- Lancet Commission on Stroke (as Lead Co-Chair), and the COUNCIL initiative for control of cardiovascular diseases in low and middle income countriers (initiator).

He has supervised 5 doctorates, including one who is already an Associate Professor; and currently has 5 doctorals students and a post-doctoral fellow.

Academies that the Nominee is a member of

Fellow, American Academy of Neurology , 2017

Fellow, Academy of Sciences (Nigeria), 2018

Biographical Information

Mayowa Ojo OWOLABI MBBS, MSc, Dr.Med, MWACP, FMCP, FAAN, FAS, Professor of Neurology, University of Ibadan, has won numerous awards including AU-TWAS Young Scientist National Award (Earth and Life Sciences-2011) Inter-academy Medical Panel–Young Physician Leaders Award (2011) and was elected into the Presidium of the World Federation for Neurorehabilitation WFNR (2018).

He is an innovative scientist with several inventions including the stroke levity scale, the stroke recovery cycle, the Seed of Life Model, the HRQOLISP, a quality of life measure, in use across the world including Spain, Jamaica, Germany, Nigeria, and Ghana. A scholar with a stroke phenotyping software patent (Reg.#:NG/PT/NC/2016/2007); over94 international scientific presentations; over 175 publications in peer-reviewed journals including The Lancet,  Science, and New England Journal of Medicine; his first landmark publication, ‘Mapping Africa’s way into prominence in the field of Neurology’ motivated the World Federation for Neurology, International Brain Research Organization, WFNR to make the development of neurosciences in Africa their top priority. 

Prof. Owolabi is a recognized global leader in science covering neurology, neuro-rehabilitation, and community-based genomic epidemiology of stroke in Africa. He is on the editorial boards of several high impact journals and a reviewer for grants and numerous journals. He has supervised 5 doctorates and discovered novel risk factors for stroke on the continent; and is the pioneer leader of the largest study of cardiovascular diseases in Africa (H3Africa-CVD WG with >55 000 subjects). He is the pioneer Regional Vice-President, World Federation of Neurorehabilitation (Africa); Co-Chair, Joint Publication Committee-Global Alliance for Chronic Diseases, pioneer Director, Centre for Genomic and Precision Medicine, University of Ibadan; Founder of COUNCIL (Control Unique to CVDs in LMIC) initiative; and Lead Co-chair, WHO-Lancet Commission on Stroke in developing countries. He is a Fellow of the American Academy of Neurology and a Fellow of the Academy of Science (Nigeria).

Scientific expertise:

Neurosciences, Human Genetics and Molecular Medicine

Scientific expertise:

Neurosciences, Human Genetics and Molecular Medicine

List of some of my published work (out of over 260 publications) available at ResearchGate

https://www.researchgate.net/profile/Mayowa_Owolabi/3

https://www.ncbi.nlm.nih.gov/sites/myncbi/mayowa.owolabi.1/bibliography/46357736/public/?sort=date&direction=ascending.

https://scholar.google.com/citations?user=76K2iYgAAAAJ&hl=en

Journal Reference

Web of Science h-index: 19

( Based on 111 items out of 173 Journal articles in January 2018

 34,016 reads, 1,445 citations, Research Gate score of 41.43, h index 17 (Scopus) over 15 years for 111 items)

Journal Reference

  40,166 reads, 2072, citations, Research Gate score of 42.41, h index 19 (Scopus) over 15 years for 111 items)  May 31, 2018

Scientific expertise:

Neurosciences, Human Genetics and Molecular Medicine

Journal Reference

Web of Science h-index: 19

( Based on 111 items out of 173 Journal articles in January 2018

 34,016 reads, 1,445 citations, Research Gate score of 41.43, h index 17 (Scopus) over 15 years for 111 items)

Journal Reference

  40,166 reads, 2072, citations, Research Gate score of 42.41, h index 19 (Scopus) over 15 years for 111 items)  May 31, 2018

Principal Publications:

LIST OF  MOST SIGNIFICANT/RELEVANT PUBLICATIONS

  1. Owolabi M,  Sarfo F, Akinyemi R, Gebregziabher M, Akpa O, Akpalu A, Wahab K, Obiako R, Owolabi L, Ovbiagele B on behalf of SIREN Team as part of H3Africa Consortium. Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study. The Lancet Global Health, 2018. LANGLH-D-17-00836 S2214-109X(18)30002-0

“About 98% of population-attributable risk of stroke in 2118 case-control pairs of people from Ghana and Nigeria was associated with 11 potentially modifiable factors. In descending order of population-attributable risk (PAR), hypertension, dyslipidaemia, regular meat intake, central obesity, diabetes, stress, added salt at the table, cardiac diseases, physical inactivity, and tobacco use were independently associated with stroke occurrence. We were the first to demonstrate a dose-response protective effect of consumption of green leafy vegetables against all types of stroke in Africans. Our findings from the largest study on stroke among people in Nigeria and Ghana highlight novel associations in this population between stroke and dietary, lifestyle, and psychosocial factors, while underscoring the potent effect of hypertension on stroke occurrence among individuals of African descent. Using data science, we are translating this into the first-ever Afrocentric stroke risk calculator mobile phone application.” This publication attracted an Editorial [ Kengne P, Mayosi B, Modifiable stroke risk factors in Africa: lessons from SIREN. Lancet Global Health 2018: 6(4), E363-E364, https://doi.org/10.1016/S2214-109X(18)30030-5

  • Sarfo FS,Ovbiagele B,Gebregziabher M,   Akpa A, Akpalu A, Wahab K,  Ogbole G, Akinyemi R, Obiako R, Komolafe M,  Owolabi L, Lackland D, Arnett D, Tiwari H,  Markus HS, Akinyemi J, Oguntade A, Fawale B, Adeoye A, Olugbo O, Ogunjimi L, Osaigbovo G, Jenkins C, Chukwuonye I, Ajose O, Oyinloye L, Mutiso F, Laryea R, Calys-Tagoe B,  Salaam A, Amusa G, Olowookere S, Imoh C, Mande A, Arulogun O, Adekunle F, Appiah L, Balogun O, Singh A, Adeleye O, Ogah O, Makanjuola A, Owusu D, Kolo P, Adebayo O, Agunloye A, Shidali V, Faniyan M, Lakoh S, Diala S, Iheonye H, Efidi C, Sanya E, Sunmonu T, Akintunde A, Owolabi M,  on behalf of SIREN. Unraveling the Risk factors for Spontaneous Intracerebral Hemorrhage and its Severity among West Africans. Neurology 2020;94:e1-e15. doi:10.1212/WNL.0000000000009056

“ Eight factors independently associated with hemorrhagic stroke occurrence by decreasing order of population attributable risks were hypertension; dyslipidemia, meat consumption, family history of CVD, nonconsumption of green vegetables, diabetes mellitus, stress, and current tobacco use. Factors associated with severe hemorrhage using an NIH Stroke Scale score >15 were nonconsumption of leafy green vegetables, systolic blood pressure for each mm Hg rise, presence of midline shift, lobar ICH, and supratentorial bleeds. These factors can be targeted to improve hemorrhagic  stroke prevention and outcome among Africans”. This article attracted an editorial from the journal. [Saylor D, Vora N,  Spontaneous intracerebral hemorrhage in West Africa :A call to action. Neurology 2020; 94 (10), DOI: https://doi.org/10.1212/WNL.0000000000009054 ]

  • Akpalu A, Gebregziabher M, Ovbiagele B, Sarfo F, Iheonye H, Akinyemi R, Akpa O, Tiwari HK, Arnett D, Wahab K, Lackland D, Abiodun A, Ogbole G, Jenkins C, Arulogun O, Akpalu J, Obiako R, Olowoyo P, Fawale M, Komolafe M, Osaigbovo G, Obiabo Y, Chukwuonye I, Owolabi L, Adebayo P, Sunmonu T, Owolabi M. Differential Impact of Risk Factors on Stroke Occurrence Among Men Versus Women in West Africa. Stroke. 2019 Mar 18:STROKEAHA118022786. doi: 10.1161/STROKEAHA.118.022786. [Epub ahead of print] PMID:30879432

“The study explored the differential impact of stroke risk factors in men compared to women. Salt intake and income were significantly different between males and females. Six modifiable factors had a combined population attributable risk of 99.1% (98.3%–99.6%) among females with 9 factors accounting for 97.2% (94.9%–98.7%) among males. Hemorrhagic stroke was more common among males (36.0%) than among females (27.6%), but stroke was less severe among males than females/”

  • Akinyemi RO, Arnett DK, Tiwari HK, Ovbiagele B, Sarfo F, Srinivasasainagendra V, Irvin MR, Adeoye A, Perry RT, Akpalu A, Jenkins C, Owolabi L, Obiako R, Wahab K, Sanya E, Komolafe M, Fawale, Adebayo P, Osaigbovo G, Sunmonu T, Olowoyo P, Chukwuonye I, Obiabo Y, Akpa O, Melikam S, Saulson R, Kalaria R, Ogunniyi A, Owolabi MO, for the SIREN Investigators (2017). Interleukin–6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men. Journal of the Neurological Sciences, 379:229–235

We discovered Interleukin–6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 to be associated with ischemic stroke in indigenous West African Men.

  • Sarfo F, Gebregziabher M, Ovbiagele B, Akinyemi R, Owolabi L, Obiako R, Akpa O, Armstrong K, Akpalu A, Adamu S, Obese V, Boa-Antwi N, Appiah L, Arulogun O, Mensah Y, Adeoye A, Tosin A, Adeleye O, Tabi-Ajayi E, Phillip I, Sani A, Isah S, Tabari N, Mande A, Agunloye A, Ogbole G, Akinyemi J, Laryea R, Melikam S, Uvere E, Adekunle G, Kehinde S, Azuh P, Dambatta A, Ishaq N, Saulson R, Arnett D, Tiwari H, Jenkins C, Lackland D, Owolabi MO; Stroke Investigative Research Educational Networks. (2016). Multilingual Validation of the Questionnaire for Verifying Stroke-Free Status in West Africa. Stroke, 47(1):167-72. doi: 10.1161/STROKEAHA.115.010374. 

“We developed and validated the pictographic version of the QVSFS. Negative predictive value of the QVSFS across the 3 languages was 0.97, sensitivity, specificity, and positive predictive value were 0.98, 0.82, and 0.80, respectively. QVSFS is a valid tool for verifying stroke-free status across culturally diverse populations in West Africa.”

  • Owolabi MO,  Gebregziabher M, Akinyemi RO, Akinyemi JO, Akpa O,  Olaniyan O.,  Salako BL, Arulogun O,  Tagge R,  Uvere E, Fakunle A., Ovbiagele B.Randomized Trial of an Intervention to Improve Blood Pressure Control in Stroke Survivors.Circulation: Cardiovascular Quality and Outcomes. 2019;12:e005904. DOI: 10.1161/CIRCOUTCOMES.119.005904

“The study ist he first-ever clinical trial of an intervention (THRIVES) for secondary prevention of stroke in Africans of which Prof Owolabi was the Multi-Principal Investgator and LMIC PI. In subjects with baseline BP >140/90 mm Hg (n=168), THRIVES showed a significant mean SBP (diastolic BP) decrease of 11.7 (7.0) mm Hg while control group showed a significant mean SBP (diastolic BP) decrease of 11.2 (7.9) mm Hg at 12 months.

THRIVES intervention did not significantly reduce SBP compared with controls. As text-messaging and a modest financial incentive were the common elements between both treatment arms, further research is required to establish whether these measures alone can improve BP control among stroke survivors. This publication attracted an Editorial from the Journal. Burke JF, Nallamothu BK, Learning From Null Negative Trials Are Important, Particularly in Low- to Middle-Income Countries. Circulation: Cardiovascular Quality and Outcomes. 2019;12 https://doi.org/10.1161/CIRCOUTCOMES.119.006280 ”

  • Akpa OM, Made F, Ojo A, Ovbiagele B, Adu D,  Motala AA, Mayosi BM, Adebamowo SN, Engel ME, Tayo B, Rotimi C, Salako B, Akinyemi R, Gebregziabher M, Sarfo F, Wahab K, Agongo G, Alberts M, Ali SA, Asiki G, Boua RP, Gómez-Olivé FX, Mashinya F, Micklesfield L, Mohamed SF, Nonterah EA, Norris SA,  Sorgho H, Tollman S, Parekh RS, Chishala C, Ekuro K, Waddy SP, Peprah E, Mensah GA, Wiley K, Troyer J, Ramsay M, Owolabi MO, as members of the CVD Working Group of the H3Africa Consortium . Regional Patterns and Association Between Obesity and Hypertension in Africa :Evidence From the H3Africa CHAIRStudy Hypertension. 2020;75:1167–1178. OI:10.1161/HYPERTENSIONAHA.119.14147

“In the largest study ever using data from over 30,000 adults across 13 African countries, Obesity was independently associated with hypertension in population-based controls (adjusted odds ratio, 2.5 [2.3–2.7]) and odds of hypertension in obesity increased with increasing age from 2.0 (1.7–2.3) in younger age to 8.8 (7.4–10.3) in older age. Hypertension is common across multiple countries in Africa with 11.9% to 51.7% having BP≥140/90 mmHg and 39.5% to 69.4% with BP≥130/80 mmHg. Obese Africans were more than twice as likely to be hypertensive and the odds increased with increasing age.”

  • Owolabi MO.  What are the consistent predictors of generic and specific post-stroke health-related quality of life? Cerebrovascular Diseases 2010; 29:105-110 (DOI: 10.1159/000262305)

“This study identified factors which consistently influenced both generic and specific post-stroke health-related quality of life (HRQOL) in the same study population. Stroke severity, a component of physical health, impaired psychological health, psychological dysfunction in turn negatively influenced physical and other domains of health, thereby creating a vicious cycle”

  • Owolabi MO, Platz T: Proposing the stroke levity scale: a valid, reliable, simple and time-saving measure of stroke severity. European Journal of Neurology 2008 ;15(6), 627-633.

“The authors developed and validated a novel instrument for measuring stroke severity. The instrument was valid, reliable, simpler and time-saving compared to the National Institute of Health Stroke Scale and can be taught to non-neurologists for assessing stroke severity and outcome”

  1. Owolabi M, Salaam K, Ogunniyi A, Ogbole G, Akinyemi R, Mongkolwat P, Omisore A, Agunloye A, Makanjuola A, et al, SIREN; AIM on Clear Canvas Enriched Stroke phenotyping Software (ACCESS). 2016.PATENT NG/PT/NC/2016/2007 .

“The inventors developed the ACCESS application and determined its inter-rater and intra-rater reliability in the Stroke Investigative Research and Educational Network (SIREN) study. The ACCESS application was discovered to facilitate concordant and reproducible classification of all stroke subtypes by multiple investigators, making it suitable for clinical use and deployment in multicenter studies”

Sarfo F, Ovbiagele B, Gebregziabher M,  Wahab K, Akinyemi R, Akpalu A,  Akpa O,  Obiako R, Owolabi L, Jenkins C, Owolabi M, on behalf of SIREN (2018). Stroke Among Young West Africans: Evidence from the SIREN Large Multi-site Case-Control Study. Stroke. 2018 May;49(5):1116-1122. . doi: 10.1161/STROKEAHA.118.020783. [Epub ahead of print] PMID: 29618553

The role of context in implementation research for non-communicable diseases: Answering the ‘how-to’ dilemma.

Daivadanam M, Ingram M, Sidney Annerstedt K, Parker G, Bobrow K, Dolovich L, Gould G, Riddell M, Vedanthan R, Webster J, Absetz P, Mölsted Alvesson H, Androutsos O, Chavannes N, Cortez B, Devarasetty P, Fottrell E, Gonzalez-Salazar F, Goudge J, Herasme O, Jennings H, Kapoor D, Kamano J, Kasteleyn MJ, Kyriakos C, Manios Y, Mogulluru K, Owolabi M, Lazo-Porras M, Silva W, Thrift A, Uvere E, Webster R, van der Kleij R, van Olmen J, Vardavas C, Zhang P; GACD Concepts and Contexts working group.PLoS One. 2019 Apr 8;14(4):e0214454. doi: 10.1371/journal.pone.0214454. eCollection 2019. PMID: 30958868

Akpalu A, Gebregziabher M, Ovbiagele B, Sarfo F, Iheonye H, Akinyemi R, Akpa O, Tiwari HK, Arnett D, Wahab K, Lackland D, Abiodun A, Ogbole G, Jenkins C, Arulogun O, Akpalu J, Obiako R, Olowoyo P, Fawale M, Komolafe M, Osaigbovo G, Obiabo Y, Chukwuonye I, Owolabi L, Adebayo P, Sunmonu T, Owolabi M. Differential Impact of Risk Factors on Stroke Occurrence Among Men Versus Women in West Africa. Stroke. 2019 Mar 18:STROKEAHA118022786. doi: 10.1161/STROKEAHA.118.022786. [Epub ahead of print] PMID:30879432

Research In Progress  

  1. Tailored Hospital-based Risk reduction to Impede Vascular Events after Stroke (THRIVES)

Principal Investigator (PI) : Ovbiagele, B., Co-PI : Owolabi, M. O.                               

There is an urgent need to craft and validate effective solutions that can mitigate the devastating consequences of stroke in low and middle income countries (LMIC) which bear over 86% of the increasing global burden of stroke. For this purpose, we have custom-designed a chronic care model-based intervention called THRIVES. To ensure that the THRIVES intervention is culturally-relevant and locally sustainable, we first obtained information about barriers and facilitators of adherence to evidence-based secondary stroke prevention treatments in Nigeria based on input during focus groups and interviews from stroke patients, caregivers, health providers, and hospital administrators. We used this information to appropriately develop an intervention comprising a stroke patient report card, cell phone text messaging from providers, and in-clinic educational video sessions.

In the second phase, we are testing the efficacy and cost-effectiveness of the tailored THRIVES intervention among 400 stroke patients recently discharged from four medical care facilities in South Western Nigeria via a randomized-controlled trial. A multidisciplinary THRIVES task force with representation from the government is providing oversight functions, and will assist with translation of findings into policies. We anticipate that a successful program could also serve as a model of cost-effective quality stroke preventive care for implementation in other countries.

Consortium: Global Alliance for Chronic Diseases Funding: U01NS079179 2012-2018

 $2,126,772                          U01 Research Grant from NIH (NINDS), Global Alliance for Chronic Diseases.

Countries: Nigeria, USA Main Institutions : 5 Universities/Health institutions

  •  Stroke Investigative Research & Educational Network (SIREN)

Overall PI : Owolabi, M.O.,  Overall Co-PI: Ovbiagele, B. 

The burden of stroke is increasing rapidly in people of African ancestry, but the unique factors contributing to its occurrence, pattern, subtype, and outcome remain poorly understood. SIREN is a multidisciplinary collaborative research network focused on exploring ways to promote a better understanding of the genetic and environmental risk factors for stroke among people of African ancestry. SIREN, which is the largest study of stroke in Africa to date, is comprehensively phenotyping over 3000 case-control pairs (6000 subjects). The findings will then be compared to those in a cohort of African American stroke survivors, all the while simultaneously building sustainable capacities in phenomics, biobanking, genomics, biostatistics and bioinformatics for future high-level investigation of stroke and other vascular disease entities in Africa. SIREN is poised to substantially enhance our understanding of factors that could be addressed to improve stroke outcomes .

Consortium : H3Africa Funding:  U54HG007479   $ 4,236,930   ] Collaborative Center Research Grant from NIH (NINDS and NHGRI), H3 Africa.Countries: Nigeria, Ghana, South Africa, USA, UK Main Institutions: 12 Universities / Research institutions .Products: >50 Publications, 16 Presentations, 1 Patent.

Related ongoing work:

Principal Investigator: Stroke information and Surveillance System Grant. Center for Global Health Pilot Grant, Medical University of South Carolina, USA. 2017 to 2019. $20,000.

Principal Investigator,  Systematic Investigation of Blacks with Stroke using Genomics (SIBS Genomics) R01. NIH . 2018 to 2021. R01NS107900 . >$1, 704, 193.00

Principal Investigator Africa-UK Collaboration for the genetic Epidemiology of Stroke (ACES). Academy of Medical Sciences Global Challenges Research Fund Networking Grant Scheme. GCRFNGR2\10190,   £25,000. 2018 to 2019

Co- Investigator,  African Neurobiobank for Precision Stroke Medicine – (ELSI) Project . NIH . 2018 to 2021. 1U01HG010273 . >$412,588.00

  • Improving neurologic outcome measurement for interventional research in Ibadan

Neurologic  oUtcome Measurement in Research for Intervention and Care (NUMERIC)

PI: Ogunniyi, A. Co-Investigator: Owolabi, M.O.

NUMERIC outlines an innovative research education plan involving a partnership between neurologists and neuroradiologists from the University of Ibadan/University College Hospital in Ibadan and a multidisciplinary team of clinicians and scientists from Northwestern University in Chicago. Overall, this project aims to advance research capabilities to reduce the burden of neurological disease in Nigeria through an educational program that combines methodology for neurological studies and clinical research training opportunities in adult and pediatric neurology. In addition, the research potential of equipment available in a major Nigerian hospital will be scaled up for brain imaging, which can be used for nearly any kind of neurological study. This research educational program is anticipated to yield broad returns in developing capacity to address public health threats to the brain and cognitive function.

Consortium: The Medical Education Partnership Initiative Linked Awards (MEPI)              Funding: MEPI-linked R25 grant .NIH (NINDS).2012-2014

$541, 507          Countries: Nigeria, USA                                 Main Institutions: 2 Universities/Research institutions

  • Ibadan Brain Bank. IbaDAN (Dementia, Ageing and Neurodegeneration) Brain Bank [IBADAN Brain Bank] (CRIM Grant) 1,000,000 million naira .African populations are ageing rapidly with concomitant increase in the prevalence of ageing – associated neurodegenerative disorders. New evidence appears to suggest unique pattern of neuropathology of Neurodegerative disorders in African-Americans with implications for severity and outcome. Barriers to undertaking similar post- mortem neuropathological studies in Nigeria include lack of expertise, facilities and relevant brain tissue due to declining autopsy rate. It is absolutely essential to explore barriers and facilitators of participation in autopsy and brain donation programme among Nigerians in order to establish a successful brain bank programme, and chart a part for the future of neuropathology of neurodegenerative disorders in people of African ancestry.Objectives The broad aim of this study is to determine awareness and willingness to donate brain for research purpose, establish the first brain bank in Africa and evaluate the immunohistochemical features of ageing – associated degenerative Alzheimer pathology in brain tissue from a pilot cohort of adult Nigerians. Expected Outcomes :Important information on the barriers and incentives for post-mortem brain tissue examination in Ibadan, Nigeria will be generated. This should allow for effective engagement and education on the importance of post – mortem brain tissue examination, establish a pilot brain tissue repository, and generate preliminary data on Alzheimer’s neuropathology among Nigerians with the disease.
    • Enhancing Capacity for Stroke Recognition, Documentation, Care and Prevention in Nigeria. Investigators: Akinyemi, R.O., Owolabi, M.O.                                                                                The specific objectives of this project are as follows: i) to build capacity of non – neurologist health workers to recognize, provide early care and take appropriate referral decision for acute stroke patients; ii) to develop an educational programme for community dwelling stroke survivors, their families and/or caregivers to enhance prevention and rehabilitation, and serve as a strategy to reach the general people in the community; and iii) to  develop a model multi-centre stroke registry for effective documentation of cases and collaborative stroke research towards ultimate formulation of evidence-based policies on stroke in Nigeria.

This project is poised to reduce the burden of stroke through prevention, early detection, efficient refferal and appropriate intervention.

Funding: World Federation for Neurology/ World Stroke Organisation. $40,000 Countries: UK, Nigeria Main Institutions: 4 Health Institutions.

SUMMARY OF SOME PUBLICATIONS: CONTRIBUTION TO SCHOLARSHIP  

I have concentrated my research efforts on vascular neurology and neuro-rehabilitation now expanding into community-based genomic epidemiology of stroke and vascular risk factors in Africa and beyond. As a solution to the escalating burden of stroke on the continent I proposed the stroke quadrangle comprising stroke epidemiological surveillance and research network, prevention, acute care and rehabilitation. My contributions to knowledge of stroke epidemiology include the evaluation of risk factors for stroke among Africans. In addition to other factors, we found white matter hyperintensities and increased common carotid diameter to be independent risk factors for stroke among African patients. We are currently pioneering the largest ever study of stroke in Africa examining the genomic and exposomic (environmental) risk factors for stroke type, subtype and outcome among Africans. The knowledge of the established risk factors as well as the new ones we would unravel would be useful in designing stroke prevention programs. Meanwhile, based on the knowledge of barriers and facilitators of risk factor control, obtained from the qualitative phase of the THRIVES study, we have commenced a randomized control trial of a novel multi-pronged intervention to improve the wellbeing of stroke survivors.  We have also commenced community engagement activities to raise awareness about stroke based on our studies which found poor stroke literacy in Ghana and Nigeria.

I am the pioneering Regional Vice-President of the World Federation of Neurorehabilitation, a position which I occupy in recognition of my focus and contributions to neurorehabiltation. I pioneered the development of probably the only holistic stroke-specific health related quality of life instrument. The HRQOLISP is a multiculturally validated QOL measure, available in several languages including Spanish, English, German, Hausa, and Ghanaian languages. It is available as full, 40-item and 26 item versions which have demonstrated good content, construct, known groups and factorial validity; excellent test-retest and internal consistency reliability as well as good responsiveness and sensitivity to change. Application of this tool (in Nigerian, Ghanaian, and German stroke survivors) consistently demonstrated a ‘disability disparity’, with relative sparing of the spiritual sphere and impairment of the domains in the physical sphere to an extent directly proportional to stroke severity in support of the seed of life model. Moreover, we identified stroke severity, disability, emotional disorder and sense of purpose in life as major and cross-culturally consistent determinants of HRQOL after stroke. I proposed the stroke recovery spiral as a composite hypothetical model for development of interventions for stroke patients.

Furthermore, we developed a valid, simple, brief and reliable stroke severity scale (SLS). Utilizing this scale along with other tools, we demonstrated distinct recovery trajectories for mild, moderate and severe stroke over 12 months. We have also demonstrated that daily reinforcement on walking speeds improved outcomes in stroke patients. Similarly, we developed a unique primary health care based physiotherapy intervention which led to improved clinical outcomes in stroke survivors.

My other major contributions include the first description and documentation of the ‘Cervical vertigo tetrad’ as well as the observation of the superior role of aggregate cardiovascular risk factors in the occurrence and severity of diabetic polyneuropathies compared to HbA1c.

A.  Vascular Neurology: The Stroke Quadrangle

Based on earlier published highly acclaimed needs assessment for the African continent , I focused on vascular neurology. As a solution to the escalating burden of stroke on the continent, I proposed the stroke quadranglecomprising stroke epidemiological surveillance and research network, prevention, acute care and rehabilitation. My contributions to knowledge of stroke epidemiology comprised the evaluation of risk factors for stroke among Africans. As part of the INTERSTROKE study, and in the SIREN study we described the ten predominant risk factors with combined population-attributable risk of 90% for stroke globally. Novel risk factors included meat and added salt; while green leafy vegetables demonstrated a very strong protective effect.

We also discovered Interleukin-6 SNP as a risk factor for stroke among male West Africans. Interleukin–6 gene promoter rs1800796 polymorphism is associated with ischemic stroke in men and the relationship is mediated by abnormal waist: hip ratio.( Implication: Inflammatory genes contribute to the neurobiology of ischemic stroke, and the expression of IL-6 may be particularly enhanced in men who have the genetic risk and further develop abdominal obesity). Cyclin dependent kinase inhibitor rs2383207 polymorphism is associated with ischemic stroke among indigenous male West Africans. ( Implication: Presence of this gene in an individual (especially men) may predispose males to ischemic stroke).

We developed and patented ACCESS software for the phenotyping of stroke patients. In a transnational study we found cerebral infarction to be significantly more common in Germany, while in Nigeria, hypertension was more common but cardiac causes, atherosclerosis and cigarrete smoking were less. Furthermore, in another study, we observed that higher blood pressure was more associated with hemorrhagic stroke while previous transient ischemic attacks (TIAs) and older age were the only independent risk factors for ischemic stroke. We concluded that racial disparity in risk factors for stroke may account for the difference in proportions of stroke subtype in black and white populations. We also discovered white matter hyperintensities to be an independent risk factor for stroke among Africans.

Moreover, we were probably the first to report increased common carotid diameter and end diastolic velocity to be the predominant (independent) risk factors for stroke among African hypertensive patients. Indeed, we found carotid intima-media thickness to be an indicator of both cardiovascular phenotype and risk among Africans. These parameters should be explored further as screening tools for stroke among hypertensive patients in hospitals and/or communities. Our novel findings of differential diameter/flow velocity relationship in the cerebral circulation gave an insight into the adaptive processes (including changes in mechano-transduction processes related to arterial wall shear stress) governing vessel diameter and growth, which can be exploited for therapeutic purposes in future.                                                                                                                                                                The complications of stroke are not limited to post-stroke seizures which we characterized, it cut across systems. For instance, we found certain gastroenterological complications to be more common in ischemic stroke. Our findings on risk factors and complications of stroke have assisted us in pioneering the largest ever study of stroke in Africa (SIREN including community engagement core) in the context of a revolutionary genomic epidemiological study (in which I play a leadership role) of cardiovascular diseases in Africa, involving cohort of about 55,000 Africans. The knowledge of the established risk factors as well as the new ones we would unravel would be useful in designing stroke prevention programs. Meanwhile, we have commenced a randomized control trial of a novel customized multi-pronged intervention to improve the wellbeing of stroke survivors (THRIVES).

B.   Other Vascular Neuropidemiology 

My other major novel contribution in the field of vascular neurology include the first description and documentation of the ‘Cervical vertigo tetrad’. Rotational vertebral artery occlusion resulting from cervical spondylosis in the presence of atherosclerosed collateral vessels is a cause of posterior circulation insufficiency manifesting as vertigo. Vascular risk factors do not only affect the brain, causing stroke, they also affect the peripheral nervous system. We documented a U-shaped relationship between body mass index and diabetic peripheral neuropathy (DPN). Moreover, we were probably the first to show that aggregate cardiovascular risk score but not HbA1c was an independent statistical predictor of DPN severity. We therefore recommended that early detection and meticulous control of all cardiovascular risk factors (and not HbA1c alone) is important for the prevention and amelioration of DPN in Africans.                                                                            

 Furthermore, in collaboration with other scientists, we performed a community-based epidemiological study of cardiovascular risk factors which predispose to stroke and peripheral neuropathy.  We observed a high prevalence of obesity and metabolic syndrome among apparently healthy Nigerian traders. We found increased level of leptin in patients with metabolic syndrome, a recognized risk factor for stroke. We also demonstrated that a short-term dietary intervention improved cardiovascular risk, inflammation and oxidative stress indices in Nigerians with metabolic syndrome. In conclusion, in order to reduce the burden of stroke in Africans, the identified risk factors must be controlled. In addition, primordial prevention of stroke would involve the prevention of risk factors of stroke such as obesity, high leptin, and poor dietary habits. 

C.  Neurorehabilitation: Modeling, Instrument Development and Application 

Modeling: Health-related quality of life (HRQOL) measures are used to assess the multifaceted impact of diseases. In addition, the impact of medical interventions must be assessed by psychometrically robust HRQOL measures based on a comprehensive and dynamic model. To develop such a model, the concepts of life, its quality, domains, essence, and purpose must be properly and clearly understood. The correct understanding of these entities is specifically important for patient-centered medicine and has universal implications for all fields of human endeavor. Working from this philosophical perspective (including the development of the seed of life model SOLM), I pioneered the development of probably the only holistic stroke-specific health- related quality of life instrument which assesses the entire spectrum, of HRQOL. The SOLM was based on extensive exploration of the (often neglected) belief systems of stroke patients and reinforced by analysis of the philosophies of Socrates, Plato, Aristotle, Descartes, Spinoza and Leibniz. The model addressed HRQOL and spirituality, which is a very difficult but extremely important issue, seldom addressed in science. The SOLM is an advancement over previous theories (eg Hartmann’s and Scheller’s) of the nature of human beings presenting a dualistic configuration of the human nature comprising the physical and spiritual spheres.     

Instrument: The Health-related quality of life in stroke patients questionnaire (HRQOLISP) as a holistic multiculturally-validated multidimensional measure.  It was developed progressively as full, 40-item and 26 item versions each of which demonstrated good content, construct (convergent and discriminant), known groups and factorial validity; excellent test-retest and internal consistency reliability as well as marked responsiveness and sensitivity to change over 12 months. It was much better than SF-36 for stroke patients in Ibadan as was first documented in a conference proceeding and later in greater details as a full paper. HRQOLISP is available and validated in several languages and cultures including Jamaican, Colombian, Yoruba, Spanish, English, German, Hausa, and Ghanaian languages. Using the HRQOLISP and (later also SF-36), first in Nigeria and later in Germany, we showed that stroke had a multifaceted effect on HRQOL, which was more pronounced in the physical dimension. Furthermore, application of this tool (in Nigerian, Ghanaian, and German stroke survivors) consistently demonstrated a ‘disability disparity’, with relative resilience of the spiritual sphere and decremental impairment of the four concentric domains in the physical sphere to an extent directly proportional to stroke severity in support of the seed of life model. 

D.  Neurorehabilitation: Recovery Factors, Trend and Intervention  Factors: I initially documented that aside from stroke severity and disability, psychosocial factors such as emotional responses and social support determine HRQOL in Nigerian stroke survivors. In addition to these factors, we later identified sense of purpose in life as major and cross-culturally consistent determinants of HRQOL after stroke explaining most of the variance in post-stroke HRQOL. We established this initially using the HRQOLISP (first) and SF-36 (combined) in Ibadan, and subsequently the HRQOLISP in Germany and Ghana. Furthermore, we found depression (more common in women) and cognitive impairment to be the modifiable strong determinants of functional dependency after stroke. I therefore proposed the stroke recovery spiral, a novel therapeutic model targeting these factors, aimed at improving the sense of purpose and meaning in life after stroke, while promoting emotional and physical wellbeing. This model, flowing from the SOLM is a composite hypothetical model for development of interventions for stroke patients.  Perhaps as now ‘is the time to expand the philosophy of rehabilitation and investigate interventions beyond healing the body to healing the spirit’; if we heal the spirit, through the mind we may also heal the body.     

Trend: Furthermore, we developed a simple, brief and time-saving stroke levity scale. It is calculated as maximum power (0–5) in the dexterous hand + maximum power in the weaker lower limb + mobility score)1(if aphasia present). Utilizing this scale along with other tools, we demonstrated distinct recovery trajectories for mild, moderate and severe stroke over 12 months. The observed comparatively poorer outcome in the upper extremity indicates the need for extra rehabilitation strategies to enhance upper-extremity motor recovery in the first year of stroke.                              

Interventions: In a Phase 2 single-blinded multicenter randomized clinical trial, (SIRROWS), we demonstrated that giving daily verbal feedback about performance reinforced walking speed to permit unlimited slow community ambulation at discharge from inpatient rehabilitation in stroke patients. Similarly, we developed a unique primary health care based physiotherapy intervention comprising a synthesis of selected exercises targeted at improving muscle strength in the paretic limbs as a pre-requisite for ambulation activities, restoration of postural balance, gait re-training and functional use of the arm and hand.  This led to improved clinical outcomes in stroke survivors as was demonstrated later in a randomized clinical trial with similar results when delivered at home or in primary health care settings. The concepts of the iterative spiral of neurorehabilitation and the wheel (spectrum) of neurorehabilitation were also presented. These concepts summarize the processes involved in the journey towards the attainment of a meaningful, purposeful, fruitful and prolonged life targeted at rea

E. Other Neurology (Epileptology, Movement disorder, Cognitive neurology); Other Internal Medicine and BioMedical Education

We reported a case (perhaps the first report) of Rasmussen’s encephalitis in a Nigerian girl. I later provided a very comprehensive invited review of Rasmussen’s encephalitis, which has been downloaded over 3,040 times across over 130 countries.  In another study, we observed that in Nigerian patients presenting with late-onset epilepsy (after age of 25 years), seizure as the initial and only symptom of brain tumor was common. Furthermore, we characterized elderly Nigerians  (>60 years) with late onset seizures. We later demonstrated that seizure severity relates to health-related quality of life in an inverse, graded manner and independent of perceived stigma. Seizure-free people with epilepsy had quality of life comparable with healthy individuals.                                                                                                                         We investigated patients with Parkinson’s disease (PD) which is a common neurological condition in our practice. Despite the original description of PD as a disorder in which ‘‘the senses and intellect remain uninjured,’’ we observed that cognitive dysfunction occurs in specific domains more frequently in Nigerians with PD compared to demographically matched controls particularly in those with severe disease. In another study, we found the determinants of HRQOL to be severity and duration of the disease as well as depression. To maximize HRQOL in PD, interventions aimed at mitigating the severity of the disease and reducing depression are therefore needed.                                                                                                                             Other areas covered by my research include cognitive neurology (fronto-temporal dementia, cognitive disorder in patients with stages 3 to 5 chronic kidney disease), spinal tuberculosis, Gélineau syndrome and neuroimmunology.      

As part of other contributions to general medicine, we presented an overview of the aetio-pathogenesis, manifestations, investigations and management of gastroesophageal reflux disease. I augmented the Stanford Faculty Development Program Questionnaire (the most widely used assessment method of clinical teaching) by adding the Teacher’s attitude domain, a pivotal aspect of clinical teaching. This led to improved internal consistency, content, construct and factorial validity.

RESEARCH FOCUS

I have concentrated my research efforts on vascular neurology and neuro-rehabilitation now expanding into community-based genomic epidemiology of stroke and vascular risk factors in Africa and beyond. As a solution to the escalating burden of stroke on the continent I proposed the stroke quadrangle comprising stroke epidemiological surveillance and research network, prevention, acute care and rehabilitation. My contributions to knowledge of stroke epidemiology include the evaluation of risk factors for stroke among Africans. In addition to other factors, we found white matter hyperintensities and increased common carotid diameter to be independent risk factors for stroke among African patients. We are currently pioneering the largest ever study of stroke in Africa examining the genomic and exposomic (environmental) risk factors for stroke type, subtype and outcome among Africans. The knowledge of the established risk factors as well as the new ones we would unravel would be useful in designing stroke prevention programs. Meanwhile, based on the knowledge of barriers and facilitators of risk factor control, obtained from the qualitative phase of the THRIVES study, we have commenced a randomized control trial of a novel multi-pronged intervention to improve the wellbeing of stroke survivors.  We have also commenced community engagement activities to raise awareness about stroke based on our studies which found poor stroke literacy in Ghana and Nigeria.

I am the pioneering regional vice president of the World Federation of Neurorehabilitation, a position which I occupy in recognition of my focus and contributions to neurorehabiltation. I pioneered the development of probably the only holistic stroke-specific health related quality of life instrument. The HRQOLISP is a multiculturally validated QOL measure, available in several languages including Spanish, English, German, Hausa, and Ghanaian languages. It is available as full, 40-item and 26 item versions which have demonstrated good content, construct, known groups and factorial validity; excellent test-retest and internal consistency reliability as well as good responsiveness and sensitivity to change. Application of this tool (in Nigerian, Ghanaian, and German stroke survivors) consistently demonstrated a ‘disability disparity’, with relative sparing of the spiritual sphere and impairment of the domains in the physical sphere to an extent directly proportional to stroke severity in support of the seed of life model. Moreover, we identified stroke severity, disability, emotional disorder and sense of purpose in life as major and cross-culturally consistent determinants of HRQOL after stroke. I proposed the stroke recovery spiral as a composite hypothetical model for development of interventions for stroke patients.

Furthermore, we developed a valid, simple, brief and reliable stroke severity scale (SLS). Utilizing this scale along with other tools, we demonstrated distinct recovery trajectories for mild, moderate and severe stroke over 12 months. We have also demonstrated that daily reinforcement on walking speeds improved outcomes in stroke patients. Similarly, we developed a unique primary health care based physiotherapy intervention which led to improved clinical outcomes in stroke survivors.

My other major contributions include the first description and documentation of the ‘Cervical vertigo tetrad’ as well as the observation of the superior role of aggregate cardiovascular risk factors in the occurrence and severity of diabetic polyneuropathies compared to HbA1c.

Brief Biographical Sketch

Mayowa Ojo OWOLABI MBBS, Cert. Epid.&Glob.Health(Dundee), MSc, Dr.Med(Berlin), MWACP, FMCP, FAAN, FAS, is Professor of Neurology, and Dean, Faculty of Clinical Sciences, University of Ibadan, Nigeria.  He is an innovative scientist with several inventions including the Seed of Life Model; HRQOLISP, a multiculturally-validated quality of life measure for stroke, available in many languages globally in several versions and languages; stroke quadrangle; stroke severity scale; stroke recovery spiral; cervical vertigo tetrad; and implementation cycle . Mayowa Owolabi is among the top Nigerian scientists among the world top 2 per cent scientists.

He is an entrepreneur and scholar with a stroke phenotyping software patent and  over 192 publications in peer reviewed journals including the Lancet, New England Journal of Medicine, Science, his first landmark publication, ‘Mapping Africa’s way into prominence in the field of Neurology’ got the attention of the WFN in 2007. He is an Associate Editor for BMC Neurology, a member of the editorial boards of several high impact neurology journals, reviewer for >20 top journals; and a much-sought-after speaker globally with >104 scientific oral presentations. He has chaired several sessions in the International Stroke Conference and World Congress for Neurorehabiliation among others. He has supervised 8 doctoral theses.

His research covers vascular neurology, neuro-rehabilitation, and genomic epidemiology. He leads two NIH funded grants- SIREN: the largest study of stroke in Africa, >8000 subjects and discovered novel risk factors for stroke on the continent; and THRIVES the first RCT of multipronged intervention to improve BP after stroke in Africa. He is the pioneer Chair of the largest consortium investigating cardiovascular diseases in Africa  with >55 000 subjects.

Prof. Owolabi is a leader par excellence recognised locally and globally. He is the pioneer Regional Vice-President, World Federation of NeuroRehabilitation (sub-Saharan Africa);  a member of the Presidium of the WFNR; Co-Chair, Joint Publication Committee-Global Alliance for Chronic Diseases; Chair and pioneer founder of COUNCIL (Control Unique to CVDs in LMIC) initiative; pioneer Director, Centre for Genomic and Precision Medicine, University of Ibadan; and Lead Co-chair, The Lancet Neurology Commission on Stroke in developing countries established in collaboration with WSO and WHO. He is Pallatucci Advocate of the American Academy of Neurology, a Fellow of the American Academy of Neurology and a Fellow of the Nigerian Academy of Science.

Brief Biographical Sketch

Mayowa Ojo OWOLABI MBBS, Cert. Epid.&Glob.Health(Dundee), MSc, Dr.Med(Berlin), MWACP, FMCP, FAAN, FANA, FAS, is Professor of Neurology, and Dean, Faculty of Clinical Sciences, University of Ibadan, Nigeria.  He is an innovative scientist with several inventions including the Seed of Life Model; HRQOLISP, a multiculturally-validated quality of life measure for stroke, available in many languages globally in several versions and languages; stroke quadrangle; stroke severity scale; stroke recovery spiral; cervical vertigo tetrad; and implementation cycle .

He is an entrepreneur and scholar with a stroke phenotyping software patent and  over 210 publications in peer reviewed journals including the Lancet, New England Journal of Medicine, Science, his first landmark publication, ‘Mapping Africa’s way into prominence in the field of Neurology’ got the attention of the WFN in 2007. He is an Associate Editor for BMC Neurology, a member of the editorial boards of several high impact neurology journals, reviewer for >20 top journals; and a much-sought-after speaker globally with >104 scientific oral presentations. He has chaired several sessions in the International Stroke Conference and World Congress for Neurorehabiliation among others. He has supervised 8 doctoral theses.

His research covers vascular neurology, neuro-rehabilitation, and genomic epidemiology. He leads two NIH funded grants- SIREN: the largest study of stroke in Africa, >8000 subjects and discovered novel risk factors for stroke on the continent; and THRIVES the first RCT of multipronged intervention to improve BP after stroke in Africa. He is the pioneer Chair of the largest consortium investigating cardiovascular diseases in Africa  with >55 000 subjects.

Prof. Owolabi is a leader par excellence recognised locally and globally. He is the pioneer Regional Vice-President, World Federation of NeuroRehabilitation (sub-Saharan Africa);  a member of the Presidium of the WFNR; Co-Chair, Joint Publication Committee-Global Alliance for Chronic Diseases; Chair and pioneer founder of COUNCIL (Control Unique to CVDs in LMIC) initiative; pioneer Director, Centre for Genomic and Precision Medicine, University of Ibadan; and Lead Co-chair, The Lancet Neurology Commission on Stroke in developing countries established in collaboration with WSO and WHO. He is Pallatucci Advocate of the American Academy of Neurology, a Fellow of the American Academy of Neurology and a Fellow of the Nigerian Academy of Science.

Mayowa OWOLABI FAAN, FANA, FAS, is Professor of Neurology, and Dean, Faculty of Clinical Sciences, University of Ibadan, Nigeria.  His clinical and research interests covers cardiovascular diseases, vascular neurology, neuro-rehabilitation, and genomic epidemiology. He is an innovative scientist with several inventions including the Seed of Life Model; HRQOLISP, a multiculturally-validated quality of life measure for stroke, available in many languages globally in several versions and languages; stroke quadrangle; stroke severity scale; stroke recovery spiral; cervical vertigo tetrad; and implementation cycle .

He is the pioneer Regional Vice-President, World Federation of NeuroRehabilitation (sub-Saharan Africa);  a member of the Presidium of the WFNR; Co-Chair, Joint Publication Committee-Global Alliance for Chronic Diseases; Chair and pioneer founder of COUNCIL (Control Unique to CVDs in LMIC) initiative; pioneer Director, Centre for Genomic and Precision Medicine, University of Ibadan; and Lead Co-chair, The Lancet Neurology Commission on Stroke in developing countries established in collaboration with WSO and WHO. He is Pallatucci Advocate of the American Academy of Neurology, a Fellow of the American Academy of Neurology and a Fellow of the Nigerian Academy of Science.

Biographical Information

I am Mayowa Ojo OWOLABI MBBS, Cert. Epid.&Glob.Health(Dundee), MSc, Dr.Med(Berlin), MWACP, FMCP, FAAN, FANA, FAS, a Professor of Neurology and stroke medicine, and Dean-elect Faculty of Clinical Sciences, University of Ibadan, Nigeria, Africa. I have won several awards including the 2011 AU-TWAS Young Scientist National Award & IAMP Young Physician Leaders Award.

I am an innovative scientist with several inventions in stroke medicine including the Seed of Life Model which I used to develop HRQOLISP, a multiculturally-validated quality of life measure for stroke, available in many languages globally; stroke quadrangle; stroke severity scale; stroke recovery spiral; cervical vertigo tetrad; and implementation cycle .

I am an entrepreneur and scholar with a stroke phenotyping software patent and  over 280 publications mostly on stroke in peer reviewed journals including the Lancet, New England Journal of Medicine, Science. I am Associate Editor for BMC Neurology, a member of editorial boards of several high impact neurology journals, reviewer for >20 top journals; and a much-sought-after speaker globally with >110 scientific oral presentations and have supervised 8 doctoral theses.

My research covers vascular neurology, neuro-rehabilitation,  and genomic epidemiology. I lead two NIH funded grants- SIREN: the largest study of stroke in Africa, N>8000 subjects and discovered novel risk factors for stroke on the continent; and THRIVES the first RCT of multipronged intervention to improve BP after stroke in Africa.

I am recognised as a global leader in stroke medicine: the pioneer Regional Vice-President, World Federation of NeuroRehabilitation (sub-Saharan Africa);  member, Presidium, WFNR; Co-Chair, Joint Publication Committee-Global Alliance for Chronic Diseases; pioneer Director, Centre for Genomic and Precision Medicine, University of Ibadan; and Lead Co-chair, The Lancet Neurology Commission on Stroke in collaboration with WSO and WHO. I am a Fellow of the American Academy of Neurology and a Fellow of the Nigerian Academy of Science. I pioneered the establishment of  the First Center for Neurorehabilitation in East West and Central Africa, and I am pioneering the establishment of the African Stroke Organization as Co-Chair of the Steering Committee.

As a member of the WSO Board, I will leverage my extensive professional networks, expertise and productivity, to support the WSO mission to reduce the global burden of stroke through prevention, treatment and rehabilitation. Specifically, I will upscale the activities of the Lancet Neurology Commission, to revolutionize stroke control programs across 130 countries where we have commissioners. We will use the data collected from these countries to develop evidence-based pragmatic recommendations and promote advocacy using the stroke video documentary I co-created.

The 473rd University of Ibadan Inaugural Lecture will be delivered by Professor Mayowa Ojo Owolabi of the Department of Medicine, on behalf of the Faculty of Clinical Sciences.

 Professor Mayowa Owolabi was born on the 17th November, 1973 into the family of Late Pa Clement Ebun and Florence Monisola Owolabi at Aisegba Ekiti. He shares the same birthday with the University of Ibadan. He attended St. Cyprians Primary School, Aisegba Ekiti from 1978 to 1984 and Aisegba Community Secondary School from 1984 to 1988 where he spent only 4 years instead of the 6 years due to double promotions. He was admitted to the University of Ibadan to study Medicine and Surgery in 1989/90. He won the Faculty prize/Undergraduate scholarship, Faculty of Basic Medical Sciences (1990- 1991), Departmental prize in Anatomy (1991/1992) and  May and Baker prize for best student in preclinical Medical School (1991/1992). He graduated with an MBBS degree in 1997 as the best student in Medicine (Departmental Prize, Part IV MBBS exam) and won the Ekpo Eyo prize in Medicine and Radiology.  He was appointed a House Officer at the University College Hospital (UCH) from 1997 to 1998. He later worked as a Medical Officer and a Youth Corper at the General Hospital, Katangora from 1998 to 1999.  He was admitted into the Residency training programme in Neurology in 1999 and subsequently obtained the Fellowship of the National Postgraduate Medical College of Nigeria (NPMCN) in 2002. He had the best result at the National Postgraduate Medical College of Nigeria, FMCP Part I, Faculty of Internal Medicine examination and won the Dr. A.E. Ohwovoriole Endowed Prize for the best candidate in Part II FMCP Exams. He holds a Masters degree (with distinction) in Biomedical Education from the University of Ibadan. He was awarded a doctorate degree in Medicine (Doctor Medicinae) in 2010 by  Charité University of Medicine, Humboldt University, and  Free University, Berlin, Berlin, Germany .

 Professor Owolabi worked briefly as a Consultant Neurologist at the Federal Medical Centre, Abeokuta and joined the Department of Medicine, College of Medicine, University of Ibadan in 2006 as a Lecturer grade 1. He was appointed Honorary Consultant Neurologist, at the University College Hospital, Ibadan in 2006. He was promoted Senior Lecturer in 2009 and Professor of Neurology in 2014.

 He has served the University in several capacities, he was Sub-Dean (Postgraduate), Faculty of Clinical Sciences, 2012 to 2014; Congregation Representative to Senate, University of Ibadan;  pioneer Director, Centre for Genomic and Precision Medicine, University of Ibadan in 2016.  Professor Mayowa Owolabi was elected Dean of the Faculty of Clinical Sciences, University of Ibadan from 2018 till date. 

Professor Owolabi is a recipient of several international awards. He was awarded the DAAD Research Scholar and Clinical Fellow at the Department of Neurology, Charité Germany in 2004. He won the 2011 AU-TWAS Young Scientist National Award; the Interacademy Medical Panel (IAMP) International Award for Young Physician Leaders in 2011; the American Academy of Neurology Palatucci Advocacy Leadership Award in 2012; and the World Congress for Neurorehabilitation (WCNR) Early Career Development Award in 2012.

 Professor Owolabi holds the Fellowship of several bodies including the American Academy of Neurology; the Academy of Science (Nigeria); the American Neurological Association; and the Royal College of Physicians (London).

 As a co-investigator/principal investigator, he has led two National Institutes of Health (NIH) funded grants – the Stroke Investigative Research and Education Network (SIREN) which is the largest study of stroke in Africa with over 10,000 subjects with ground-breaking discovery of novel risk factors for stroke on the African continent; the Tailored Hospital-based Research to impede Vascular Events after Stroke (THRIVES) which was the first randomized control trial (RCT) of multipronged intervention to improve blood pressure after stroke in Africa.

Currently, he is the Principal Investigator of the Systemic Investigation of Blacks with Stroke using genomics (SIBS-Genomics), SIBS Gen-Gen; co-investigator of the African Neurobiobank for Precision Stroke Medicine – (ELSI) Project); Mentor  of the African Academy of Sciences -Royal Society and Global Challenges Research Fund (FLAIR grant), and key investigator in the first study aimed at unravelling the contributions of copy number variations to stroke occurrence (CaNVAS study). He is also co-investigator on several grants.

 Professor Owolabi is an innovative scientist with several inventions in stroke medicine including the Seed of Life Model which he used to develop HRQOLISP, a multiculturally-validated quality of life measure for stroke, available in many languages globally; stroke quadrangle; stroke severity scale; stroke recovery spiral; cervical vertigo tetrad; and implementation cycle. He is indeed an entrepreneur and scholar with a stroke phenotyping software patent duly registered and certified by the Federal Government of Nigeria. He is an Associate Editor for BMC Neurology, a member of editorial boards of several high impact neurology journals, reviewer for numerous top journals including The Lancet; reviewer for many International Grant awarding institutions, and a much-sought-after speaker globally with over 120 scientific oral presentations.

He is a recognised global leader in stroke medicine. He is Regional Vice-President, World Federation of NeuroRehabilitation, WFNR (sub-Saharan Africa) and pioneer of the First Center for Neurorehabilitation in East West and Central Africa; Regional Director World Hypertension League (Sub-Saharan Africa),  pioneering member of the Steering Committee and Co-chair of the African Stroke Organization; Presidium member, WFNR; Co-Chair, Joint Publication Committee-Global Alliance for Chronic Diseases; pioneer Director, Centre for Genomic and Precision Medicine, University of Ibadan; and Lead Co-chair, The WHO/WSO Lancet Neurology Commission on Stroke among others.

Professor Mayowa Owolabi has mentored and supervised many undergraduates and postgraduate trainees including over 30 residents and have supervised 8 doctoral theses to completion. He is widely published with over 280 publications mostly on stroke in peer reviewed journals including the Lancet, New England Journal of Medicine, Science etc.  He has a Google scholar citation of 40,386 and Google Scholar h-index: 58.

 Professor  Mayowa Owolabi is a devoted Christian. He is married to Mrs. Bose Christianah Owolabi and the marriage is blessed with two wonderful children, Ayomide and Dayo.

I now invite Professor Mayowa OWOLABI to present his lecture titled “EXPLORING THE STROKE QUADRANGLE THROUGH THE TRANSOMIC AND SPIRITUAL BINOCULARS: TWO WINGS OF AN EAGLE”

Brief Biographical Sketch

Mayowa Ojo OWOLABI MBBS, Cert. Epid.&Glob.Health(Dundee), MSc, Dr.Med(Berlin), FMCP, FAAN, FRCP, FAS, is Professor of Neurology, and Dean, Faculty of Clinical Sciences, University of Ibadan, Nigeria.  He is an innovative scientist with several inventions including the Seed of Life Model; HRQOLISP, a multiculturally-validated quality of life measure for stroke, available in many languages globally in several versions and languages; stroke quadrangle; stroke severity scale; stroke recovery spiral; cervical vertigo tetrad; and implementation cycle .

He is an entrepreneur and scholar with a stroke phenotyping software patent and  over 280 publications in peer reviewed journals including the Lancet, New England Journal of Medicine, Science,. He is an Associate Editor for BMC Neurology, a member of the editorial boards of several high impact neurology journals, reviewer for >40 top journals; and a much-sought-after speaker globally with >120 scientific oral presentations. He has chaired several sessions in the International Stroke Conference and World Congress for Neurorehabiliation among others. He has supervised 8 doctoral theses.

His research covers vascular neurology, neuro-rehabilitation, and genomic epidemiology. He leads two NIH funded grants- SIREN: the largest study of stroke in Africa, >8000 subjects and discovered novel risk factors for stroke on the continent; and THRIVES the first RCT of multipronged intervention to improve BP after stroke in Africa. He is the pioneer Chair of the largest consortium investigating cardiovascular diseases in Africa  with >55 000 subjects.

Prof. Owolabi is a leader par excellence recognized locally and globally. He is the pioneer Regional Vice-President, World Federation of NeuroRehabilitation (sub-Saharan Africa);  a member of the Presidium of the WFNR; member , Board of Directors, World Hypertension League, African Regional Office Director, World Hypertension League, Co-Chair, Joint Publication Committee-Global Alliance for Chronic Diseases; Chair and pioneer founder of COUNCIL (Control Unique to CVDs in LMIC) initiative; pioneer Director, Centre for Genomic and Precision Medicine, University of Ibadan; and Lead Co-chair, WHO- World Stroke Organization- Lancet Neurology Commission on Stroke established in collaboration with WSO and WHO. He is a Fellow of the American Academy of Neurology and a Fellow of the Nigerian Academy of Science.

Brief Biographical Sketch

Mayowa Ojo OWOLABI MBBS, MSc, Dr.M, MD, FMCP, FAAN, FANA, FRCP, FAS is Professor of Neurology, and Dean, Faculty of Clinical Sciences, University of Ibadan, Nigeria.  He is an innovative scientist with several inventions/innovations including the Seed of Life Model; HRQOLISP, a multiculturally-validated quality of life measure for stroke, available in many languages globally in several versions and languages; stroke quadrangle; stroke severity scale; stroke recovery spiral; cervical vertigo tetrad; and implementation cycle .

He is an entrepreneur and scholar with a stroke phenotyping software patent and  over 280 publications in peer reviewed journals including the Lancet, New England Journal of Medicine, Science,. He is an Associate Editor for BMC Neurology, a member of the editorial boards of several high impact neurology journals, reviewer for >40 top journals; and a much-sought-after speaker globally with >120 scientific oral presentations. He has chaired several sessions in the International Stroke Conference and World Congress for Neurorehabiliation among others. He has supervised 8 doctoral theses.

His research covers vascular neurology, neuro-rehabilitation, and genomic epidemiology. He leads two NIH funded grants- SIREN: the largest study of stroke in Africa, >8000 subjects and discovered novel risk factors for stroke on the continent; and THRIVES the first RCT of multipronged intervention to improve BP after stroke in Africa. He is the pioneer Chair of the largest consortium investigating cardiovascular diseases in Africa  with >55 000 subjects. Currently, he is the Principal Investigator of the African Rigorous Innovative Stroke Epidemiological Surveillance (ARISES), Systemic Investigation of Blacks with Stroke using genomics (SIBS-Genomics), Mentor  of the African Academy of Sciences -Royal Society and  Global Challenges Research Fund (FLAIR grant). He is Director, University of Ibadan Hub, African Research Universities Alliance, Center of Excellence for NCDs.

Prof. Owolabi is a leader par excellence recognized locally and globally. He is the pioneer Regional Vice-President, World Federation of NeuroRehabilitation (sub-Saharan Africa);  a member of the Presidium of the WFNR; member , Board of Directors, World Hypertension League, African Regional Office Director, World Hypertension League, Co-Chair, Joint Publication Committee-Global Alliance for Chronic Diseases; Chair and pioneer founder of COUNCIL (Control Unique to CVDs in LMIC) initiative; pioneer Director, Centre for Genomic and Precision Medicine, University of Ibadan; and Lead Co-chair, WHO- World Stroke Organization- Lancet Neurology Commission on Stroke established in collaboration with WSO and WHO. He is a Fellow of the American Academy of Neurology , Royal College of Physicians and  the Nigerian Academy of Science.

List of some of my published work (out of over 280 publications) available at ResearchGate

https://www.researchgate.net/profile/Mayowa_Owolabi/3

https://www.ncbi.nlm.nih.gov/sites/myncbi/mayowa.owolabi.1/bibliography/46357736/public/?sort=date&direction=ascending.

https://scholar.google.com/citations?user=76K2iYgAAAAJ&hl=en